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Minimising	risk	and	improving	the	management	of	colonoscopic	adverse	
events	
	
	
	
Abstract	
	
Introduction	Colonoscopy	is	the	gold	standard	screening	tool	for	colorectal	cancer	and	is	used	as	 such	 in	 the	 English	 National	 Health	 Service	 Bowel	 Cancer	 Screening	Programme	(NHSBCSP).	It	does,	however,	carry	a	risk	of	adverse	events	that	may	compromise	patient	 safety	 and	 the	 integrity	 of	 the	 screening	programme.	This	thesis	examined	the	colonoscopic	adverse	events	perforation,	post	polypectomy	bleeding	(PPB)	and	post	colonoscopy	colorectal	cancer	(PCCRC)	in	the	NHSBSCP.		
	
Aims	&	Methods	1.	Determine	the	frequency	of	perforation,	PPB	and	PCCRC	in	the	NHSBCSP.	2.	Determine	the	impact	of	perforation	and	PPB	on	patients	and	colonoscopists.	3.	Identify	risk	factors	for	perforation	so	that	its	risk	can	be	minimised.	4.	 Improve	 the	 management	 of	 perforation	 and	 PPB	 to	 improve	 patient	outcomes.		
	To	 achieve	 the	 aims	 of	 this	 thesis	 I	 used	mixed	methodology	 comprising	 both	quantitative	and	qualitative	health	research	methods.	
	
Results	The	 frequency	 of	 the	 colonoscopic	 adverse	 events	 studied	 was	 0.06%	 for	perforation	and	0.44%	for	post	polypectomy	bleeding.	
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Perforation	 led	 to	 hospital	 admission	 in	 98.7%	 of	 patients,	 with	 53.9%	 of	admissions	 having	 surgery	 and	 26.1%	 of	 admissions	 leaving	 hospital	 with	 a	stoma.	Only	perforations	that	had	surgery	developed	post	perforation	morbidity	and	were	admitted	to	intensive	care.		Perforation	has	a	profound	psychological	impact	on	the	colonoscopist	involving	four	stages	of	reaction.	Risk	factors	for	perforation	include	time	pressure,	colonoscopist	fatigue,	a	longer	procedure	than	the	colonoscopist	expected	and	equipment	failure.		PPB	 led	 to	 hospital	 admission	 in	 64.7%	 of	 patients	 studied	 with	 27.9%	 of	patients	studied	having	a	repeat	endoscopic	examination.	1.47%	of	the	patients	with	PPB	studied	had	surgery	and	1.47%	of	 the	patients	with	PPB	studied	had	radiological	intervention.			
	
	
Conclusions	
	1.	 The	 rates	 of	 perforation	 and	 PPB	 in	 the	 NHSBCSP	 are	 in	 line	 with	 other	similarly	sized	studies	reported	globally.	The	robust	system	for	capturing	details	of	 perforation	 and	 PPB	 in	 the	 NHS	 BCSP	 suggest	 the	 rates	 reported	 in	 these	studies	accurately	reflect	their	true	rate.	2.	 Perforation	 leads	 to	 hospital	 admission	 in	 nearly	 all	 patients.	 Of	 those	perforations	admitted	to	hospital,	surgery	occurred	in	approximately	a	half,	with	stoma	 formation	 in	 approximately	 a	quarter	 and	post	perforation	morbidity	 in	approximately	one	fifth.			3.	PPB	leads	to	hospital	admission	in	approximately	two	thirds	of	patients.	Over	half	of	the	Post	Polypectomy	Bleeds	are	of	minor	severity	
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4.	Colonoscopists	should	be	aware	that	time	pressure,	colonoscopist	fatigue,	a	longer	procedure	than	the	colonoscopist	expected	and	equipment	failure		may	be	associated	with	perforation.	
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Chapter	1			
	
Introduction		Patient	 safety	 is	one	of	 the	primary	concerns	 for	all	 those	who	are	 involved	 in	healthcare1.	This	is	particularly	the	case	in	the	setting	of	a	screening	programme	where	 people	 have	not	 initially	 sought	medical	 attention	 for	 the	 disorder	 they	are	being	screened	for.			Since	its	introduction	into	clinical	practice,	colonoscopy	has	played	an	increasing	role	in	the	diagnosis,	management	and	screening	of	colorectal	disease2.	It	is	now	the	gold	standard	screening	tool	for	colorectal	cancer	and	is	used	as	such	in	the	English	 National	 Health	 Service	 (NHS)	 Bowel	 Cancer	 Screening	 Programme	(BCSP)3.	As	uptake	into	the	BCSP	increases	and	the	demand	for	colonoscopy	as	a	diagnostic	 and	 therapeutic	 tool	 increases,	 the	 need	 for	 colonoscopy	 and	colonoscopists	is	likely	to	increase	further.		Colonoscopy	 is	 considered	 a	 safe	 procedure	 and	 has	 been	 beneficial	 in	 the	diagnosis,	 treatment	 and	 screening	 of	 many	 people	 with	 colorectal	 disease.	However,	it	will	always	carry	a	risk	of	events	that	may	compromise	the	safety	of	patients.	Such	events,	in	healthcare,	are	termed	‘adverse	events’;	in	the	context	of	a	 colonoscopy,	 these	 events	 are	 called	 ‘colonoscopic	 adverse	 events’.	 A	colonoscopic	 adverse	 event	 may	 be	 defined	 as	 an	 ‘event	 that	 prevents	completion	 of	 a	 planned	 procedure,	 excluding	 technical	 failure	 or	 bowel	preparation,	 or	 results	 in	 admission	 to	 or	 prolongation	 of	 an	 existing	 hospital	
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stay,	 subsequent	 medical	 consultation	 or	 another	 procedure	 which	 may	 be	endoscopic,	radiological	or	surgical’4.			Colonoscopic	 adverse	 events	 may	 occur	 at	 any	 point	 from	 the	 start	 of	preparation	for	a	colonoscopy	to	days	or	even	weeks	following	completion	of	the	procedure.	Potential	adverse	events	are	numerous	and	relate	to	the	many	facets	of	having	a	complete	colonoscopy.	The	potential	for	a	patient	to	have	an	adverse	event	 starts	 with	 the	 bowel	 preparation	 required.	 	 Cardiopulmonary	 adverse	events	may	occur	following	the	use	of	analgesia	and	sedative	medication	given	to	patients	in	the	endoscopy	room.	Therapy	performed	during	a	colonoscopy,	such	as	 a	 polypectomy,	may	be	 associated	with	 an	 adverse	 event,	 for	 example,	 post	polypectomy	electrocoagulation	syndrome5.			However,	 it	 is	 colonoscopic	 perforation	 and	 post	 polypectomy	 bleeding	 (PPB)	that	are	the	most	serious	adverse	events.	They	have	been	associated	with	patient	morbidity	 and	 mortality6.	 I	 proposed	 that	 post	 colonoscopy	 colorectal	 cancer	(PCCRC)	can	also	be	 included	within	 the	definition	of	an	adverse	event.	A	post	colonoscopy	 colorectal	 cancer,	 by	 definition,	 results	 in	 subsequent	 medical	consultation	and/or	another	procedure	that	may	be	endoscopic,	radiological	or	surgical.	All	three	of	these	adverse	events	potentially	pose	the	greatest	threat	to	the	safety	of	people	who	take	part	in	colorectal	cancer	screening	as	they	all	have	the	potential	to	result	in	patient	death.		This	thesis	examined	these	three	colonoscopic	adverse	events	in	the	English	NHS	BCSP.	This	 examination	 comprised	 several	distinct	 themes.	 Initially,	 I	 aimed	 to	
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determine	 how	 often	 these	 events	 occurred	 to	members	 of	 the	 English	 public	who	 accept	 the	 invitation	 to	 have	 a	 colonoscopy	 in	 the	 NHS	 BCSP.	 It	 then	explored	the	impact	of	these	adverse	events,	not	only	on	the	patients	within	the	programme,	 but	 also	 on	 the	 health	 care	 professionals	 who	 perform	 the	colonoscopies.			I	 then	 intended	 to	 identify	 risk	 factors	 for	 these	 adverse	 events	 with	 the	intention	 that	 such	 risk	 factors	 could	potentially	 be	 removed	 from	 subsequent	practice.	 Despite	 the	 identification	 of	 risk	 factors	 these	 adverse	 events	 may	continue	 to	 occur.	 It	 is	 therefore	 imperative	 that	 those	 patients	 who	 suffer	should	be	assessed	and	managed	to	the	best	possible	standard	so	that	they	have	the	 best	 possible	 outcomes.	 A	 further	 intention	 of	 writing	 this	 thesis	 was	 to	provide	 an	 evidence	 base	 of	 how	 to	 ensure	 patients	 have	 the	 best	 possible	outcomes.		Work	 has	 appropriately	 focused	 on	 patients	 who	 have	 been	 subject	 to	colonoscopic	 adverse	 events.	 However,	 it	 is	 important	 to	 recognise	 that	 the	association	 with	 an	 adverse	 event	 may	 also	 affect	 the	 colonoscopist.	Furthermore,	 the	 adverse	 event	 may	 be	 to	 the	 detriment	 of	 their	 subsequent	colonoscopic	practice.		This	 thesis	 also	 planned	 to	 provide	 a	 reference	 point	 that	 all	 colonoscopists	could	use	and	relate	to	should	they	encounter	an	adverse	event	associated	with	a	colonoscopy	they	perform	in	the	future.		
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Combining	 these	 themes	 and	 the	 research	 studies	 in	 this	 thesis	 I	 aimed	 to	provide	 an	 evidence	 base	 to	 minimise	 risk	 and	 improve	 the	 management	 of	colonoscopic	 adverse	 events.	 By	 establishing	 this	 evidence	 base,	 I	 intended	 to	improve	patient	safety	surrounding	colonoscopy.		
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Chapter	2	
	
Literature	review	
	
2.1	Strategy	for	literature	review	
	The	aims	of	this	literature	review	were	to:		1.	 Provide	 an	 overview	 of	 the	 current	 use	 of	 colonoscopy	 in	 screening	programmes	 for	 colorectal	 cancer	 and	 the	 benefits	 that	 such	 screening	programmes	confer.	2.	To	explain	the	potential	adverse	events	that	are	associated	with	colonoscopy	and	how	they	are	classified.	3.	 Provide	 a	 detailed	 overview	of	 the	 colonoscopic	 adverse	 events	 perforation,	post	polypectomy	bleeding	and	post	colonoscopy	colorectal	cancer.	4.	Critically	review	the	available	literature	covering	the	definition,	incidence,	risk	factors,	 presentation,	 management	 and	 prognosis	 of	 perforation,	 post	polypectomy	bleeding	and	post	colonoscopy	colorectal	cancer.	5.	 Explore	 the	 potential	 reaction	 of	 a	 colonoscopist	 to	 an	 adverse	 event	 by	reviewing	 the	 available	 literature	 on	 the	 reaction	 of	 other	 health	 care	professionals	to	adverse	events	in	the	health	care	setting.		The	literature	review	is	a	comprehensive	review	of	the	most	up	to	date,	globally	published	 literature	 on	 these	 topics.	 When	 I	 reviewed	 the	 incidence	 of	 these	adverse	events,	I	provided	a	historical	perspective	over	time.	
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	Online	 literature	 searches	 were	 performed	 using	 PubMed	(http://www.ncbi.nlm.nih.gov/pubmed),	 NHS	 Evidence	(https://www.evidence.nhs.uk/about-evidence-services/journals-and-databases)	and	the	electronic	journal	resource	of	the	Durham	University	Library.	Personal	 membership	 of	 the	 British	 Society	 of	 Gastroenterology	 and	 the	American	 Society	 of	 Gastrointestinal	 Endoscopy	 allowed	 literature	 searches	 in	Gut	 online	 (http://gut.bmj.com)	 and	 Gastrointestinal	 Endoscopy	(http://www.giejournal.org).		A	 review	 of	 literature	 should	 take	 place	 according	 to	 guidelines	 such	 as	 those	published	 in	 the	 ‘Preferred	 Reporting	 Items	 for	 Systematic	 Reviews	 and	Meta	Analyses’	 (PRISMA)	 statement	 published	 in	 2009.	 The	 PRISMA	 statement	 was	extensively	 published	 in	 order	 to	 encourage	 its	 widespread	 use	 following	 sub	optimal	reporting	of	meta	analyses7.			The	PRISMA	statement	consists	of	a	checklist	and	flow	diagram,	which	are	used	in	conjunction	with	an	explanation	and	elaboration	document.	Checklist	items	to	cover	 when	 reviewing	 literature	 are:	 (a)	 the	 abstract	 includes	 a	 structured	summary	 (b)	 the	 introduction	 includes	 the	 rationale	 and	 objectives	 (c)	 the	methods	 section	 includes	 the	 protocol,	 eligibility	 criteria,	 information	 sources,	search	strategy,	process	for	selecting	studies,	data	collection	process,	data	items,	risk	of	bias,	summary	measures,	synthesis	of	results,	risk	of	bias	across	studies	and	 additional	 analyses	 (d)	 the	 results	 include	 the	 study	 selection,	 study	characteristics,	risk	of	bias	within	studies,	results	of	individual	studies,	synthesis	
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of	results,	 risk	of	bias	across	studies	and	additional	analyses	(e)	 the	discussion	includes	 a	 summary	of	 evidence,	 limitations,	 conclusions	 and	 (f)	 that	 a	 section	relating	to	describing	sources	of	funding	is	included8.			The	 PRISMA	 flow	 diagram	 records	 the	 number	 of	 studies	 that	 are	 identified	through	 database	 searching	 and	 other	 sources	 then	 the	 number	 of	 duplicate	studies	that	are	removed.	This	process	is	termed	‘identification’.	‘Screening’	then	follows	 by	 documenting	 the	 number	 of	 records	 screened	 and	 excluded.	 The	number	of	full	text	articles	assessed	for	eligibility	and	number	of	full	text	articles	excluded	 with	 reasons	 is	 then	 documented	 during	 the	 phase	 of	 ‘eligibility’.	Finally,	 the	 number	 of	 studies	 then	 included	 in	 the	 qualitative	 synthesis	 is	recorded7.		
2.2	The	adenoma	to	carcinoma	sequence		The	 development	 of	 screening	 programmes	 for	 colorectal	 cancer	 such	 as	 the	English	National	Health	Service	Bowel	Cancer	Screening	Programme	is	based	on	the	 fact	 that	 colorectal	 cancer	 has	 a	 detectable	 early	 pre	malignant	 stage.	 The	majority	 of	 colorectal	 cancers	 develop	 from	 pre	 cancerous	 polyps	 called	adenomas.	 The	 development	 of	 pre	 cancerous	 polyps	 to	 colorectal	 cancers	 is	commonly	 referred	 to	 as	 the	 adenoma	 to	 carcinoma	 sequence.	 The	 term	describes	the	stages	of	progression	from	normal	colonic	mucosa	to	adenoma	to	cancer.	Evidence	 for	 the	adenoma	carcinoma	sequence	 is	 taken	 indirectly	 from	epidemiological,	histopathological,	clinical	and	genetic	data.		
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The	prevalence	of	both	adenomas	and	carcinomas	has	been	reported	to	increase	with	increasing	age.	Muto	et	al.	reported	how	those	patients	who	have	adenomas	were	approximately	5	years	younger	than	patients	with	cancers9.	Observational	studies	of	polyps	left	in	situ,	before	polypectomy	took	place,	reported	both	polyp	growth	and	cancer	development	at	the	colorectal	 location	where	the	polyp	was	observed10.			Histopathological	 studies	 have	 shown	how	both	 cancer	may	be	 present	within	adenomatous	 tissue	 and	 vice	 versa.	 Muto	 et	 al.	 also	 found	 that	 adenomatous	tissue	 was	 present	 in	 14.2%	 of	 colorectal	 cancers9.	 In	 addition,	 the	 degree	 of	adenomatous	tissue	has	been	shown	to	be	related	to	the	stage	of	the	cancer	with	adenomatous	 remnants	 found	 in	 57-60%	 of	 cancer	 limited	 to	 the	 submucosal	layer	but	in	only	7-17%	of	cancers	with	extramural	spread11	12.	This	suggests	as	the	cancer	grows	adenomatous	tissue	is	replaced	by	the	cancer.			Clinical	 studies	have	 shown	how	 the	 colorectal	 location	of	 both	 adenomas	 and	colorectal	 cancers	 is	 similar	 with	 most	 being	 left	 sided.	 Adenomas	 of	 the	 left	colon	 are	 also	 more	 likely	 to	 contain	 invasive	 adenocarcinoma	 or	 severe	dysplasia.	 Eide	 et	 al	 reported	 how	 those	 patients	 with	 colorectal	 cancers	 will	have	 adenomas	 elsewhere	 in	 the	 colon	 at	 diagnosis11.	 Granqvist	 et	 al.	 showed	how	the	distribution	of	cancers	and	adenomas	in	the	colon	was	similar13.	More	recently	 the	 incidence	 of	 colorectal	 cancer	 has	 also	 been	 shown	 to	 fall	 by	breaking	 the	 adenoma	 –	 carcinoma	 sequence	 through	 colorectal	 cancer	screening	using	colonoscopy	and	polypectomy14.				
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Vogelstein	 et	 al.	 proposed	 a	 genetic	 model	 for	 the	 adenoma	 to	 carcinoma	sequence	in	198815.	The	genes	involved	in	genetic	alterations	include	oncogenes,	tumour	suppressor	genes	and	DNA	repair	genes.	Genes	involved	in	the	adenoma	to	carcinoma	sequence	include	inactivation	of	the	APC	tumour	suppressor	gene,	K-ras	oncogene	mutation	and	inactivation	of	p53	16	17	18.			
	
2.3	Screening	programmes	for	colorectal	cancer	
	Each	 year	 150,000	 European	 citizens	 die	 from	 colorectal	 cancer,	 known	colloquially	as	bowel	cancer19.	The	United	Kingdom	accounts	for	16,000	of	these	cases.	 Only	 lung	 cancer	 results	 in	 a	 higher	 annual	 death	 rate	 in	 the	 United	Kingdom	and	in	Europe20.			Despite	recent	advances	in	the	diagnosis	and	treatment	of	colorectal	cancer,	 its	mortality	is	not	declining.	Reducing	its	mortality	rate	is	dependent	on	the	early	detection	of	 the	cancer	before	 it	has	 the	opportunity	 to	cause	symptoms	 in	 the	individual	if	affects19.	Individuals	diagnosed	with	a	colorectal	cancer	earlier	in	its	development	have	been	shown	to	have	a	much	higher	rate	of	survival	than	those	who	are	diagnosed	when	the	cancer	is	more	advanced21.	It	is	for	these	reasons,	in	addition	to	the	fact	that	colorectal	cancer	fulfils	all	of	the	criteria	for	a	screening	programme	 established	 by	 Junger	 and	 Wilson	 in	 1968,	 that	 many	 countries	across	the	world	have	adopted	a	screening	programme	for	colorectal	cancer22.		The	 Faecal	 Occult	 Blood	 Test	 (FOBT)	 is	 the	 most	 widely	 used	 and	 studied	primary	screening	investigation.	It	was	initially	recommended	as	such	following	
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the	 research	 of	 the	 American	 physician,	 DH	 Greegor,	 which	 was	 published	 in	197123.	 Two	 different	 types	 of	 FOBT	 are	 now	 used.	 The	 guaiac	 test	 (gFOBT),	proposed	by	Greegor,	is	based	on	the	response	of	guaiac	resin	to	the	peroxidase	activity	of	haemoglobin.	The	immunochemical	test	detects	the	globin	protein	of	human	haemoglobin19.		Screening	 for	 colorectal	 cancer	 with	 the	 FOBT	 has	 been	 shown	 to	 reduce	colorectal	 cancer	mortality.	A	 systematic	 review	of	 colorectal	 cancer	 screening	using	the	FOBT,	including	four	randomised	controlled	trials,	showed	that	the	test	resulted	 in	 a	 16%	 relative	 risk	 reduction	 in	 colorectal	 cancer	mortality.	When	adjusted	 for	 screening	 attendance	 in	 the	 individual	 studies,	 there	 was	 a	 25%	relative	risk	reduction	for	those	attending	at	least	one	round	of	screening	using	the	FOBT24.	In	addition	to	the	reduction	in	mortality,	bowel	cancer	screening	has	also	 been	 shown	 to	 be	 cost	 effective.	 Economic	 analyses	 suggested	 a	 quality	adjusted	life	year	gained	of	<£3000	for	guaiac	based	FOBT	screening20.		Germany	 first	 introduced	 a	 FOBT	 based	 screening	 programme	 for	 colorectal	cancer	 in	 197619.	 By	 2009,	 screening	 programmes	 were	 planned	 or	 fully	functional	 in	 19	 of	 27	 European	 countries.	 Such	 programmes	 vary	 in	 their	methodology;	 in	data	collected	 from	2007,	guaiac	based	FOBT	was	used	as	 the	primary	screening	test	in	12	European	countries	including	England25.			By	 2007,	 colonoscopy	was	 the	 only	 screening	 test	 being	 used	 in	 Poland	 in	 an	opportunistic	 nationwide	 program	 although	 roll	 out	 of	 the	 program	 was	 on	going.	In	Austria,	Cyprus,	Germany,	Greece	and	the	Slovak	Republic	guaiac	based	
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FOBT	was	used	with	 colonoscopy	while	 Italy	 used	 immunochemical	 FOBT	and	Flexible	 Sigmoidoscopy25.	 Colonoscopy	 is	 also	offered	opportunistically	 in	 Italy	to	those	aged	45	years	or	over19.		The	English	National	Health	Service	(NHS)	Bowel	Cancer	Screening	Programme	(BCSP)	 commenced	 in	 2006,	 with	 the	 programme	 being	 fully	 functional	 by	January	 2010.	 	 All	 members	 of	 the	 English	 public	 registered	 with	 a	 general	practitioner	are	invited	to	take	part	using	a	gFOBT	around	the	time	of	their	60th	birthday.	 For	 those	with	 a	 negative	 gFOBT,	 the	 invitation	 to	 repeat	 the	 test	 is	made	every	two	years	until	the	age	of	74	years20.	Those	with	an	abnormal	gFOBT	are	advised	of	the	need	for	a	secondary	screening	investigation	in	order	to	reach	a	 diagnosis.	 This	 investigation	will	 usually	 be	 a	 colonoscopy.	All	 colonoscopies	are	 performed	 at	 Joint	 Advisory	 Group	 (JAG)	 on	 Gastrointestinal	 Endoscopy	approved	 screening	 centres	 by	 screening	 accredited	 colonoscopists	 who	 have	undertaken	both	written	and	practical	assessment20.		Two	years	into	the	BCSP	in	England,	18,135	people	had	undergone	colonoscopy.	Of	these,	1,772	were	diagnosed	with	a	colorectal	cancer.	12%	of	men	and	6.2%	of	women	were	found	to	have	high	risk	colorectal	adenomatous	polyps	and	invited	for	a	further	surveillance	colonoscopy	one	year	later.	19.3%	of	men	and	14.6%	of	women	had	 intermediate	risk	polyps	and	were	 therefore	offered	a	surveillance	colonoscopy	 three	 years	 later.	 Overall,	 further	 treatment	 or	 investigation	 was	required	 in	43%	of	men	and	29%	of	women	investigated20.	 In	March	2013,	 the	English	NHS	BCSP	piloted	flexible	sigmoidoscopy	as	a	primary	screening	tool	to	all	persons	around	the	time	of	their	55th	birthday.		
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	In	Germany,	a	screening	colonoscopy	is	available	to	all	insured	persons	from	the	age	 of	 55	 onwards.	 4.2	 million	 people	 had	 undergone	 colonoscopy	 by	 2010.	These	screening	colonoscopies	detected	adenomas	in	30.1%	of	men	and	19.1%	of	 women.	 Advanced	 adenomas	 were	 recorded	 in	 9%	 of	 men	 and	 5.1%	 of	women,	 while	 colorectal	 cancer	 was	 detected	 in	 1.4%	 of	 men	 and	 0.8%	 of	women19.			Of	 those	 countries	 within	 the	 European	 Union,	 in	 addition	 to	 England,	 using	FOBT	as	a	primary	screening	investigation,	17,813	screening	colonoscopies	were	carried	out	in	the	Czech	Republic	as	a	result	of	positive	FOBT	between	2006	and	2008.	A	carcinoma	was	diagnosed	during	colonoscopy	in	5.9%	and	adenomas	in	30.1%	of	people	examined.	In	three	rounds	of	screening	colonoscopy	in	Finland	between	2004	and	2011	involving	345,283	citizens,	colorectal	cancer	was	found	in	 three	 to	 four	 per	 cent	 of	 females	 and	 three	 to	 five	 per	 cent	 of	 males	 with	adenomas	found	in	18-24%	of	females	and	29-35%	of	males.			The	development	of	such	screening	programmes	in	England,	across	Europe	and	the	 rest	 of	 the	world	has,	 therefore,	 been	 to	 the	benefit	 of	many	 in	diagnosing	and	 removing	 colorectal	 adenomas,	 so	 breaking	 the	 adenoma	 to	 carcinoma	sequence.	 They	have	 also	 been	 to	 the	benefit	 of	many	 in	 diagnosing	 colorectal	cancer	 at	 an	 early	 stage	 in	 its	 development,	 thus	 improving	 the	 affected	individual’s	 chances	 of	 survival.	 However,	 despite	 these	 successes,	 there	 is	undoubtedly	 a	 human	 cost	 to	 pay	 for	 them.	 Colonoscopy	 and	 Flexible	Sigmoidoscopy	are	considered	safe	procedures,	but	their	invasive	nature	means	
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they	will	always	carry	a	risk	of	events	that	may	harm	patients,	even	in	the	most	experienced	 operators’	 hands.	 The	 accepted	 name	 for	 such	 events	 is	 ‘adverse	events’.	 In	 the	 context	 of	 a	 colonoscopy,	 the	 event	 is	 termed	 a	 ‘colonoscopic	adverse	event’.	Such	events	occurring	on	a	regular	basis	would	be	disastrous	in	maintaining	 the	 benefits	 and	 uptake	 of	 screening	 programmes	 for	 colorectal	cancer.	 	 Minimising	 the	 risk	 of	 colonoscopic	 adverse	 events	 and	 ensuring	 the	best	possible	outcomes,	through	the	development	of	an	evidence	base,	for	when,	inevitably,	 they	 do	 occur,	 is	 therefore	 vital	 to	 maintaining	 the	 integrity	 of	screening	programmes	for	colorectal	cancer.		
2.4	Colonoscopic	adverse	events		
	In	 2008,	 the	 American	 Society	 for	 Gastrointestinal	 Endoscopy	 (ASGE)	 Quality	Task	Force	convened	a	workshop	specifically	to	assess	the	current	situation	and	develop	recommendations	surrounding	endoscopic	adverse	events.	The	society	termed	this	a	‘lexicon	for	endoscopic	adverse	events’4.	It	did	so	in	response	to	a	perceived	lack	of	clarity	and	standardization	regarding	adverse	event	definition,	reporting	 and	 significance.	 The	 phrases	 ‘complications’,	 or	 ‘negative	 outcomes’	may	 have	 previously	 been	 used	 synonymously	 with	 ‘adverse	 event’;	 however,	the	 term	 ‘adverse	 event’,	 it	 was	 felt,	 better	 encompassed	 the	 principles	 of	informed	consent	which	are	fundamental	to	having	a	colonoscopy4.		The	‘lexicon’	had	several	aims	which	included:		to	provide	a	clear	definition	of	an	adverse	 event,	 to	 define	 levels	 of	 adverse	 event	 severity	 grading,	 to	 define	 the	minimum	level	at	which	an	adverse	event	should	be	documented	and	to	consider	
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how	 to	 attribute	 delayed	 adverse	 events4.	 The	 English	 NHSBCSP	 incorporated	some	 of	 the	 ‘lexicon’s’	 report	 into	 its	 quality	 assurance	 guidelines	 for	colonoscopy	 published	 in	 2011	 and	 all	 of	 these	 factors	 are	 relevant	 when	examining	adverse	events	in	this	thesis26.		The	 ‘lexicon’	 defined	 an	 endoscopic	 adverse	 event	 as	 ‘an	 event	 that	 prevents	completion	 of	 a	 planned	 procedure	 and/or	 results	 in	 admission	 to	 hospital,	prolongation	of	an	existing	hospital	 stay	or	another	procedure/consultation’.	 It	recommended	 their	 timing	 may	 be	 pre	 procedure,	 intra	 procedure	 (from	entering	the	preparation	area	for	the	endoscopy	to	leaving	the	endoscopy	room),	post	 procedure	 (up	 to	 14	 days	 following	 completion	 of	 the	 procedure)	 or	 late	(any	 time	 after	 14	 days).	 Regarding	 the	 attribution	 of	 an	 adverse	 event	 to	 the	procedure,	it	recommended	these	being	described	as	definite,	probable,	possible	or	 unlikely	 and	 when	 reporting	 on	 severity,	 the	 recommendation	 was	 for	adverse	events	to	be	graded	as	fatal,	major,	intermediate	or	minor4.			In	a	position	 statement	by	 the	European	Society	of	Gastrointestinal	Endoscopy	(ESGE)	 of	 quality	 in	 screening	 colonoscopy	 published	 in	 2012,	 the	 ESGE	encouraged	national	screening	boards	to	use	the	ASGE’s	classification	of	adverse	events	 in	 addition	 to	 their	 own	 ‘Minimum	 Standard	 Terminology	 Version	 3.0’	when	defining	and	classifying	adverse	events27	28.		
2.4.1	Colonoscopic	adverse	events	occurring	before	the	colonoscopy	
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Colonoscopic	adverse	events	occurring	before	the	colonoscopy	are,	for	the	most	part,	related	to	the	bowel	preparation	the	patient	requires.	Colonoscopy	requires	all	 faecal	matter	 to	be	 removed	 from	the	colon	and	rectum	to	enable	adequate	visualisation	 of	 the	 colorectal	 mucosa.	 All	 bowel-cleansing	 regimes	 may	 be	uncomfortable	and	physically	tiring	for	patients	but	these	factors	will	only	rarely	prevent	 a	 planned	 colonoscopy.	 The	 agents	 used	 may	 result	 in	 fluid	 and	electrolyte	shifts.	Patients	who	already	have	co-morbidity	such	as	renal	 failure,	cardiac	 failure	 and	hypertension	are	particularly	 susceptible	 to	 adverse	 events	from	the	bowel	preparation29.		Polyethylene	Glycol	solutions	are	a	commonly	used	group	of	bowel	preparation	agents	 for	 colonoscopy.	 Polyethylene	 Glycol	 solutions	 have,	 however,	 been	associated	 with	 Mallory-Weiss	 tear,	 toxic	 colitis,	 aspiration	 pneumonia,	hypothermia,	 cardiac	 arrhythmias,	 pancreatitis	 and	 syndrome	of	 inappropriate	anti	diuretic	hormone	secretion30.		Sodium	 phosphate	 solutions	 are	 the	 other	major	 group	 of	 bowel	 preparations	currently	 in	 use.	 Due	 to	 electrolyte	 shifts,	 such	 solutions	 may	 result	 in	 Acute	Kidney	Injury	(AKI).	The	AKI	may	present	symptomatically,	within	a	 few	hours	to	 days,	 because	 of	 hypocalcaemia	 with	 hyperphosphataemia.	 Some	 patients	with	AKI	may	present	much	later,	from	a	few	days	to	even	weeks,	following	the	ingestion	 of	 sodium	 phosphate	 solutions.	 Other	 reported	 electrolyte	disturbances,	with	the	potential	to	result	in	a	pre	colonoscopic	adverse	event	are	hypokalaemia,	hypo-	or	hypernatraemia	and	hypo-	or	hypermagnesaemia31.			
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2.4.2	Colonoscopic	adverse	events	occurring	during	the	colonoscopy	
	A	 patient	 presenting	 for	 colonoscopy	 will	 normally	 be	 offered	 analgesia	 and	sedation	 after	 entering	 the	 endoscopy	 room	 but	 prior	 to	 intubation	 with	 the	colonoscope.	 Some	 health	 care	 centres	 will	 offer	 colonoscopy	 under	 general	anaesthesia,	 using,	 for	 example,	 propofol,	 although	 this	 is	 rarely	 used	 in	 the	English	National	Health	Service.	Analgesia	 and	 sedation	 is	used	 in	order	 to	 aid	patients’	 comfort	during	 the	procedure.	Additional	 analgesia	 and	 sedation	may	be	 required	 during	 the	 examination.	 The	 aim	 should	 be	 for	 the	 patient	 to	 be	moderately	or	consciously	sedated.	This	state	can	be	defined	as	‘a	drug	induced	depression	 of	 consciousness	 during	 which	 patients	 respond	 purposefully	 to	verbal	 commands,	 either	 alone	 or	 accompanied	 by	 light	 tactile	 stimulation.	No	interventions	 are	 required	 to	 maintain	 a	 patient’s	 airway	 and	 spontaneous	ventilation	is	adequate’29.	Analgesia	may	be	inhaled	in	the	form	of	nitrous	oxide	or	intravenous	with	opioids.	Intravenous	sedation	is	usually	administered	in	the	form	of	a	benzodiazepine.			However,	 such	medications	 can	 result	 in	over	 sedation	where	 the	patient	does	not	 respond	 to	 verbal	 commands,	 with	 or	 without	 light	 tactile	 stimulation,	 so	much	 so	 that	 the	 over	 sedation	 becomes	 an	 adverse	 event.	 Furthermore,	intravenous	 opioids,	 while	 attaching	 to	 pain	 receptors	 producing	 an	 analgesic	effect,	also	attach	to	receptors	in	the	brain	and	brainstem	controlling	respiratory	drive.	 If	 given	 in	 too	 great	 a	 quantity,	 intravenous	 opioids	 may	 result	 in	respiratory	 depression	 and	 respiratory	 arrest.	 Prolonged	 over	 sedation	 or	respiratory	 depression	 increases	 the	 likelihood	 of	 aspiration	 pneumonitis.	 A	
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systematic	 review	 and	meta	 analysis	 of	 randomised	 control	 trials	 of	moderate	sedation	 for	 endoscopic	 procedures	 published	 in	 2008	 reported	 a	 6%	hypoxaemia	 rate	 from	 706	 patients	 when	 midazolam	 was	 administered	 in	addition	 to	a	narcotic.	These	706	patients	were	cumulatively	assessed	 from	12	studies	 although	 one	 of	 the	 studies	 reported	 sedation	 for	 just	Oesophagogastroduodenoscopies	 (OGDs)	 and	 not	 colonoscopies.	 It	 is	 unclear,	however,	 how	 many	 of	 these	 episodes	 of	 hypoxaemia	 resulted	 in	 a	 failure	 to	complete	the	procedure	or	necessitated	another	consultation32.			As	 well	 as	 respiratory	 adverse	 events,	 colonoscopy	 is	 also	 associated	 with	cardiovascular	 adverse	 events	 during	 the	 procedure.	 As	 a	 possible	 result	 of	stretching	of	the	viscus	and	its	mesentery,	autonomic	responses	events	such	as	hypertension,	 arrhythmias,	 ST	 segment	 changes	 on	 electrocardiogram,	myocardial	 infarction	 and	 stroke	 may	 all	 occur29.	 Hypotension	 has	 also	 been	observed	 during	 colonoscopy,	 one	 study	 reporting	 a	 rate	 of	 480	 episodes	 per	100,000	 colonoscopies,	 however,	 it	 is	 uncertain	 how	 many	 of	 these	 episodes	would	have	fallen	into	the	definition	of	an	adverse	event	I	have	outlined5.		Systematic	 reviews	 and	meta	 analyses	 of	 20	 studies	 examining	 the	 cumulative	incidences	of	both	 cardiovascular	and	 respiratory	 complications	have	 reported	rates	of	19.1%	for	patients	of	65	years	and	older,	increasing	to	28.9%	for	those	of	80	years	or	older.	These	meta	analyses	described	an	approximately	even	split	of	severe	 and	 non-severe	 cardiovascular	 and	 pulmonary	 complications	 in	 these	groups.	We	could	assume,	therefore,	that	half	of	these	cases	could	be	considered	to	 be	 adverse	 events,	 however,	 the	 meta	 analyses	 do	 not	 include	 a	 clear	
	 33	
definition	of	what	 constitutes	a	 severe	 complication	or	 the	percentage	of	 them	occurring	during	the	colonoscopy33.		A	patient	experiencing	abdominal	pain	during	colonoscopy	may	also	prevent	its	completion.	Pain	commonly	occurs	from	over	insufflation	of	air	into	the	colon	or	from	 loop	 formation	 with	 stretching	 of	 the	 colon	 and	 its	 mesentery.	 Pain	 has	been	reported	in	series	as	occurring	in	5-11%	of	cases5.	As	with	the	systematic	reviews	and	meta	analyses	described	above,	whether	the	pain	described	can	be	considered	within	the	boundaries	of	an	adverse	event	is	unclear.		
2.4.3	Colonoscopic	adverse	events	occurring	within	14	days	 following	 the	
colonoscopy		
	Abdominal	pain,	cardiovascular	and	respiratory	events	that	require	consultation	may	also	occur	following	completion	of	the	colonoscopy.	From	a	study	of	33,086	patients	who	either	had	a	screening	or	non	screening	colonoscopy	published	by	Stock	 et	 al.	 ten	 non-screening	 patients	 presented	 with	 a	 median	 time	 to	admission	 of	 12	 days	 post	 completion	 of	 colonoscopy	 due	 to	 myocardial	infarction.	Three	screening	and	eleven	non-screening	patients	presented	with	a	median	time	to	admission	of	ten	and	eight	days	respectively	post	completion	of	colonoscopy	 due	 to	 stroke34.	 Although	 the	 exact	 time	 to	 admission	 was	 not	recorded,	 a	 similar	 study	by	Ko	 et	 al.	 of	 21,375	patients	having	 a	 screening	or	surveillance	colonoscopy	recorded	adverse	events	requiring	consultation	within	seven	days;	angina,	myocardial	infarction,	stroke	and	transient	ischaemic	attack	were	reported	as	possibly	related	to	the	colonoscopy	in	13	patients35.	
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	This	study	also	reported	two	patients	requiring	consultation	within	seven	days	of	 colonoscopy	 with	 post	 polypectomy	 electrocoagulation	 syndrome35.	 This	syndrome	occurs	as	a	result	of	a	 full	 thickness	burn	to	the	colon	with	 localised	peritonitis	but	no	evidence	of	radiological	perforation.	Reported	incidence	varies	from	0.003%	to	0.1%	of	colonoscopies5.	
	
2.4.4	 Colonoscopic	 adverse	 events	 occurring	 after	 14	 days	 post	
colonoscopy		The	adverse	events	 reported	 in	chapter	2.3.3	may	also	 require	consultation	14	days	after	completion	of	the	colonoscopy.	The	previously	described	study	by	Ko	et	al.	reported	adverse	events	up	to	30	days	post	colonoscopy.	In	addition	to	the	patients	 described	 from	 this	 paper	 in	 chapter	 2.3.3,	 a	 further	 12	 patients	who	had	a	colonoscopy	were	reported	to	have	angina	or	myocardial	Infarction	up	to	30	days	post	colonoscopy.	Furthermore,	seven	patients	had	a	stroke	during	this	time	possibly	related	to	the	colonoscopy.	A	further	two	patients	presented	with	post	 polypectomy	 syndrome35.	 These	 figures	 were	 similar	 in	 the	 previously	described	 study	 by	 Stock	 et	 al.	 with	 the	 incidence	 of	 stroke	 and	 myocardial	infarction	being	0.4%	per	1000	colonoscopies	after	30	days	follow	up34.		Other	described	colonoscopic	adverse	events	include	rupture	of	the	spleen,	acute	appendicitis,	 diverticulitis,	 subcutaneous	 emphysema,	 intra	 abdominal	haemorrhage,	 chemical	 colitis	 from	glutaraldehyde	 exposure,	 bacteraemia,	 and	retroperitoneal	abscess36	37	38.	
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	When	I	considered	perforation,	post	polypectomy	bleeding	and	post	colonoscopy	colorectal	 cancer	 in	 the	 context	 of	 the	 adverse	 events	 described	 so	 far	 in	 this	chapter	I	concluded	that	these	three	adverse	events	are	among	the	most	serious.	It	 is	for	these	reasons	that	these	adverse	events	are	a	major	focus	of	this	thesis	and	 are	 described	 separately	 in	 sections	 2.4,	 2.5	 and	 2.6	 respectively	 in	 this	chapter.			
2.5	Colonoscopic	Perforation			
2.5.1	The	definition	of	colonoscopic	perforation		A	colonoscopic	perforation	may	be	defined	as	evidence	of	air,	 luminal	contents	or	 instrumentation	 outside	 the	 gastrointestinal	 tract39.	 The	 English	 NHS	 BCSP	uses	this	definition	to	identify	patients	who	had	a	colonoscopic	perforation	and	is,	 therefore,	 the	 definitive	 definition	 used	 in	 this	 thesis.	 However,	 a	 small	contained	 perforation	 into	 the	 omental	 reflection	 of	 the	 colon	 or	 a	microperforation	 which	 is	 immediately	 closed	 by	 the	 application	 of	 clips	 may	also	be	regarded,	by	some,	as	being	a	perforation27.		
2.5.2	The	incidence	of	colonoscopic	perforation		There	is	variation	in	the	reported	incidence	of	colonoscopic	perforation	since	the	first	use	of	 colonoscopy	 in	1969,	both	 in	relation	 to	diagnostic	and	 therapeutic	procedures.	Some	of	this	variation	may	be	de	to	the	methodology	used	to	capture	
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details	of	the	perforation.	Earlier	studies	using	less	robust	methodology	may	be	more	prone	to	under	reporting	whereas	as	reporting	systems	have	evolved	and	improved	 in	conjunction	with	health	care	systems	being	more	conscious	of	 the	need	 to	 report	 adverse	 events,	 so	more	 accurate	 data	 relating	 their	 incidence	may	be	apparent.		By	1974,	 little	 research	had	 taken	place	 into	 ‘complications’	 from	colonoscopy.	This	prompted	the	committee	of	endoscopic	research	of	the	American	Society	of	Gastroenterology	 to	 survey	 its	 members	 regarding	 ‘complication’	 incidence.	 A	total	 of	 25,298	 diagnostic	 colonoscopies	 were	 reported	 resulting	 in	 53	perforations.	Two	perforations	were	reported	occurring	after	biopsy	and	6,214	colonoscopic	 polypectomies	 were	 described	 resulting	 in	 16	 perforations.	 This	paper	 quotes	 a	 diagnostic	 perforation	 rate	 of	 0.22%,	we	 presume	 from	 the	 53	perforations	 from	diagnostic	 colonoscopy	plus	 two	 from	biopsy,	 i.e.	 55/25,298	but	 this	 isn’t	 clear.	 In	 addition,	 it	 is	 also	 unclear	 from	 the	 paper	 whether	 the	colonoscopic	 polypectomies	 were	 included	 within	 the	 figure	 of	 25,298	 or	 are	separate	 colonoscopies.	 We	 presume	 they	 have	 been,	 the	 methodology	 states	‘diagnostic	colonoscopy	was	considered	 to	be	part	of	every	polypectomy’	but	a	therapeutic	 perforation	 rate	 isn’t	 recorded	 leading	 to	 doubts	 about	 the	 above	figures.	Furthermore,	642	ASGE	members	were	mailed	a	questionnaire,	only	444	returned	 it	and	 there	 is	no	 indication	of	 the	 total	number	of	ASGE	members	at	the	time	suggesting	the	perforation	rate	could	have	been	under	reported40.			A	similar	large	series	from	the	late	1970s,	this	time	a	survey	from	the	American	Society	 of	 Colon	 and	 Rectal	 surgeons,	 was	 more	 concrete.	 It	 reported	 a	
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perforation	 rate	 of	 0.358%.	 This	 was	 from	 a	 definite	 total	 of	 20,139	colonoscopies.	Again,	only	66%	of	members	responded	which	may	suggest	under	reporting41.	Lower	perforation	rates	were	stated	from	a	survey	of	West	German	hospitals	 in	 1978.	 From	 35,	 892	 colonoscopies,	 diagnostic	 and	 therapeutic	perforation	rates	of	0.14%	and	0.34%	respectively	were	reported42.		The	 issue	 of	 under	 reporting	 from	 surveys	was	 addressed	 by	Macrae	 et	 al.	 in	1983.	 The	 detailed	 records	 of	 5,000	 colonoscopies	 all	 performed	 at	 St.	 Marks	Hospital,	 London	 were	 reviewed.	 Six	 perforations	 producing	 a	 rate	 of	 0.12%	were	 recorded	 in	 line	 with	 the	 German	 series43.	 A	 lower	 perforation	 rate	 of	0.09%	 was	 observed,	 again	 from	 the	 United	 Kingdom,	 in	 a	 survey	 of	 17,500	colonoscopies	in	199144.	An	even	lower	diagnostic	perforation	rate	of	0.02%	and	therapeutic	 rate	 of	 0.03%	 was	 observed	 in	 an	 American	 series	 of	 26,708	consecutive	colonoscopic	procedures	from	1986	to	1992.			The	increasing	use	of	colonoscopy	coupled	with	improved	reporting	systems	and	collaboration	lead	to	much	larger	series	being	published	during	the	final	decade	of	 the	 twentieth	 century	 and	 the	 first	 decade	 of	 the	 twenty	 first	 century.	 The	figures	from	these	are	similar	to	the	smaller	series	that	preceded	them.	
A	computer	based	retrospective	analysis	of	57,028	colonoscopic	procedures	over	a	15-year	period	from	1980	to	1995	produced	a	perforation	rate	of	0.075%45.	A	similar	retrospective	review	of	105,786	colonoscopies	performed	over	a	21	year	period	from	January	1986	to	October	2007	resulted	in	35	perforations	(a	rate	of	
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0.033%),	 24	 of	 the	 perforations	 occurred	 during	 diagnostic	 colonoscopies	whereas	only	11	occurred	were	as	a	result	of	therapy46.		
A	 greater	 number	 of	 colonoscopies	 (116,000)	 was	 reviewed	 by	 Korman	 et	 al.	within	one	network	of	45	endoscopic	ambulatory	surgical	centres	in	the	United	States	 of	 America	 from	 before	 the	 new	 millennium	 reporting	 an	 overall	perforation	 rate	 of	 0.03%.	 Similarly	 to	 the	 series	 above,	 nearly	 two	 thirds	 of	these	perforations	occurred	as	a	result	of	diagnostic	procedures47.	These	results	are	in	contrast,	however,	to	a	study	over	twice	this	size	number	of	colonoscopies	by	Iqbal	et	al.	published	in	2008	that	reported	a	perforation	incidence	of	0.07%.	Diagnostic	 procedures	 accounted	 for	 42%	 of	 these	 perforations48.	 Perforation	incidence	published	a	year	later	from	a	similarly	sized	study,	again	from	the	USA,	was	marginally	higher	at	0.08%2.	An	even	larger	study	from	France,	published	in	2013,	of	a	cohort	of	nearly	one	million	colonoscopies	reported	424	colonoscopic	perforations,	an	incidence	of	0.04%49.	
Perforation	rate	in	the	English	NHS	BCSP	has	been	reported	from	the	start	of	the	programme	 in	 2006	 up	 to	 and	 including	 January	 2012.	 From	 130,831	colonoscopies,	 the	 overall	 perforation	 rate	 was	 0.06%	 with	 a	 therapeutic	perforation	rate	of	0.09%	and	diagnostic	perforation	rate	of	0.03%39. 
2.5.3	Risk	factors	for	colonoscopic	perforation	
	Many	retrospective	observational	case	control	studies	have	 focused	specifically	on	 identifying	 risk	 factors	 for	 colonoscopic	perforation.	Factors	 that	have	been	associated	 with	 increasing	 the	 risk	 of	 perforation	 may	 relate	 to	 the	 patient	
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having	the	colonoscopy,	the	procedure	itself	or	the	colonoscopist	who	performs	the	procedure.	
Increasing	 age	has	 consistently	 been	 shown	 to	 be	 a	 patient	 related	 risk	 factor.		Gatto	et	al.	showed	that	patients	of	75	years	or	over	had	a	four	times	greater	risk	of	perforation	than	those	aged	65-69	years50.		A	Canadian	study	found	age	to	be	a	significant	risk	factor	for	perforation	but	only	differentiated	between	those	aged	60-75	years	and	50-59	years,	with	a	higher	odds	ratio	for	perforation	in	the	older	group51.	Age	was	also	significant	 in	 larger	series	than	these;	the	relative	risk	of	perforation	 increasing	 over	 three	 fold	 for	 those	 over	 the	 age	 of	 80	 years	compared	 to	 those	 65-80	 years	 in	 one	 such	 study2.	 Similarly,	 a	 further	 study	from	Thailand	reported	a	six	fold	rise	in	the	colonoscopic	perforation	rate	in	the	over	75s	when	comparing	this	with	those	under	7552.	Blotiere	et	al.	studied	age	not	 just	 between	 two	 groups	 but	 in	 10	 year	 intervals	 from	 the	 age	 40	 to	 80,	showing	 a	 step	 wise	 increase	 in	 odds	 ratios	 for	 perforation	 for	 each	 decade.		Further	 series	 including	 ones	 published	 in	 2014	 have	 corroborated	 these	findings53	54.	A	suggested	reason	for	this	risk	is	declining	colonic	wall	mechanical	strength,	due	to	changes	in	its	collagen	structure52.		In	line	with	increasing	patient	age,	patient	co-morbidity	has	too	been	associated	with	an	increased	risk	of	colonic	perforation.	 	Those	patients	with	two	or	more	co-morbidities	had	a	higher	risk	 than	those	with	no	or	one	co-morbidity	 in	 the	study	 by	 Gatto	 et	 al.50.	 Similar	 findings	were	 reported	 by	 Arora	 et	 al.	where	 a	Charlson	 co-morbidity	 score	 of	 two	 or	more	was	 found	 to	 increase	 the	 risk	 of	
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perforation	by	over	50%	and	by	Warren	et	al.	where	those	with	a	history	Stroke,	COPD,	Atrial	Fibrillation	or	Chronic	Heart	Failure	had	increased	risk2	54.		Female	sex	has	been	documented	as	a	risk	factor	for	perforation53	55.	This	may	be	due	 to	 women	 having	 longer	 colons,	 more	 mobile	 transverse	 colons,	 smaller	body	habitus	or	possibly	a	hormonal	effect	on	collagen55	 6.	 Indeed,	Hamdani	et	al.’s	 review	 of	 risk	 factors	 showed	 lower	 Body	 Mass	 Index	 to	 be	 a	 significant	predictor	 of	 perforation	 in	 addition	 to	 female	 sex53.	 These	 findings	 are	 in	contrast	to	those	of	Rabeneck	et	al.	who	found	male	sex	to	be	significant51.		The	nature	of	the	patient’s	indication	for	colonoscopy	may	too	be	a	factor.	Such	indications	 include	 colonic	 obstruction	 or	 diverticular	 disease50	 2	 55.	 Crohn’s	Disease,	 colitis,	 strictures	 and	 adhesions	 have	 all	 been	 reported	 as	 potential	patient	 related	 risk	 factors.	 Similarly,	 abdominal	 pain	 as	 the	 indication	 for	 the	colonoscopy	and	an	uncooperative	patient	during	the	examination	have	too	been	reported	as	risk	factors	55	53.		Factors	 related	 directly	 to	 the	 colonoscopy	 itself	 are	 also	 important.	 There	 is	consistent	 evidence	 that	 therapeutic	 colonoscopy,	 including	 polypectomy,	carries	a	greater	risk	of	perforation	than	diagnostic	colonoscopy51	2	 55	 6.	As	the	polyp	 size	 increases	 and	 the	 number	 of	 polypectomies	 increases,	 so	 too	perforation	 risk	 increases56.	 In	 a	 recently	 published	 study	 from	 France,	 of	947,061	patients	in	whom	colonoscopy	was	performed	also	described	in	chapter	2.3.2,	polypectomy	of	polyps	greater	than	1	centimetre	and	a	colonoscopy	where	more	 than	 4	 polypectomies	 take	 place	 was	 associated	 with	 an	 increased	
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perforation	 risk.	 In	 addition	 to	 increasing	 polyp	 size	 and	 number	 of	polypectomies,	 the	Munich	Polypectomy	Study,	of	3976	snare	polypectomies	 in	2257	patients,	also	reported	right	sided	colonic	 location	as	a	risk	factor	though	reported	this	using	‘complications’	overall	rather	than	just	for	perforation56.	The	polyp	 morphology	 and	 polypectomy	 method	 may	 also	 be	 a	 factor;	 a	 study	specifically	 examining	 endoscopic	 submucosal	 dissection	 of	 large	 sized,	 non-pedunculated	 colorectal	 tumours,	 found	 that	 the	 laterally	 spreading	 type	 of	tumour	 and	 submucosal	 injection	 with	 hyaluronic	 acid	 were	 independent	predictive	factors	for	perforation57.			When	 examining	 the	 role	 of	 the	 colonoscopist,	 those	 colonoscopists	 who	 are	inexperienced	or	perform	a	 relatively	 small	number	of	 colonoscopies	per	year,	are	 a	 further	 risk	 factor	 for	 perforation.	 In	 one	 study,	 the	 risk	 was	 increased	below	a	threshold	of	300	colonoscopies	per	year	per	endoscopist51.	Similarly	in	Lorenzo-Zuniga	et	al.’s	study,	the	relative	risk	ratio	for	complications,	 including	perforation,	 was	 highest	 for	 those	 colonoscopists	 performing	 less	 than	 591	procedures	per	year58.	These	findings	have	been	corroborated	by	other	studies,	including	from	Canada	where	the	colonoscopist	being	a	‘family	physician’	rather	than	a	gastroenterologist	or	surgeon	was	significant49	59	60	61.		Risk	 factors	 for	 perforation	 studied	 in	 the	 English	 NHSBCSP,	 from	 130,831	colonoscopies	and	167,208	polypectomies,	included	patient	age,	gender,	physical	status,	polyp	morphology,	polyp	size,	polyp	location	and	polypectomy	device.	On	multivariable	 analyses	 of	 patients	 undergoing	 a	 single	 polypectomy	 procedure	
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who	 had	 a	 perforation,	 the	 size	 of	 the	 polyp	 and	 a	 location	 of	 a	 polyp	 in	 the	caecum	were	significant39.			
2.5.4	The	mechanisms	associated	with	colonoscopic	perforation		
	The	mechanism	that	is	most	directly	associated	with	a	colonic	perforation	varies	depending	on	what	occurs	as	the	colonoscopy	progresses.	Classifying	the	direct	cause	 or	 mechanism	 depends	 on	 whether	 the	 colonoscopy	 is	 a	 diagnostic	 or	therapeutic	procedure.		Two	 main	 mechanisms	 of	 perforation	 have	 been	 reported	 during	 diagnostic	colonoscopy.	 Mechanical	 forces	 against	 the	 colorectal	 mucosa	 may	 lead	 to	tearing	 through	 the	 entire	 wall	 of	 the	 colon.	 The	mechanical	 force	may	 result	from	the	tip	of	the	colonoscope,	for	example,	 following	the	mistaken	intubation	of	a	diverticulum,	or	from	the	shaft	of	the	colonoscope,	resulting	in	stretching	of	the	 colon,	 particularly	 during	 loop	 formation	 or	 when	 the	 colonoscope	 is	advanced	 by	 ‘sliding	 by’	 the	 mucosa	 rather	 under	 direct	 visualisation	 of	 the	lumen5	62.	The	rectosigmoid	colon	has	been	reported	as	the	commonest	site	for	mechanical	colonoscopic	perforation.	This	may	be	due	to	the	sharp	angulation	of	the	colon	in	this	segment,	the	greater	mobility	of	the	sigmoid	colon,	formation	of	sigmoid	 loops	and	 the	presence	of	diverticular	disease6.	Diagnostic	perforation	may	 also	 occur	 from	 extreme	 air	 insufflation	 or	 barotrauma62.	 A	 single	 centre	case	 series	 from	 the	Netherlands	 of	 the	 cause	 of	 26	 colonic	 perforations	 from	19,135	 procedures	 showed	 that	 all	 perforations	 from	 mechanical	 forces	occurred	 in	 the	sigmoid	colon	whereas	 those	 from	barotrauma	occurred	 in	 the	
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caecum63.	Air	‘trapping’	may	occur	in	the	caecum,	the	most	proximal	segment	of	colon,	where	the	colonic	wall	is	at	its	thinnest	and	most	distensible62.		Therapeutic	colonoscopy	may	be	associated	with	colorectal	perforation	through	a	 variety	 of	 methods	 and	 therapies.	 Instruments	 such	 as	 biopsy	 forceps	 and	snares	inserted	blindly,	forcibly	and	without	control	through	the	biopsy	channel	of	 the	 colonoscope	may	 directly	 puncture	 the	 colon	 or	 rectum29.	 	 Any	 therapy	involving	 electrical	 current	 may	 result	 in	 perforation,	 particularly	 when	polypectomy	takes	place.	Polyps	larger	than	six	millimetres	will	usually	require	some	 form	 of	 current	 to	 complete	 the	 polypectomy.	 Electrical	 current	 applied	close	 to	 the	 colonic	wall	may	 burn	 through	 the	 serosa	 exacerbated	 by	 greater	current	 intensity,	 for	 longer	 periods	 over	 smaller	 diameters29	 62.	 There	 have	been	reports	of	perforation	from	gas	explosion	in	the	colon.	This	can	occur	when	combustible	levels	of	hydrogen	or	methane	gas	in	the	colon	and	rectum	mix	with	oxygen	 and	 electrical	 current	 or	 Argon	 Plasma	 Coagulation5.	 Stretching	 and	rupture	 of	 the	 colorectal	 wall	 during	 dilatation	 of	 strictures	 is	 another	therapeutic	mechanism	of	perforation.		
2.5.5	 How	 a	 patient	 with	 colonoscopic	 perforation	 presents	 for	
consultation	
	Perforations	may	present	during	the	colonoscopy	or	after	its	completion.	Those	patients	 presenting	 following	 its	 completion	 seek	 consultation	 because	 of	symptoms	that	are	attributable	to	the	perforation.		
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The	 perforation	 may	 be	 visible	 to	 the	 colonoscopist	 when	 an	 extra	 intestinal	structure	 is	seen	 from	the	colorectal	 lumen6.	 It	may	be	apparent	as	mesenteric	fat,	mesenteric	vessels	or	the	external	surface	of	surrounding	bowel29	55.	Studies	up	 to	 2008	 suggest	 this	 is	 the	mode	 of	 presentation	 in	 23%	 of	 cases62.	 These	figures	have	been	corroborated	 in	more	 recent	 studies;	one	 reporting	 this	was	the	mode	 of	 presentation	 in	 37.5%	 of	 cases64.	 If	 the	 perforation	 is	 not	 visible	during	 colonoscopy,	 there	may	 be	 a	 sudden	 inability	 to	 insufflate	 the	 colon	 to	allow	adequate	mucosal	visualisation.	A	patient	complaining	of	new	abdominal	or	back	pain	during	the	procedure	with	or	without	changes	in	vital	observations	such	 as	 tachycardia,	 tachypnoea,	 hypotension	 and	 pyrexia	 may	 also	 indicate	perforation29.	 A	 recently	 published	 7	 year	 survey	 from	 a	 German	 university	hospital	reported	the	perforation	being	suspected	during	colonoscopy	in	28%	of	cases	but	didn’t	specify	the	exact	reasons	for	the	suspicion65.		For	 those	patients	who	present	 following	 completion	of	 the	 colonoscopy,	most	complain	of	abdominal	pain,	but	back	pain	and	abdominal	distension	may	also	occur.	 Abdominal	 pain	 occurs	 as	 a	 result	 of	 peritoneal	 irritation.	 A	 degree	 of	abdominal	pain	is	expected	post	procedure,	usually	because	of	retained	air	in	the	colonic	 lumen,	 but	 this	 should	 settle	 as	 a	 patient	 expels	 the	 air.	 Persistent	abdominal	pain	 raises	 the	possibility	of	peritoneal	 irritation.	 Studies	up	 to	and	including	 2008	 suggest	 the	majority	 (74.6%)	 of	 patients	 with	 perforation	will	present	within	24	hours	following	completion	of	the	colonoscopy62.	More	recent	studies	also	suggest	similar	figures,	one	reporting	presentation	within	24	hours	in	 78%	 of	 cases,	 and	 on	 the	 same	 day	 as	 the	 colonoscopy	 in	 85.1%	 of	 cases,	although,	again	the	exact	nature	of	the	presentation	is	not	described66	49.	
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2.5.6	 Making	 the	 diagnosis	 of	 colonoscopic	 perforation	 when	 a	 patient	
presents	after	the	colonoscopy	
	Common	 clinical	 signs	 on	 examination	 of	 such	 patients	 who	 present	 post	procedure	 include	 localised	 or	 generalised	 abdominal	 tenderness,	 rebound	tenderness,	 rigidity,	 tachycardia	 and	 pyrexia.	 Routine	 haematological	 and	biochemical	 testing	 may	 reveal	 leucocytosis	 and	 other	 raised	 inflammatory	markers.		Radiological	 investigation	 may	 confirm	 the	 diagnosis	 in	 those	 patients	 with	symptoms,	signs,	haematology	and	biochemistry	suggesting	perforation.	An	erect	chest	 x-ray	 may	 reveal	 pneumoperitoneum;	 abdominal	 x-ray	 may	 reveal	intraperitoneal	air.	Retroperitoneal	air	can	also	be	seen	along	the	psoas	muscle	and	around	the	kidneys	in	certain	cases62.			Cross	sectional	imaging	of	the	abdomen	and	pelvis	showing	intraperitoneal	free	air	 may	 be	 required	 if	 plain	 x-rays	 are	 unhelpful	 in	 making	 the	 diagnosis.	Computed	Tomography	(CT)	of	 the	abdomen	and	pelvis	 is	better	 than	an	erect	chest	 x-ray	 at	 detecting	 intraperitoneal	 free	 air5.	 Double	 or	 triple	 contrast	scanning	 may	 enhance	 CT	 findings	 in	 relation	 to	 the	 perforation.	 Magnetic	Resonance	Imaging	of	the	abdomen	also	has	a	role	in	its	detection6.		
2.5.7	The	management	of	colonoscopic	perforation		
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Management	 options	 are	 dependent	 on	 many	 variables,	 including	 how	 the	perforation	 has	 presented	 and	 the	 timing	 that	 the	 diagnosis	 is	 made.		Perforations	may	be	managed	endoscopically,	when	the	mode	of	presentation	is	visualisation	 or	 suspicion	 of	 the	 perforation	 during	 the	 colonoscopy,	conservatively	through	medical	management	only	or	surgically.	These	subgroups	of	management	are,	of	course,	not	exclusive;	patients	may	require	a	combination	of	two	of	these	management	strategies,	or	indeed	all	three.		
2.5.7.1	The	endoscopic	management	of	colonoscopic	perforation	
	For	the	most	part,	endoscopic	management	will	only	occur	when	the	endoscopist	visualises	or	strongly	suspects	a	perforation	during	the	procedure.	Yoshikane	et	al.	reported	the	first	successful	endoscopic	closure	of	a	colonic	perforation	with	clips	 in	 1997.	 A	 four	millimetre	 perforation	was	 sealed	with	 five	 clips	 using	 a	rotating	 clip	 fixing	 device.	 The	 patient	 was	 kept	 nil	 by	 mouth,	 prescribed	antibiotics	 and	 discharged	 two	 weeks	 later67.	 The	 feasibility	 of	 this	 technique	was	enhanced	by	results	from	studies	in	porcine	models68	69.	Several	similar	case	reports	 emerged	 following	 this	 initial	 success	 with	 clips	 placed	 ‘through	 the	scope’70	 71	 72	 73	 74.	 Subsequent	 series	 suggested	 the	 use	 of	 endoscopic	 clipping	was	effective	in	68-93%	of	patients	who	were	managed	in	this	way75	76	77	78.		However,	 the	 use	 of	 ‘through	 the	 scope’	 clips	 does	 not	 allow	 the	 trans	 mural	closure	of	a	perforation	that	would	be	achieved	during	surgery.	It	is	also	difficult	for	 larger	 perforations	 that	 are	 beyond	 the	 reach	 of	 the	 clip.	 For	 this	 reason,	studies	 of	 full	 thickness	 perforation	 closure	 using	 suturing	 devices	 in	 porcine	
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models	have	since	taken	place	with	encouraging	results79	80.	Similarly,	‘Over	The	Scope	Clip’	devices	may	be	a	better	method	 for	 the	endoscopic	management	of	larger	perforations81	 82.	The	use	of	a	 covered	metal	 stent	and	endoscopic	band	ligation	has	also	been	described83	84.		
2.5.7.2	Conservative	management	of	colonoscopic	perforation	
	Many	series	consider	 ‘conservative’	management	 to	 involve	anything	excluding	surgery.	For	the	purposes	of	this	review,	I	considered	three	distinct	management	strategies:	endoscopic,	conservative	and	surgical,	although,	of	course,	there	may	be	overlap	between	the	three.		Standard	 conservative	 management	 of	 colonoscopic	 perforation	 involves	 the	admission	 to	 the	 inpatient	 ward	 for	 observation,	 keeping	 the	 patient	 nil	 by	mouth	 in	 order	 to	 rest	 the	 colon,	 the	 administration	 of	 intravenous	 fluids	 and	prescription	of	broad-spectrum	intravenous	antibiotics.	This	management	alone	may	 be	 successful	 in	 a	 cautiously	 chosen	 sub	 group	 of	 patients.	 Such	management	has	been	advocated	for	a	perforation	presenting	within	24	hours	of	the	colonoscopy,	when	bowel	preparation	is	good,	thus	reducing	the	chances	of	bacterial	 and	 faecal	 contamination	 in	 the	 peritoneum.	 The	 patient	 being	haemodynamically	 stable,	 with	 little	 or	 no	 co-morbidity	 and	 without	 signs	 of	peritonitis	are	also	factors	that	may	favour	conservative	management62	85	86.			The	 numbers	 of	 patients	 managed	 in	 this	 way	 described	 in	 recent	 published	series	have	been	small.	Tam	et	al.	described	four	of	26	cases	of	perforation	being	
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managed	 non-operatively,	 however,	 one	 of	 these	 was	 also	 managed	endoscopically.	 None	 of	 these	 patients	 died	 or	 required	 surgery,	 though	 one	required	a	percutaneous	drain	for	an	abscess.	Their	length	of	in	patient	stay	was	not	specified.	A	South	Korean	study	of	perforations	after	endoscopic	submucosal	dissection	successfully	managed	five	microperforations,	defined	as	the	presence	of	free	air	on	radiographic	imaging,	conservatively.	Hagel	et	al.	and	Tulchinsky	et	al.	 at	 reported	 one	 patient	 each	 managed	 successfully	 like	 this,	 though	 in	 the	former’s	 case,	 the	patient	had	 refused	surgery65	 87.	One	of	 the	 largest	 reported	series	 managed	 successfully	 conservatively	 was	 by	 Iqbal	 et	 al.	 including	 13	patients,	the	majority	of	whom	presented	within	24	hours,	were	clinically	stable	and	 devoid	 of	 peritonitis	 on	 physical	 examination48.	 The	Munich	 Polypectomy	Study	reported	7	patients	managed	in	this	fashion	with	mortality	being	zero	for	all56.		
2.5.7.3	The	surgical	management	of	colonoscopic	perforation	
	Those	who	fail	endoscopic	management,	conservative	management,	or	both	will	require	 surgery.	 Surgery	 is	 also	 recommended	 for	 those	 patients	who	 present	after	completion	of	 the	colonoscopy,	who	are	haemodynamically	unstable,	who	have	 signs	 of	 diffuse	 peritonitis	 or	 who	 have	 other	 pathology	 that	 requires	surgery.	 The	 surgery	 may	 be	 laparoscopic	 or	 by	 open	 laparotomy.	 In	 certain	cases	a	laparoscopy	may	need	to	be	converted	to	an	open	laparotomy.	There	is	a	range	 of	 surgical	 options	 available	 that	 depend	 on	 many	 factors6.	 The	 final	decision	to	operate	is	also	highly	subjective	and	is	likely	to	depend	on	the	clinical	judgement	of	surgeon,	their	experience	and	skills.	
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	A	 primary	 repair	with	 a	 suture	 to	 close	 the	 perforation	 is	 an	 option	when	 the	perforation	 is	 small	and	 there	 is	 little	or	no	 faecal	matter	 in	 the	peritoneum.	A	stoma	in	the	form	of	a	colostomy/ileostomy	may	be	required	with	such	cases.	A	resection	of	the	perforated	segment	of	colon	with	anastomosis	of	the	remaining	bowel	or	with	colostomy/ileostomy	may	be	required	if	the	perforation	is	larger.	In	such	cases,	colonic	resection	with	anastomosis	is	more	likely	if	there	is	little	or	no	faecal	peritonitis	and	there	is	no	concomitant	pathology.	Iqbal	et	al.	reported	that	most	patients	with	faecal	peritonitis	received	a	stoma	compared	with	those	with	moderate	 or	minimal	 contamination48.	 These	 findings	were	 corroborated	by	 Teoh	 et	 al.	 who	 identified	 peritoneal	 contamination	 and	 the	 presence	 of	malignant	colonic	neoplasms	as	significant	risk	factors	for	stoma	formation86.		Laparoscopic	 repair	 of	 colonoscopic	 perforation	 using	 the	 above	 approaches	may	also	be	feasible	in	certain	cases.	The	laparoscopic	approach	to	surgery	has	been	 associated	 with	 a	 lower	 length	 of	 hospital	 stay	 and	 fewer	 complications	than	 traditional	 open	 surgery,	 however,	 in	 one	 such	 series	 was	 performed	 on	patients	 who	 presented	 sooner	 with	 less	 faecal	 contamination	 of	 the	peritoneum88	 89	 90.	 The	 quicker	 time	 to	 surgery	 among	 perforations	 repaired	laparoscopically	 was	 corroborated	 in	 a	 similar	 series	 specifically	 comparing	open	and	laparoscopic	techniques	91.		
2.5.8	The	prognosis	following	colonoscopic	perforation	
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Any	of	the	management	strategies	described	in	chapter	2.3.7	may	be	associated	with	in	patient	admission,	patient	morbidity	and	even	patient	death.			Post	 perforation	 morbidity	 ranges	 from	 31%	 to	 48.7%	 in	 recently	 reported	series	 comprising	 patients	 who	 have	 been	 managed	 endoscopically,	conservatively	 or	 surgically	 with	 morbidity	 referring	 to	 both	 post	 operative	complications	 and/or	 new	diagnoses	 post	 perforation66	 86.	 In	 series	 examining	only	post	 surgical	morbidity,	 rates	vary	 from	34.5	–	40%92	 93.	Post	perforation	mortality	 can	 be	 as	 high	 as	 25.6%,	with	 post	 perforation	 surgical	mortality	 as	high	as	10%86	92.		Many	 factors	 may	 be	 associated	 with	 increasing	 the	 risk	 of	 post	 perforation	morbidity	 and	mortality	 depending	 on	 the	 patient,	 what	 happened	 during	 the	colonoscopy	and	 the	 time	 they	present.	A	poorer	physical	 status	 as	defined	by	higher	 physical	 American	 Society	 of	 Anaesthesiology	 (ASA)	 grade	 has	consistently	 been	 reported	 as	 significant86	 92	 94.	 Similarly,	 patients	 taking	antiplatelet	medication	 or	 corticosteroids,	 suggesting	 other	 co-morbidity,	 have	also	been	shown	to	be	significant86	48.	Smoking,	which	can	lead	to	co-morbidity	and	 higher	 ASA	 status,	 was	 also	 shown	 to	 be	 significant	 in	 one	 series95.	 As	reported	earlier,	patients	who	present	later	with	greater	faecal	contamination	of	the	 peritoneum	 are	 likely	 to	 be	more	 unwell	 and	 have	 poorer	 outcomes.	 This	chain	of	events	can	be	linked	to	post	perforation	mortality	and	morbidity;	poorer	bowel	 preparation,	 the	 size	 of	 the	perforation	 and	 the	 time	 to	 presentation	 all	being	significant	in	3	separate	series48	95	66.	
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Table	 1:	 Perforation	 incidence	 including	 diagnostic	 and	 therapeutic	
perforation	rates	
Therapeutic	Perforation	Rate	
Therapeutic	Perforations	
D
iagnostic	Perforation	Rate	
D
iagnosti	Perforations	
Perforation	Rate	
Perforations	
Colonoscopies	
Year	
Study	
	 	 0.23%	 55	 0.23%	 55	
25,298	 1975	
Rogers		et	al.			 	 	 	 0.358%	
	 20,139	
1976	 Smith	et	
al.	
0.34%	 	 0.14%	 	 	 	 35,892	
1979	 Frumorg
hen	et	
al.	
	 	 	 	 0.12%	 6	 5000	 1983	 Macrae	
et	al.		 	 	 	 0.09%	 15	 17,500	
1991	 Hall	et	
al.	
0.03%	 7	 0.02%	 5	 0.045%	
12	 26,708	
1994	 Lo	et	al.		 	 	 	 0.075%	
	 57,028	
1997	 Farley	et	
al.	
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0.01%	 11	 0.022%	
24	 0.033%	
33	 105,786	
200	 Avering
os	et	al.	0.011%	
13	 0.021%	
24	 0.03%	 37	 116,000	
2003	 Korman	
et	al.		 	 	 	 0.07%	 180	 258,248	
2008	 Iqbal	et	
al.	
	 	 	 	 0.08%	 228	 277,434	
2009	 Arora	et	
al.		
	 	 	 	 0.04%	 424	 947,061	
2013	 Blotiere	
et	al.		0.09%	 	 0.03%	 	 0.06%	 	 130,831	
2014	 Rutter	et	al.		
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2.6	Post	polypectomy	bleeding	(PPB)		
2.6.1	The	definition	of	post	polypectomy	bleeding		
	The	 terms	 ‘bleeding’	 and	 ‘haemorrhage’	 are	 used	 interchangeably	 when	describing	 them	 in	 association	with	 a	 colonoscopy	 and	 polypectomy.	 Although	haemorrhage	may	sound	more	severe,	there	is	no	distinction	drawn	between	the	two.	Blood	 is	 commonly	visualised	 in	 the	 lumen	of	 the	 colon	or	 rectum	during	colonoscopy,	 for	example,	 the	colorectal	mucosa	may	bleed	when	 it	comes	 into	contact	with	the	tip	or	shaft	of	the	colonoscope	and	blood	is	nearly	always	seen	after	biopsy	or	polypectomy.	When	bleeding	occurs	it	may	stop	spontaneously	or	require	 a	 therapeutic	 intervention,	 such	 as	 the	 injection	 of	 adrenaline	 or	 the	application	 of	 clips,	 to	 stop	 it,	 also	 known	 as	 achieving	 haemostasis.	 However,	bleeding	 such	 as	 this	 does	 not	 usually	 prevent	 completion	 of	 the	 colonoscopy,	necessitate	 in	 patient	 admission	 or	 subsequent	 consultation	 and	 therefore	doesn’t	 form	part	of	 the	definition	of	an	adverse	event,	as	 is	 the	case	with	peri	operative	bleeding.			For	 the	 purposes	 of	 this	 thesis,	 I	 defined	 PPB	 as	 blood	 or	 melaena	 in	 the	colorectal	 lumen	 following	 polypectomy	 that	 prevents	 completion	 of	 the	colonoscopy	 and/or	 that	 results	 in	 admission	 to	 hospital,	 prolongation	 of	 an	existing	 hospital	 stay	 or	 necessitates	 subsequent	 consultation	 that	 may	 be	endoscopic,	medical,	surgical	or	radiological.	This	definition	of	PPB	incorporates	that	of	an	adverse	event	proposed	by	Cotton	et	al.	in	2008	and,	therefore,	is	the	definition	 of	 a	 post	 polypectomy	 bleeding	 used	 in	 the	 English	 NHSBCSP4	 39.	 A	
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similar	definition	has	been	suggested	by	the	European	Society	of	Gastrointestinal	Endoscopy27.			‘Post	 Polypectomy	 Haemorrhage’,	 ‘Delayed	 Bleeding/Haemorrhage’	 and	‘Secondary	Bleeding/Haemorrhage’	 are	 all	 published	 terms	 that	 fall	within	 the	boundaries	of	the	definition	outlined	above.			In	 this	 thesis	 I	have	considered	 two	types	of	bleeding;	peri	procedure	bleeding	which	is	controlled	during	the	procedure	but	results	in	an	admission	to	hospital	and	 post	 polypectomy	 bleeding	 when	 the	 bleeding	 presents	 following	 the	completion	of	the	procedure	and	results	in	admission	to	hospital,	prolongation	of	an	 existing	 hospital	 stay	 or	 necessitates	 subsequent	 consultation	 that	 may	 be	endoscopic,	medical,	surgical	or	radiological.		
2.6.2	Post	polypectomy	bleeding	by	grade	of	severity	
	Despite	 the	use	of	 the	above	definition	 to	clearly	outline	what	constitutes	PPB,	some	episodes	of	PPB	may	be	 trivial	 yet	 still	 lead	 to	 a	patient	 seeking	medical	consultation	 post	 procedure.	 As	 part	 of	 the	 work	 of	 the	 lexicon	 for	 adverse	events	 convened	 by	 the	 ASGE	 in	 2008,	 a	 severity	 grading	 system	 for	 adverse	events	was	developed	recommending	four	grades	of	severity	based	on	the	type	of	medical	attention	that	is	required.	This	severity	grading	system	categorizes	an	adverse	 event	 into	 minor,	 intermediate,	 major	 or	 fatal4.	 This	 severity	 grading	system	has	been	applied	to	how	PPB	is	reported	in	the	English	NHS	BCSP	and	is	detailed	in	quality	assurance	guidelines	published	on	behalf	of	the	programme26.		
	 55	
	When	 specifically	 considering	 PPB,	 major	 PPB	 is	 that	 resulting	 in	 surgery,	 an	unplanned	admission	or	prolongation	of	a	hospital	stay	for	more	than	ten	nights	or	 ITU	 admission	 for	 more	 than	 one	 night.	 PPB	 would	 be	 considered	intermediate	when	 leading	 to	any	of:	 a	drop	 in	haemoglobin	of	more	 than	 two	grams	per	 demi	 litre,	 a	 blood	 transfusion,	 an	 unplanned	hospital	 admission	 or	prolongation	of	stay	for	four	to	ten	nights,	an	ITU	admission	for	one	night	or	an	interventional	 procedure	 which	 may	 endoscopic	 or	 radiological.	 Minor	 PPB	occurs	 when	 a	 colonoscopy	 is	 aborted,	 results	 in	 an	 unplanned	 medical	consultation,	admission	or	prolongation	of	hospital	stay	for	3	nights	or	less.	
	
2.6.3	The	incidence	of	post	polypectomy	bleeding		
	Due	to	the	differences	in	how	PPB	may	be	defined,	there	is	wide	variation	in	its	reported	incidence.	Not	only	do	some	reports	not	use	the	definition	outlined	in	section	 2.5.1,	 PPB	 incidence	 has	 also	 been	 reported	 per	 number	 of	 patients,	colonoscopies,	 colonoscopies	 where	 a	 polypectomy	 is	 performed	 and	 per	polypectomy.	Therefore,	providing	an	accurate	representation	of	PPB	incidence	over	 time	 requires	 clarity	 in	 how	 it	 is	 defined	 and	how	 its	 incidence	 has	 been	calculated.		The	previously	cited	1974	ASGE	survey	of	complications	relating	to	colonoscopy	and	polypectomy	reported	a	total	of	115	cases	of	haemorrhage.	These	cases	were	associated	 with	 6,214	 polypectomies.	 This	 gave	 an	 overall	 post	 polypectomy	haemorrhage	 rate	 of	 1.09%	when	measured	 per	 number	 of	 polypectomies.	 As	
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previously	 described	 in	 chapter	 2.4.1,	 the	 lack	 of	 responses	 to	 this	 survey	 is	likely	to	have	resulted	in	under	reporting.	Also,	31	of	these	haemorrhages	were	immediate	 (occurred	 during	 the	 colonoscopy),	 but	 it	 is	 unclear	 whether	 they	prevented	 completion	 of	 the	 colonoscopy	 and	 therefore	 if	 they	 would	 be	considered	within	our	definition	of	PPB.	Similarly,	 in	73	cases	the	timing	of	the	haemorrhage	 is	 not	 stated,	 again	 this	 may	 have	 lead	 to	 an	 inaccurate	representation	of	PPB	rate	by	our	definition40.			Macrae	 et	 al.’s	 report	 of	 complications	 from	 5000	 diagnostic	 and	 therapeutic	colonoscopies	 at	 St.	 Marks	 Hospital,	 London	 between	 January	 1971	 and	November	1980	provided	the	necessary	detail	with	regard	to	the	classification	of	PPB.	Snare	polypectomy	of	1,795	polyps	over	7mm	in	size	was	associated	with	haemorrhage	 in	 48	 patients.	 Importantly,	 those	 with	 haemorrhage	 were	 sub	divided	 into	 minor,	 major	 and	 secondary	 haemorrhage.	 In	 those	 with	 major	haemorrhage,	measures	 to	 control	 it	 during	 the	 colonoscopy	 had	 failed.	 Those	with	secondary	haemorrhage	presented	at	5-14	days	post	procedure.	These	two	groups	would	therefore	be	considered	within	our	definition.	This	gives	a	rate	of	1.06%	per	number	of	polypectomies.	In	this	series,	however,	we	are	told	that	late	complications,	 which	 would	 include	 those	 with	 secondary	 haemorrhage	however,	 may	 not	 always	 have	 been	 captured	 which	 may	 have	 lead	 to	 under	reporting	in	this	group43.			Studies	 specifically	 reporting	 PPB	 from	 single	 centres	 may	 be	 best	 placed	 to	reflect	its	true	incidence	within	the	definition	I	have	used	in	this	thesis.	Rosen	et	al.	 reported	 on	 16,910	 patients	 who	 had	 a	 colonoscopy	 between	 1987-1991.	
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Polypectomies	 took	 place	 in	 4,721	 of	 these	 patients	 and	 20	 (0.4%)	 of	 these	patients	experienced	haemorrhage	requiring	hospital	admission96.				A	 further	 study	 of	 over	 12,000	 patients	who	 underwent	 colonoscopy	 between	1989	and	1993	resulted	in	a	total	of	6,365	procedures	where	polypectomies	or	biopsies	took	place.	It	described	major	haemorrhage,	which	would	be	considered	within	 our	 definition	 of	 PPB	 in	 13	patients,	 equating	 to	 0.2%	of	 colonoscopies	where	a	polypectomy	or	biopsy	was	performed.	Unfortunately,	the	breakdown	of	haemorrhage	rate	is	not	given	for	polypectomies	and	biopsies	and	therefore	the	true	rate	of	PPB	cannot	be	determined97.		We	can	be	confident	that	more	accurate	representation	of	PPB	rates,	within	the	definition	 used	 in	 this	 thesis,	 are	 reported	 by	 subsequent	 larger	 series.	 	 This	includes	 Sorbi	 et	 al.’s	 descriptive	 analysis,	 which	 reported	 on	 14,575	colonoscopies	where	 a	 polypectomy	had	 occurred	 over	 a	 period	 from	1989	 to	1996.	 83	 cases	 of	 post	 polypectomy	bleeding	were	 identified,	 all	 of	which	 had	been	admitted	to	hospital.	This	gave	a	PPB	rate	of	0.57%	per	colonoscopy	where	a	 polypectomy	was	 performed98.	 A	 study	 of	 6066	 colonoscopies	 from	 Sweden	published	 in	 2001	 describes	 a	 total	 of	 2635	 hot	 biopsies	 and	 snare	polypectomies.	The	number	of	post	polypectomy	bleeds	admitted	is	recorded	as	9	of	12	post	polypectomy	bleeds	 in	 total,	 a	 rate	of	0.34%	per	polypectomy.	An	Australian	study	of	30,463	colonoscopies	from	1989	–	1999	breaks	down	those	cases	 of	 post	 colonoscopy	 bleeding	 requiring	 hospital	 admission	 to	 those	 that	occurred	 specifically	 after	 polypectomy;	 this	 gave	 a	 PPB	 rate	 of	 0.14%	 per	colonoscopy99.	
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	Studies	published	after	the	turn	of	the	new	millennium	have	specifically	reported	the	 incidence	 of	 PPB	 within	 specific	 time	 periods	 after	 colonoscopy,	 thus	ensuring	it	meets	the	criteria	for	PPB	defined	in	this	thesis.	Rathgaber	reported	complication	rates	from	12,407	colonoscopies	and	5074	polypectomies	with	23	Post	 Polypectomy	 Bleeds	 identified.	 Another	 such	 study	 of	 24,	 509	 lower	gastrointestinal	 endoscopies	 allowed	 calculation	 of	 PPB	 rate	 per	 number	 of	colonoscopies	(0.15%)	up	to	30	days	post	colonoscopy	but	did	not	offer	the	total	number	of	polypectomies60.	The	same	primary	author	later	reported	on	29,990	lower	gastrointestinal	endoscopies	with	a	PPB	rate	per	number	of	colonoscopies	of	0.07%100.		A	study	of	severe	delayed	Post	Polypectomy	Bleeding	among	4,592	patients	that	underwent	colonoscopy	and	polypectomy	published	in	2008	helpfully	states	that	all	patients	presenting	1-14	days	after	polypectomy	with	PPB	were	admitted	to	hospital	or	observed	for	at	least	12	hours.	This	reflects	a	true	PPB	rate	of	0.89%	per	number	of	patients101.	This	figure	is	similar	to	the	number	reported	by	Kim	at	al.	which	was	published	in	2011,	0.98%	per	number	of	patients,	all	be	it	with	a	smaller	 sample	 size102.	A	much	 larger	 series	 from	Canada	 reported	on	hospital	admission	 with	 bleeding	 in	 the	 30	 days	 after	 colonoscopy	 in	 67,632	 patients.	There	 were	 80	 cases	 of	 bleeding	 reported	 following	 either	 hot	 biopsy	polypectomy	 or	 snare	 polypectomy	 resulting	 in	 a	 PPB	 rate	 per	 patient	 of	0.12%103.	The	figure	of	PPB	reported	by	Wu	et	al.	was	higher	than	this	at	0.6%	per	patient	but,	again,	with	a	smaller	sample	size104.		
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Rutter	 et	 al.’s	 study	 reporting	 adverse	 event	 rate	 related	 to	 polypectomy,	including	bleeding,	from	the	English	NHSBCSP	up	to	and	including	January	2012	is	one	of	the	few	studies	to	provide	the	detail	allowing	PPB	rate	to	be	calculated	per	 colonoscopy,	 per	 polypectomy	 and	 per	 colonoscopy	where	 a	 polypectomy	was	performed.	This	study	used	the	NHSBCSP	definition	of	bleeding	that	has	also	been	 used	 in	 this	 thesis,	 reporting	 a	 therapeutic	 bleeding	 rate	 of	 0.60%	 per	colonoscopy,	 0.47%	per	 polypectomy	 and	 1.14%	per	 number	 of	 colonoscopies	where	polypectomy	was	performed39.		When	considering	the	studies	reported	in	this	chapter	over	the	last	40	years,	we	are	 left	with	 a	 PPB	 incidence	 per	 number	 of	 colonoscopies	 of	 0.07-0.60%,	 per		number	of	polypectomies	of	0.34-1.09%	and	per	number	of	colonoscopies	where	polypectomy	is	performed	of	0.42-1.14%.			PPB	 incidence	 is	 summarised	 in	 table	 2.	 Studies	 expressing	 PPB	 rate	 with	patients	 in	 the	 denominator	 have	 been	 excluded	 from	 this	 table.	 When	expressing	 PPB	 incidence	 it	 is	 only	 using	 colonoscopies,	 polypectomies	 or	colonoscopies	 where	 polypectomies	 are	 performed	 in	 the	 denominator	 that	gives	a	true	representation	of	PPB	incidence.				
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Table	 2:	 PPB	 incidence	 per	 colonoscopy,	 polypectomy	 and	 colonoscopy	
where	polypectomy	performed	
PPB	incidence	per	colonoscopy	
w
here	a	polypectom
y	w
as	perform
ed	
PPB	incidence	per	polypectom
y	
PPB	incidence	per	colonoscopy	
Post	Polypectom
y	Bleeds	
Colonoscopies	w
here	polypectom
ies	
perform
ed	
Polypectom
ies	
Colonoscopies	
Patients	
Year	
Study	
	 1.09%	 	 115	 	 6214	 	 	 1974	
Rogers		et	al.			 1.06%	 	 48	 	 1795	 5000	 	 1980	 Macrae	
et	al.	0.42%	 	 	 20	 4721	 	 	 16910	 1991	 Rosen	et	
al.	
0.57%	 	 	 83	 14575	 	 	 	 2000	 Sorbi	et	
al.	
	 0.34%	 	 9	 	 2635	 6066	 4304	 2001	 Dafnis	et	
al.	
	 	 0.14%	 44	 	 	 30463	 26841	 2003	 Viiala	et	
al.	
	 0.45%	 0.19%	 23	 	 5074	 12,407	
	 2006	 Rathgab
er	et	al.	
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	 	 0.15%	 21	 	 	 24509	 	 2009	 Singh	et	
al.	
	 	 0.07%	 	 	 	 29990	 	 2010	 Singh	et	
al.	
0.5%	 	 	 103	 20,571	
	 43,456	
	 2012	 Inadomi	
et	al.		 0.63%	 	 66	 	 10,513	
	 4719	 2012	 Saraya	
et	al.		1.14%	 0.47%	 0.60%	 787	 69028	 167208	
130831	
112024	
2014	 Rutter	et	al.		
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2.6.4	Risk	factors	for	post	polypectomy	bleeding			Risk	 factors	 associated	 with	 PPB	 may	 relate	 to	 the	 patient	 having	 the	polypectomy,	 including	 the	 specific	 polyp	 itself,	 the	 colonoscopy	 and	polypectomy	 or	 the	 colonoscopist	 who	 performs	 the	 colonoscopy	 and	polypectomy.	As	with	the	literature	reviewed	in	chapter	2.5.2,	it	is	important	to	consider	the	precise	definition	of	PPB	used	when	evaluating	PPB	risk.		As	with	colonoscopic	perforation,	increasing	patient	age	has	been	shown	to	be	a	significant	 risk	 factor	 for	 PPB104	 105.	 Age	 was	 a	 significant	 predictor	 of	 PPB	requiring	 transfusion	 in	 one	 study	 which	 also	 showed	 the	 presence	 of	cardiovascular	 co-morbidity	and	renal	disease	 to	be	 significant98.	 Similarly,	 the	presence	of	cardiovascular	co-morbidity	in	the	form	of	hypertension	was	found	to	 be	 predictive	 of	 PPB	 in	 a	 further	 study	which	 specifically	 examined	 patient	related	 factors106.	 Although	 there	 is	 clear	 guidance	 regarding	 the	 use	 of	anticoagulant	medication	such	as	Warfarin	and	antiplatelet	medication	such	as	Clopidogrel	when	attempting	polypectomy,	 such	medications	have	been	shown	to	increase	the	risk	of	PPB	when	restarted	within	a	week	of	polypectomy	taking	place101.	Similarly,	a	patient	taking	Aspirin	may	be	at	increased	risk,	which	would	be	 consistent	 with	 the	 studies	 reporting	 cardiovascular	 co-morbidity	 as	significant	 risk	 factors105	 107.	 Diverticular	 disease	 at	 the	 site	 of	 polypectomy	 is	another	reported	patient	related	risk	factor	for	PPB108.		Studies	 have	 reported	 PPB	 risk	 factors	 specifically	 relating	 to	 the	 polyp	 itself.	Increasing	 polyp	 size	 has	 consistently	 be	 shown	 to	 be	 important101	 106	 109	 110.	
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Location	of	the	polyp	in	the	right	colon	and	particularly	in	the	caecum	have	also	been	reported	as	high	risk	 locations105	111	112	110.	One	of	 these	studies	reported	the	 shape	of	 the	polyp	 as	 being	pedunculated	 as	 a	 significant	 risk	 factor	while	another	 the	 histology	 of	 the	 polyp	 as	 either	 Juvenile	 or	 Peutz-Jegher	 as	 being	significant109	110.		Piecemeal	polypectomy,	 the	use	of	 sedation	and	bleeding	visualised	during	 the	colonoscopy	have	all	 been	 reported	as	procedure	 related	 factors	 for	PPB108	 109	
111.		A	 reported	 colonoscopist	 specific	 risk	 factor	 for	 PPB	 related	 to	 those	who	 are	less	 experienced	 colonoscopists.	 One	 study	 reported	 performing	 less	 than	 591	procedures	 per	 year	 as	 a	 significant	 risk	 factor,	 however,	 a	 clear	 definition	 of	PPB	is	not	offered	in	this	study,	it	being	described	as	that	treated	endoscopically,	leaving	 the	 reader	 to	 presume	 this	 is	 at	 the	 time	 of	 the	 polypectomy	 and	therefore	would	not	be	considered	PPB	by	this	thesis’s	definition58.		Data	 from	 the	 English	 National	 Health	 Service	 Bowel	 Cancer	 Screening	Programme	 is	 consistent	with	 that	 reporting	 polyp	 size	 and	 the	 right	 colon	 as	being	 important;	 both	 the	 size	 of	 the	 polyp	 and	 a	 location	 of	 a	 polyp	 in	 the	caecum	 were	 shown	 to	 be	 significant	 risk	 factors	 for	 bleeding	 and	 bleeding	requiring	transfusion39.		
2.6.5	 How	 a	 patient	 with	 post	 polypectomy	 bleeding	 presents	 for	
consultation	
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	PPB	usually	presents	 symptomatically	with	bleeding	or	melaena	per	 rectum.	 If	the	bleeding	is	not	visually	obvious,	patients	may	present	symptomatically	from	haemodynamic	 instability,	 orthostatic	 hypotension,	 haemorrhagic	 shock	 or	syncope.	 In	 Sorbi	 et	 al’s	 descriptive	 analysis	 of	 post	 polypectomy	 lower	gastrointestinal	 bleeding,	 presentation	 was	 at	 a	 median	 of	 five	 days	 post	colonoscopy,	 43%	 of	 patients	 were	 either	 tachycardic,	 hypotensive	 or	 had	changes	of	orthostatic	hypotension98.	
	
2.6.6	The	management	of	post	polypectomy	bleeding	
	Post	polypectomy	bleeding	may	require	another	colonoscopy	in	order	to	provide	therapy	 to	 achieve	 haemostasis.	 However,	 if	 this	 is	 not	 successful	 or	 possible,	radiological	intervention	or	surgery	are	alternative	management	strategies.		Fundamental	 to	 managing	 patients	 who	 present	 after	 the	 colonoscopy	 is	intravascular	 volume	 resuscitation	with	 intravenous	 fluids	 and	 red	blood	 cells.	Fresh	frozen	plasma,	platelets,	cryoprecipitate	and/or	vitamin	k	may	be	required	to	 reverse	 the	 effects	 of	 altered	 blood	 coagulation.	 In	 the	 series	 of	 20	patients	described	by	Rosen	et	al.	five	required	blood	transfusion96.	Gibbs	et	al.	described	12	of	13	patients	with	post	polypectomy	colonic	haemorrhage	requiring	a	mean	of	5.5	units	of	red	blood	cells,	 including	one	who	was	taking	warfarin	who	was	transfused	 14	 units	 of	 packed	 red	 blood	 cells	 and	 eight	 units	 of	 fresh	 frozen	plasma97.	 	 In	Sorbi	et	al.’s	 larger	series	of	83	patients,	45	patients	required	red	blood	cells,	eight	patients	platelets	and	ten	patients	fresh	frozen	plasma98.		
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2.6.6.1	The	endoscopic	management	of	post	polypectomy	bleeding	
	A	 repeat	 colonoscopy	 or	 flexible	 sigmoidoscopy	 examination	may	 identify	 the	site	 of	 PPB.	 There	 are	 a	 variety	 of	 endoscopic	 methods	 by	 which	 the	haemorrhage	can	then	be	controlled	and	stopped.		Mechanical	pressure	applied	to	the	bleeding	mucosa	may	be	sufficient	to	provide	haemostasis.	A	case	report	published	in	1982	described	the	use	of	polypectomy	grasping	forceps	or	the	“plumber’s	helper”	in	order	to	do	this113.	Using	a	snare	or	forceps	to	provide	the	pressure	required	is	also	feasible114.		The	use	of	an	injection	needle	through	the	scope	with	administration	of	1;10,000	dilution	 of	 adrenaline	 alone	 may	 be	 sufficient	 to	 stop	 PPB,	 though	 this	 is	commonly	used	in	conjunction	with	another	endoscopic	technique.	Endoclips	left	in	place	to	provide	pressure	to	the	site	of	haemorrhage	are	effective	in	achieving	haemostasis115.	Of	18	cases	of	PPB	described	by	Kim	et	al.,	one	was	injected	with	epinephrine	 (adrenaline)	 and	 17	 were	 managed	 with	 hemoclips,	 though	 two	suffered	 rebleeding	 and	 required	 further	 hemoclips102.	 The	 use	 of	 an	 endoclip	has	also	been	described	with	a	detachable	snare	and	with	an	endoloop116	117.			More	recent	reports	have	described	the	use	of	endoscopic	band	ligation	for	post	polypectomy	 haemorrhage	 of	 a	 large	 pedunculated	 polyp118.	 Case	 reports	published	 in	 2014	 have	 described	 the	 successful	 use	 of	 a	 polysaccharide	
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haemostatic	 system	 and	 Ovesco	 system	 for	 control	 of	 postpolypectomy	haemorrhage119	120.		
2.6.6.2	The	radiological	management	of	post	polypectomy	bleeding	
	For	 those	 patients	who	 fail	 endoscopic	management,	 radiological	 investigation	and	intervention	may	be	required	to	identify	the	source	of	bleeding	and/or	stop	it.		Technetium	 tagged	 red	 blood	 cell	 scintigraphy	 has	 been	 used	 to	 identify	 the	bleeding	source	in	cases	of	PPB.	This	may	be	followed	by	angiography	with	the	administration	 of	 selective	 vasopressin	 or	 arterial	 embolization97	 98.	 In	 one	report	 of	 such	 treatment	 intra	 arterial	 vasopressin	 infusion	 of	 the	 inferior	mesenteric	artery	was	used	in	the	treatment	of	two	patients.	These	patients	had	co-morbidity	and	were	a	high	anaesthetic	risk	for	surgery.	Vasopressin	infusion	controlled	the	haemorrhage	 in	both	patients	without	compliaction121.	A	 further	report	 of	 a	 patient	 who	 had	 continued	 to	 bleed	 despite	 the	 endoscopic	application	of	clips	described	the	use	of	angiography	and	the	embolization	of	the	sigmoid	 branches	 of	 the	 inferior	mesenteric	 artery	 using	microcoils122.	 Similar	management	was	required	 for	a	patient	with	post-polycythaemia	myelofibrosis	who	 had	 been	 not	 been	 taking	 their	 usual	 anti	 platelet	medication	 seven	 days	either	 side	 of	 a	 colonoscopy	 and	 polypectomy.	 Haemorrhage	 at	 the	 site	 of	polypectomy	was	demonstrated	by	arteriography	and	selective	embolization	of	the	 three	 branches	 of	 the	 ileo	 colic	 artery	 successfully	 controlled	 the	haemorrhage123.	 Endoclips	 that	 are	 left	 in	 place	 from	 attempted	 endoscopic	
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management	 may	 help	 in	 locating	 the	 source	 of	 PPB	 when	 angiography	 is	attempted55.	
	
2.6.6.3	The	surgical	management	of	post	polypectomy	bleeding		
	Rarely,	 a	 patient	 may	 require	 surgery	 in	 order	 to	 control	 PPB.	 Surgery	 is	indicated	 if	 the	 patient	 is	 too	 unstable	 for,	 or	 fails	 endoscopic	 or	 radiological	management,	 or	 the	 site	 of	 the	 haemorrhage	 cannot	 be	 identified	 by	 these	methods.			An	over	sew	of	the	stump	of	a	polyp	to	control	PPB	was	reported	by	Macrae	et	al.	in	one	of	this	papers	cases	of	major	haemorrhage.	Another	patient	in	this	series	with	 recurrent	 haemorrhage	 eventually	 required	 a	 laparotomy	 although	 the	exact	 nature	 of	 the	 operation	 is	 not	 specified43.	 Of	 41	 patients	 with	 post	polypectomy	bleeding	described	by	Sawhney	et	al.,	which	would	be	included	in	this	thesis’s	definition	of	PPB,	one	patient	underwent	surgery	to	control	bleeding	although,	 again,	 the	 exact	 nature	 of	 the	 case	 is	 not	 specified101.	 Of	 11	 patients	presenting	with	PPB	during	the	30	days	after	colonoscopy	in	a	study	comparing	PPB	in	those	on	Aspirin	to	those	who	were	not,	one	patient	required	emergency	surgery	 though	 further	 detail	 of	 the	 surgery	 is	 not	 provided107.	 12	 cases	 of	bleeding	 associated	 with	 1389	 therapeutic	 colonoscopies	 from	 a	 Swedish	database	included	one	with	PPB	that	required	an	exploratory	laparotomy38.		Colonic	 resection	 is	 the	 definitive	 surgical	 management	 of	 PPB	 if	 all	 other	attempts	 at	 haemorrhage	 control	 fail	 or	 the	 source	 of	 haemorrhage	 cannot	 be	
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identified.	Rosen	 et	 al.	 described	one	patient	 requiring	 subtotal	 colectomy	 and	Sorbi	et	al.	two	patients	requiring	a	hemicolectomy96	98.		
2.6.7	The	prognosis	following	post	polypectomy	bleeding			There	is	limited	data	reported	on	patient	prognosis	and	outcomes	following	PPB,	including	 recurrent	 bleeding,	 morbidity	 and	 mortality	 from	 early	 series.	However,	 Sorbi	et	al’s	descriptive	analysis	of	83	patients	published	 in	 the	year	2000	reported	a	median	in	patient	hospital	stay	of	three	days	with	one	death98.		Singh	 et	 al.	 reported	 length	 of	 hospital	 stay	 in	 17	 patients	 with	 delayed	 PPB	when	 comparing	 those	 on	 interrupted	 clopidogrel	 therapy	 to	 those	 not	 on	clopidogrel.	Hospital	stay	in	these	patients	ranged	from	0	to	4	days124.	Inoue	et	al.	 investigated	 the	 clinical	 features	 of	 PPB	 associated	 with	 Heparin	 Bridge	therapy.	Of	10	patients	with	PPB,	9	of	whom	were	on	Heparin	Bridge	therapy	at	the	 time	 of	 polypectomy,	 hospital	 stay	 ranged	 from	 7	 to	 37	 days.	 Of	 these	 9	patients,	5	(55.6%)	had	recurrent	bleeding125.		
2.7	Post	colonoscopy	colorectal	cancer	(PCCRC)		
2.7.1	The	definition	of	post	colonoscopy	colorectal	cancer			A	 colonoscopy	 has	 the	 potential	 to	 miss	 pathology.	 Patients	 attending	 for	colonoscopy	 are	 made	 aware	 of	 this	 as	 part	 of	 the	 consent	 process.	 Such	pathology	 may	 include	 pre	 cancerous	 polyps	 and	 indeed	 colorectal	 cancers	themselves.		
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	When	colonoscopy	 is	used	during	 screening	programmes	 for	 colorectal	 cancer,	cancers	 that	 present	 in	 between	 screening	 colonoscopies	 are	 termed	 interval	cancers.	Although	 interval	 cancers	may	be	 included	within	 the	definition	of	 an	adverse	 event,	 interval	 cancer	 excludes	 those	 cancers	 that	 are	 diagnosed	 on	subsequent	 screening	 and	 surveillance	 colonoscopies.	 Such	 cancers	 may	 be	regarded	 as	 successes	 when	 diagnosed	 as	 part	 of	 a	 screening	 programme.	However,	they	could	be	due	to	a	lesion	missed	or	incompletely	resected	during	a	previous	 colonoscopy,	 and	 therefore,	 can	 be	 considered	 as	 a	 colonoscopic	adverse	event	of	the	initial	colonoscopy.		Therefore,	the	term	post	colonoscopy	colorectal	cancer	is	more	encompassing	as	an	adverse	event	as	 it	 includes	both	 interval	cancers	and	cancers	diagnosed	as	part	 of	 the	 screening	 programme	 that	 were	 potentially	 missed	 at	 a	 previous	colonoscopy.		
2.7.2	Post	colonoscopy	colorectal	cancer	rate		The	rate	of	post	colonoscopy	colorectal	cancer	is	dependent	on	the	methodology	and	 formula	used	 to	calculate	 it.	There	 is	currently	no	 internationally	accepted	formula	 for	 calculating	 PCCRC	 rate;	 different	 studies	 have	 used	 differing	methodology,	which	makes	the	comparison	of	such	figures	difficult126.	Because	of	this,	 ensuring	 methodology	 is	 clear	 when	 calculating	 rates	 is	 of	 paramount	importance.		
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The	majority	of	studies	have	used	cancers	in	the	numerator	and	denominator	to	calculate	 PCCRC	 rate.	 Such	 rates,	 therefore,	 express	 PCCRCs	 within	 the	 total	number	of	 cancers	diagnosed	during	 a	period	of	 time.	However,	 different	 time	periods	 after	 the	 initial	 colonoscopy	 may	 used	 to	 define	 when	 a	 PCCRC	 has	occurred.	 In	addition,	 interval	cancers	may	also	be	defined	differently	between	studies.		Farrar	et	al	defined	interval	cancer	as	a	colorectal	cancer	developing	five	years	after	a	complete	colonoscopy.	In	this	study,	830	patients	were	diagnosed	with	a	colorectal	 cancer	 over	 an	 approximately	 14	 year	 period.	 Of	 these	 patients,	 45	were	 diagnosed	within	 five	 years	 of	 a	 previous	 colonoscopy,	 5.4%	 of	 all	 these	cancers127.	 Huang	 et	 al.	 retrospectively	 analysed	 data	 on	 patients	 having	 a	surveillance	colonoscopy	within	five	years	after	a	colonoscopic	polypectomy.	Of	1,794	 patients	 undergoing	 surveillance	 colonoscopy	 within	 five	 years	 of	 a	colonoscopic	polypectomy,	14	had	cancer128.	Similarly,	Le	Clerc	et	al.	also	defined	PCCRC	as	colorectal	cancer	that	had	been	diagnosed	within	5	years	after	an	index	colonoscopy,	2.9%	of	all	cancers	in	this	study129.		A	 time	 period	 of	 a	 colorectal	 cancer	 diagnosed	 3	 years	 after	 an	 initial	colonoscopy	 has	 also	 been	 used	 in	 several	 studies.	 Haseman	 et	 al.	 reported	 a	total	 of	 941	 cases	 of	 colorectal	 cancer	 diagnosed	 by	 colonoscopy;	 in	 47	 a	colonoscopy	performed	within	three	years	of	the	diagnosis	had	not	detected	the	cancer130.		Two	retrospective	studies	from	Canada	have	also	used	this	timescale.	Bressler	et	 al.	 studied	a	 cohort	of	12,487	patients	with	 colorectal	 cancer,	3.4%	had	a	colonoscopy	6-36	months	prior	to	the	diagnosis.	However,	this	total	study	
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cohort	 excluded	patients	with	 Inflammatory	Bowel	Disease	 and	 cancers	where	the	colorectal	cancer	site	was	not	specified	in	their	register.	It	also	assumed	that	for	those	patients	who	had	a	colonoscopy	within	six	months	of	the	diagnosis,	that	colonoscopy	had	made	the	diagnosis131.	Similarly,	Baxter	et	al.	defined	those	as	having	 PCCRC	 when	 they	 had	 undergone	 complete	 colonoscopy	 7-36	 months	prior	to	their	diagnosis.	The	overall	rate	of	PCCRC	was	9%132.		Two	more	studies	from	 the	U.S.A	 also	 used	 this	methodology	 of	 patients	 diagnosed	 6-36	months	after	 an	 initial	 colonoscopy,	 those	 cancers	 being	 diagnosed	 within	 6	 months	being	 attributed	 to	 the	 initial	 colonoscopy,	 the	 rates	 being	 6.9%	 and	 7.2%	respectively,	the	latter	being	in	a	larger	cohort133	134.			Longer	 follow	up	periods	than	five	years	after	an	 index	colonoscopy	have	been	used	in	studies	for	calculating	PCCRC	rate.	Brenner	et	al.	studied	predictors	and	characteristics	of	interval	cancers	10	years	after	a	negative	index	colonoscopy,	of	1945	cases	of	colorectal	cancer,	78	were	interval	cancers135.	A	15	year	follow	up	period	 was	 used	 by	 Rabeneck	 et	 al.	 who	 reported	 an	 interval	 cancer	 rate	 of	14.5%	among	110,402	individuals	who	had	an	initial	negative	colonoscopy136.		
2.7.3	Risk	factors	for	developing	post	colonoscopy	colorectal	cancer		Five	 possible	 mechanisms	 have	 been	 suggested	 to	 explain	 the	 occurrence	 of	PCCRC.	 PCCRC	 may	 develop	 from	 lesions	 that	 were	 missed	 during	 previous	colonoscopy	either	missed	cancers	or	missed	adenomas	that	progress	to	cancer.	PCCRC	may	present	from	an	adenoma	or	cancer	that	was	incompletely	resected	at	the	initial	colonoscopy137.	It	is	for	these	reasons	that	PCCRC	can	be	considered	
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within	the	definition	of	a	colonoscopic	adverse	event.	A	fifth	mechanism	for	the	development	 of	 PCCRC	 is	 rapidly	 developing	 colorectal	 cancers	 that	 develop	after	 an	 initial	 colonoscopy.	 These	 cancers	 cannot	 be	 attributed	 to	 the	 initial	colonoscopy.		Considerable	 recent	 research	 has	 focused	 on	 identifying	 factors	 that	 are	associated	 with	 the	 development	 of	 PCCRC	 and	 in	 identifying	 differences	 in	characteristics	between	PCCRC	and	colorectal	cancers	that	are	not	PCCRCs.		Risk	factors	for	the	development	of	PCCRC	may	relate	to	the	patient,	the	colonoscopy	itself,	the	colonoscopist	that	performs	the	procedure	or	the	setting	in	which	the	colonoscopy	is	performed.		Increasing	 patient	 age	 has	 been	 shown	 to	 be	 a	 significant	 predictor	 of	 PCCRC.	Older	age,	and	an	age	over	85	years	were	reported	as	significant	factors	in	three	studies	although	in	one	of	these	this	related	to	only	PCCRCs	in	the	distal	colon131	
132	 138.	 In	one	of	 these	studies,	male	sex	 is	also	a	reported	risk	 factor,	however,	this	 is	contrast	 to	Brenner	et	al.	who	showed	that	 female	sex	was	strongly	and	independently	associated	with	development	of	interval	cancer138	135.	Baxter	et	al.	also	corroborate	female	sex	being	a	risk	factor	for	PCCRC	development	although,	again	this	related	to	distal	colonic	cancers	only.	Increasing	patient	co-morbidity	is	also	reported	as	a	significant	predictor	of	PCCRC	development	in	this	study132.	Likewise	Cooper	et	al.	 also	 found	 increased	co-morbidity	 to	be	associated	with	interval	cancers134.		
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In	addition	to	patient	age,	sex	and	co-morbidity	the	location	of	the	cancer	in	the	patient’s	colon	has	consistently	been	shown	to	be	an	important	factor	relating	to	the	development	of	PCCRC.	A	proximal	 colonic	 location	of	 the	PCCRC	has	been	reported	 as	 a	 significant	 factor	 in	 several	 studies127	 129	 131	 132	 133	 135	 134.	 The	presence	of	 other	pathology	 in	 the	 colon,	 for	 example,	 diverticular	disease	has	also	been	proven	significant131	134.		As	proximal	 colonic	 location	 is	 such	a	 significant	 risk	 factor	 for	PCCRC,	 factors	relating	to	the	colonoscopy	itself	are	also	likely	to	be	important.	This	may	relate	to	 a	 colonoscopy	 where	 the	 proximal	 colon	 is	 not	 intubated.	 Brenner	 et	 al.	showed	that	the	colonoscopy	prior	to	development	of	the	PCCRC	was	more	likely	to	 have	 been	 incomplete	 among	 patients	 with	 interval	 cancers135.	 Similarly	incomplete	 polypectomy	 is	 associated	 with	 PCCRC	 development.	 Farrar	 et	 al.	showed	 that	 the	 location	 of	 previous	 polypectomy	 segments	was	 predictive	 of	the	location	of	interval	cancers.		As	 completeness	 of	 colonoscopic	 examination	 and	 polypectomy	 are	 important	factors	in	PCCRC	development,	it	follows	that	factors	relating	to	the	expertise	of	the	 colonoscopist	 are	 also	 likely	 to	 be	 significant.	 	 Colonoscopists	 performing	polypectomies	 at	 higher	 rates	 was	 associated	 with	 a	 lower	 risk	 of	 proximal	PCCRC	 in	one	study	and	similarly	 lower	polypectomy	rate	was	a	risk	 factor	 for	PCCRC	 in	 another132	 134.	 Patients	 undergoing	 colonoscopy	 by	 a	 colonoscopist	with	a	Caecal	Intubation	Rate	(CIR)	≥	95%	were	less	likely	to	have	a	PCCRC	than	those	with	a	CIR	≤	80%132.	The	specialty	of	the	colonoscopist	also	contributes	to	such	factors;	a	non-gastrointestinal	colonoscopist	being	a	significant	factor131	133	
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136	138.	Finally,	the	setting	in	which	the	initial	colonoscopy	has	been	reported	as	a	risk	 factor	 for	 PCCRC;	 a	 non	hospital	 setting	 being	 significant	 in	Baxter	 et	 al.’s	study132.		
2.8	The	colonoscopist	and	adverse	events		
	
	It	is	important	to	recognise	that	not	only	the	patient,	but	also	the	colonoscopist	may	 be	 affected	 by	 an	 adverse	 event	 associated	with	 a	 colonoscopy	 they	 have	performed.	This	is	particularly	the	case	in	the	context	of	a	screening	programme	for	colorectal	cancer.	Colonoscopists	require	extensive	training	and	assessment	of	 performance	 in	 order	 to	 become	 fully	 certified	 to	 perform	 colonoscopies	independently.	 	 Those	 colonoscopists	 working	 within	 the	 Bowel	 Cancer	Screening	 Programme	 in	 the	 England	 have	 undertaken	 further	 written	 and	practical	assessment	in	order	to	become	screening	accredited20.		Performing	a	colonoscopy	associated	with	an	adverse	event	may	have	a	negative	impact	 on	 the	 colonoscopist,	 both	 personally	 and	 professionally.	 The	professional	 impact	 of	 such	 an	 event	 may	 be	 to	 the	 detriment	 of	 their	 future	colonoscopic	 practice.	 	 For	 example,	 the	 colonoscopist	 may	 be	 less	 willing	 to	continue	 the	 procedure	 when	 it	 is	 difficult,	 perform	 a	 large	 polypectomy	 or	withdraw	the	colonoscope	more	quickly	than	they	should	meaning	they	may	be	more	prone	to	missing	pathology.			There	is	little	literature	specifically	surrounding	endoscopists’	reaction	to		
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colonoscopic	or	other	endoscopic	adverse	events.	However,	many	studies	have	focused	on	the	reaction	of	different	health	care	professionals	to	adverse	events	in	 a	 range	 of	 other	medical	 and	 surgical	 fields.	 Such	 studies	 often	 refer	 to	 the	health	care	professional	involved	as	the	second	victim	of	the	adverse	event,	the	first	victim	being	the	patient	and	the	family	of	the	patient	involved139,140.	
A	 second	 victim	 has	 been	 defined	 as	 “a	 health	 care	 provider	 involved	 in	 an	unanticipated	 adverse	 patient	 event,	 medical	 error	 and/or	 a	 patient	 related	injury	 that	 became	 victimised	 in	 the	 sense	 that	 the	 health	 care	 provider	 is	traumatised	by	the	event.	Frequently,	second	victims	feel	personally	responsible	for	 the	 unexpected	 patient	 outcomes	 and	 feel	 as	 though	 they	 have	 failed	 their	patient	and	feel	doubts	about	their	clinical	skills	and	knowledge	base”.141	
Scott	 et	 al.	 conducted	 semi-structured	 interviews	 with	 31	 ‘second	 victims’	 of	different	professional	backgrounds,	most	of	whom	were	doctors	and	nurses.	Six	specific	stages	in	their	reaction	were	identified.			Initially	 they	 described	 a	 ‘chaos	 and	 accident	 response’	 involving	 ‘chaotic	 and	confusing	scenarios	of	both	external	and	internal	turmoil	that	ultimately	led	to	a	realisation	 of	 what	 had	 occurred’.	 These	 often	 occurred	 in	 the	 immediate	aftermath	 of	 the	 adverse	 event	 when	 a	 patient	 was	 unstable	 and	 required	additional	 professional	 input.	 Secondly,	 there	 was	 a	 period	 of	 ‘intrusive	reflection’	with	‘feelings	of	internal	inadequacy	and	self	isolation’.	Thirdly,	Scott	et	 al.	 described	 ‘restoring	 personal	 integrity’	 by	 seeking	 support	 from	 an	individual	with	whom	they	had	a	trusting	relationship.	‘Enduring	the	inquisition’	follows	where	the	second	victim	starts	to	wonder	about	repercussions	affecting	
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job	security	and	future	litigation.		The	second	victim	then	‘obtains	emotional	first	aid’	 and	 then,	 finally	 ‘moves	 on’.	 The	 ‘moving	 on’	may	 involve	 three	 potential	paths	of	dropping	out,	surviving	or	thriving141.		The	 initial	 reaction	 of	 the	 health	 care	 professional	 to	 an	 adverse	 event	 is	described	elsewhere	as	being	similar	to	that	of	an	acute	stress	disorder	including	initial	 numbness,	 detachment	 or	 even	 depersonalisation.142	 This	 mimics	 the	initial	stage	described	by	Scott	at	al.141.		A	range	of	emotional	responses	is	a	recurring	theme	of	other	studies	examining	health	 care	 professionals’	 reactions	 to	 adverse	 events.	 Common	 reported	reactions	 among	 professionals	 are	 fear,	 guilt,	 shame,	 self	 doubt,	 loss	 of	 self	confidence,	 anger	 and	 disappointment.139	 The	 intensity	 of	 emotional	 reaction	appears	to	be	related	to	the	extent	the	patient	suffers	as	a	result	of	the	adverse	event	and	the	extent	to	which	the	professional	feels	responsible;	poorer	patient	outcomes	 and	 greater	 perceived	 responsibility	 increasing	 the	 intensity	 of	reaction143.		Some	 of	 these	 emotions	 were	 present	 in	 a	 study	 reporting	 specifically	 on	 the	emotional	 impact	 of	 adverse	 events	 on	 physicians	 including	 increased	 anxiety	about	 future	 errors,	 loss	 of	 self	 confidence,	 difficulty	 sleeping	 and	 reduced	 job	satisfaction.144		A	qualitative	study	of	second	victims	of	adverse	events	by	Ullstrom	et	al.	using		
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the	 same	 semi	 structured	 interview	methodology	of	 Scott	 et	 al.	 reported	 three	subcategories	 to	 the	 impact	 of	 the	 adverse	 event.	 The	 first	 of	 these	 was	 the	emotional	reaction	to	the	event	that	included	sadness,	anxiety,	reliving	the	event,	guilt,	 shame,	 decreased	 professional	 reputation,	 frustration	 and	 sleep	disturbance.144			Such	 experiences	 may	 result	 in	 a	 significant	 inability	 of	 the	 professional	 to	continue	with	 their	work,	some	may	choose	 to	 leave	 the	profession	completely	and	there	have	been	reports	of	others	who	commit	suicide.142		A	 second	 and	 third	 phase	 to	 the	 impact	 of	 the	 adverse	 event	 described	 by	Ullstrom	 et	 al.	 appears	 to	 confirm	 these	 findings;	 the	 impact	 on	 professional	performance	and	the	duration	of	the	impact.	Several	of	the	participants	who	were	interviewed	felt	 insecure	 in	their	professional	roles	following	the	adverse	event.	Some	doubted	their	professional	judgement	and	career	choice.	Over	50%	described	 taking	 more	 care	 over	 their	 work	 so	 as	 to	 reduce	 the	 chances	 of	further	problems.	A	majority	described	the	duration	of	the	impact	as	being	long	lasting,	 up	 to	 a	 year	 or	 more,	 with	 most	 stating	 the	 event	 will	 always	 affect	them.144	
A	 similar	 study	 by	 Luu	 et	 al.	 using	 the	 same	 semi	 structured	 interview	framework	devised	by	Scott	et	al.,	 specifically	 investigated	surgeons’	emotional	reaction	 to	 adverse	 events145	 141.	 They	 described	 4	 distinct	 phases	 in	 the	response	 to	 an	 adverse	 event,	 ‘the	 kick’,	 ‘the	 fall’,	 ‘the	 recovery’	 and	 ‘the	 long	term	 impact’.	 ‘The	 kick’	 often	 involved	 a	 physiological	 response,	 commonly	 an	
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anxiety	or	stress	reaction	similar	to	that	seen	during	Scott	et	al.’s	141‘chaos	and	accident’	 response.	 ‘The	 fall’	 follows,	 a	 period	 of	 spiralling	 out	 of	 control	 co	existent	 with	 a	 need	 to	 ‘right	 themselves’.	 ‘The	 fall’	 fits	 with	 Scott	 et	 al.’s	‘intrusive	 reflections’,	 ‘restoring	 personal	 integrity’	 and	 ‘enduring	 the	inquisition’.	During	the	third	phase,	 ‘The	recovery’	the	surgeon	reflected	on	the	event	then	experienced	‘the	long	term	impact’	of	how	the	event	had	impacted	on	their	long	term	judgement	and	decision	making.145	
Some	 authors	 have	 described	 the	 positive	 influence	 that	 involvement	 in	 an	adverse	 event	 may	 have146.	 These	 have	 included	 specific	 changes	 to	 their	practice.	Such	positive	influences	may	be	pertinent	in	the	case	of	a	colonoscopist	who	changes	a	specific	part	of	their	colonoscopic	technique	following	an	adverse	event.		
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Chapter	3	
	
Research	Study	Design	
	
3.1	Research	Studies	
	This	 thesis	consists	of	 four	 interlinked	studies	relating	 to	colonoscopic	adverse	events.	 Two	 of	 these	 studies	 relate	 to	 colonoscopic	 perforation,	with	 a	 further	two	studies	of	post	polypectomy	bleeding	(PPB)	and	post	colonoscopy	colorectal	cancer	 (PCCRC)	 respectively.	These	 studies	 can	be	 found	 in	 chapters	 four,	 five,	six	and	seven	of	this	thesis.	
	The	 review	 of	 literature	 described	 in	 chapter	 two	 of	 this	 thesis	 provided	 an	overview	 of	 the	 current	 use	 of	 colonoscopy	 in	 screening	 programmes	 for	colorectal	cancer,	 including	in	the	English	National	Health	Service	(NHS)	Bowel	Cancer	Screening	Programme	(BCSP).	It	enabled	me	to	establish	the	benefits	and	risks	 to	 the	 public	 that	 colonoscopy	 confers	when	 it	 is	 used	 in	 such	 screening	programmes.	When	I	explored	the	risks	of	colonoscopy	in	greater	detail,	 it	was	apparent	 that	 adverse	 events	 associated	 with	 colonoscopy	 potentially	 provide	the	greatest	threat	to	the	safety	of	individuals	who	accept	the	invitation	to	take	part	 in	 colorectal	 cancer	 screening.	 Evaluating	 such	 events	 still	 further,	 it	was	evident	 that	 perforation,	 post	 polypectomy	 bleeding	 and	 post	 colonoscopy	colorectal	 cancer	 are	 likely	 to	 be	 major	 contributors	 to	 this	 potential	compromise	of	patient	safety.	All	have	the	potential	to	result	in	patient	death.	
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My	intention	in	writing	this	thesis	was,	therefore,	to	examine	these	colonoscopic	adverse	 events	 in	 the	 English	 NHS	 BCSP.	 This	 examination	 comprised	 several	distinct	themes.	Initially,	I	aimed	to	determine	how	frequently	perforation,	PPB	and	PCCRC	occur	in	the	programme.	Furthermore,	I	intended	to	stratify	PPB	by	severity;	 such	 stratification	 had	 not	 been	 previously	 been	 reported	 when	considering	 adverse	 event	 rate.	 I	 then	 intended	 to	 explore	 the	 impact	 of	 these	adverse	events,	not	only	on	the	patients	within	the	programme,	but	also	on	the	health	 care	 professionals	 who	 perform	 colonoscopies.	 Thirdly,	 I	 planned	 to	identify	 risk	 factors	 for	 these	 adverse	 events,	 so	 that	 such	 factors	 could	potentially	 be	 removed	 from	 subsequent	 practice	 and	 the	 risk	 of	 such	 events	occurring	 in	 the	 future	 could	be	minimised.	Fourthly,	 I	wanted	 to	 identify	best	practice	 surrounding	 adverse	 events,	 which	 in	 turn	 may	 help	 improve	 future	management.	 Finally,	 I	 planned	 to	 provide	 a	 reference	 point	 of	 how	 a	colonoscopist	may	 feel	 following	 a	 perforation	 so	 that	 all	 colonoscopists	 could	use	 and	 relate	 to	 this	 should	 they	 encounter	 such	 an	 adverse	 event	 associated	with	one	of	their	colonoscopies	in	the	future.			In	order	to	achieve	this	examination	of	these	three	colonoscopic	adverse	events,	incorporating	all	of	 the	 themes	outlined	above,	 I	used	mixed	methodology.	The	approach	I	took	encompassed	both	quantitative	and	qualitative	health	research	methods.		One	of	 the	purposes	of	using	quantitative	health	 research	methodology	was	 to	determine	the	rates	of	colonoscopic	perforation,	PPB	and	PCCRC	 in	 the	English	NHS	BCSP.	Quantitative	health	research	methodology	was	also	used	to	establish	
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the	 impact	 these	adverse	events	had	on	the	patient	 involved.	This	 involved	the	capture	of	data	relating	 to	 the	patient’s	presentation,	assessment,	management	and	 outcome	 following	 perforation	 and	 PPB.	 I	 designed	 three	 retrospective	observational	case	series	in	order	to	collect	data	relating	to	perforation,	PPB	and	PCCRC.			Quantitative	health	research	methodology,	alone,	however,	would	not	achieve	all	of	 my	 stated	 intentions	 in	 writing	 this	 thesis.	 Minimising	 the	 risk	 of	 these	colonoscopic	 adverse	 events	 required	 identifying	 factors,	 some	 of	which	 could	not	be	measured	quantitatively.	Similarly,	exploring	the	impact	of	a	colonoscopic	adverse	event	on	the	professional	performing	the	colonoscopy	could	also	not	be	achieved	 quantitatively.	 Therefore,	 qualitative	 research	methodology	was	 used	to	achieve	these	aims.		I	 therefore	 designed	 a	 qualitative	 study	 surrounding	 colonoscopic	 perforation.	This	 study,	 ‘Colonoscopists	 narratives	 of	 a	 colonoscopy	 associated	 with	 a	colorectal	 perforation’	 involved	 colonoscopists,	 some	 of	 whom	 perform	colonoscopy	in	the	English	NHS	BCSP.			These	 four	 studies	outlined,	when	combined,	 enabled	me	 to	achieve	 the	 stated	aims	 of	 writing	 this	 thesis.	 Detailed	 methodology	 relating	 to	 each	 study	 is	described	within	chapters	four,	five,	six	and	seven.		
3.2	Ethics	
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Ethical	approval	 for	 the	 three	quantitative	 studies	outlined	 in	 this	 chapter	was	sought	and	gained	from	the	Local	Regional	Ethics	Committee:	Newcastle	&	North	Tyneside	2.	The	process	of	ethical	approval	 for	 the	qualitative	study	 in	chapter	seven	is	described	in	detail	in	that	chapter.	
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Chapter	4	
	
Colonoscopic	Perforation	
	
4.1	Aims	
	The	 following	 aims	 relate	 to	 colonoscopic	 perforation	 in	 the	 English	 National	Health	Service	Bowel	Cancer	Screening	Programme	only.	
	1.	To	determine	the	rate	of	colonoscopic	perforation.	2.	 To	 describe	 post	 perforation	 presentation,	 assessment,	 management	 and	outcomes.	3.	 To	 determine	 the	 post	 perforation	 rates	 of	 surgery,	 stoma	 formation,	morbidity	and	mortality.	4.	To	identify	factors	associated	with	poorer	patient	outcomes	post	perforation.	
	
4.2	Methods	
	
4.2.1	 The	 English	 National	 Health	 Service	 Bowel	 Cancer	 Screening	
Programme	Evaluation	Group	
	The	 English	 National	 Health	 Service	 Bowel	 Cancer	 Screening	 Programme	evaluation	 group	 is	 responsible	 for	 reviewing,	 evaluating	 and	 improving	 the	service	 provided	 by	 the	 BCSP.	 One	 of	 the	 projects	 commissioned	 by	 the	 BCSP	evaluation	 group	 was	 the	 ‘adverse	 events’	 project.	 An	 evaluation	 of	 the	
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colonoscopic	perforations	 that	have	occurred	since	 the	start	of	 the	programme	was	 a	 request	 of	 the	 evaluation	 group	 with	 regards	 to	 this	 project.	 The	requirements	 of	 the	 evaluation	 group,	 therefore,	 allowed	 me	 to	 design	 and	conduct	this	research	study	of	colonoscopic	perforation	using	data	drawn	from	the	cases	of	colonoscopic	perforation	that	had	occurred	nationally	in	the	BCSP.			
4.2.2	Initial	Thoughts	on	Colonoscopic	Perforation	–	‘The	patient	journey’		I	began	this	study	by	considering	and	summarising	the	 ‘journey’	a	patient	with	colonoscopic	 perforation	 in	 the	BCSP	would	 take.	 Ideas	 of	 how	 such	 a	 journey	would	start,	the	stages	and	potential	directions	the	patient	would	take	and	how	such	a	journey	would	finish	were	conceived	from	my	own	personal	experience	of	consulting	 and	 managing	 patients	 with	 colonoscopic	 perforation.	 Witnessing	first	hand	the	assessment	and	management	of	these	patients	by	colleagues	added	to	 these	 ideas.	 Furthermore,	 discussing	 the	 journey	 with	 colleagues	 of	 an	endoscopic,	 nursing,	 medical	 and	 surgical	 background	 enabled	 me	 to	 start	 to	develop	 definite	 stages	 in	 this	 journey	 that	would	 form	 the	 basis	 of	 the	 data	 I	would	collect.	These	stages	were	added	to	and	made	more	concrete	by	reviewing	the	literature	that	has	been	described	in	chapter	2.4	of	this	thesis.		I	 proposed	 the	 start	 of	 the	patient	 journey	would	begin	with	 the	 identification	and	 the	 demographics	 of	 a	 patient	 accepting	 the	 invitation	 for	 a	 colonoscopy	following	an	abnormal	Faecal	Occult	Blood	Test	(FOBT).	The	patient	would	then	be	 assessed	 as	 to	 their	 suitability	 for	 colonoscopy,	 which	 would	 include	assessment	 of	 their	 medical	 history,	 active	 medical	 problems	 and	 current	
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medication.	 Bowel	 preparation	 would	 be	 given	 to	 the	 patient	 prior	 to	 their	colonoscopy.		The	 journey	 would	 continue	 when	 the	 patient	 attended	 for	 the	 colonoscopy	associated	with	the	perforation.	There	may	be	many	factors	associated	with	the	perforation;	for	the	most	part	these	would	probably	be	related	to	a	polypectomy.	The	colonoscopist	may	see	 the	perforation	and	attempt	 to	manage	 it	 there	and	then,	 other	 colonoscopists	 may	 not	 make	 such	 an	 attempt,	 or	 may	 not	 even	realise	a	perforation	has	occurred.		Following	completion	of	the	colonoscopy,	the	patient	may	have	symptoms	requiring	 immediate	assessment	and	admission	to	hospital,	 others	 may	 develop	 symptoms	 and	 re-present	 at	 a	 later	 stage,	 some	may	have	no	symptoms	at	all.		For	 those	 patients	 that	 are	 admitted	 to	 hospital,	 their	 symptoms	 may	 be	numerous	 resulting	 in	 multiple	 investigations	 in	 order	 to	 reach	 a	 diagnosis.	These	patients	may	be	managed	medically	or	have	surgery.	Some	patients	may	develop	 new	 problems	 while	 in	 hospital,	 some	 may	 die.	 Others	 may	 be	discharged	home	safely	without	any	complication.		Drawing	 on	 this	 overview	 of	 the	 patient	 journey,	 I	 developed	 the	 aims	 of	 this	study,	which	are	outlined	in	chapter	4.1.			
4.2.3	Plan	for	data	capture	
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Planning	 how	 to	 acquire	 the	 data	 required	 to	 answer	 the	 aims	 of	 this	 study	comprised	 several	 distinct	 stages.	 Firstly,	 it	 was	 important	 to	 establish	 how	many	patients	in	the	BCSP	had	a	diagnosis	of	colonoscopic	perforation.	Secondly,	I	 needed	 to	 ascertain	who	 these	 patients	were	 and,	 thirdly,	 where	 in	 England	these	perforations	had	occurred.	I	then	needed	specific	patient	details	and	data	relating	 to	 the	 ‘journey’	 the	 perforation	 case	 followed.	 Determining	 exactly	where	I	would	be	able	to	get	this	data	was	the	next	stage	in	acquiring	it.		Once	I	had	an	understanding	of	where	this	data	would	be	held,	I	could	finalise	a	plan	for	capturing	it.		Progressing	through	these	stages	required	an	understanding	of	how	the	English	NHS	BCSP	is	structured,	organised	and	delivered.	Every	two	years	from	the	age	of	60	through	to	the	age	of	74,	members	of	the	public	are	invited	to	take	part	in	screening	for	bowel	cancer	by	completing	a	Faecal	Occult	Blood	Test	(FOBT).	The	FOBT	kits	are	posted	 from	and,	once	completed,	 returned	 to,	one	of	 five	bowel	cancer	screening	testing	laboratories,	known	as	‘hubs’.	Each	of	the	‘hubs’	covers	a	 large	 geographical	 region	 of	 England:	 North	 East,	 North	 &	 West,	 Eastern,	Southern	and	London20.	Those	people	who	return	an	abnormal	FOBT	are	invited	for	 a	 colonic	 investigation,	 usually	 a	 colonoscopy,	 at	 one	 of	 61	 Joint	 Advisory	Group	 on	 Gastrointestinal	 Endoscopy	 (JAG)	 approved	 Bowel	 Cancer	 Screening	Centres	 (BCSCs)	which	 are	divided	 among	 the	 regions	 outlined	 above.	When	 a	patient	attends	for	colonoscopy,	a	Specialist	Screening	Practitioner	(SSP)	is	also	present	during	the	procedure.	The	SSP	enters	data	relating	to	the	patient	and	the	colonoscopy	 onto	 a	 single	 national	 internet	 based	 database,	 the	 Bowel	 Cancer	
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Screening	 System	 (BCSS).	 Patients	 are	 informed	 of	 this	 as	 part	 of	 the	 consent	process	prior	to	the	colonic	investigation.			BCSS	enabled	me	to	establish	how	many	patients	in	the	BCSP	had	a	diagnosis	of	colonoscopic	 perforation.	 It	 also	 allowed	 me	 to	 ascertain	 who	 these	 patients	were	and	at	which	BCSC	in	England	these	perforations	had	occurred.	The	Bowel	Cancer	 Screening	 System	 (BCSS)	 also	 provided	 some	 of	 the	 data	 I	 required	relating	 to	 the	 patient’s	 demographics	 and	 the	 details	 of	 the	 colonoscopy	associated	with	the	perforation.		However,	not	all	of	the	data	required	for	this	study	was	available	through	BCSS.	Following	the	conclusion	of	a	colonoscopy	associated	with	perforation,	the	data	relating	 to	 the	 patient’s	 subsequent	 admission	 to	 hospital,	 management	 and	outcome	 would	 be	 entered	 into	 the	 patient’s	 medical	 notes	 at	 the	 NHS	 trust	where	the	patient	was	admitted.	In	the	majority	of	cases	this	NHS	trust	was	part	of	 the	 Bowel	 Cancer	 Screening	 Centre	 (BCSC),	 although	 some	 patients	 were	admitted	 to	 an	 NHS	 trust	 from	 outside	 the	 BCSC	 where	 the	 colonoscopy	 had	taken	 place.	 The	 data	 needed	 from	 the	 patient’s	 medical	 notes	 was	 therefore	delivered	to	me	by	a	nominated	third	person	 from	within	 the	NHS	trust	where	the	 patient	 had	 been	 admitted.	 	 This	 transfer	 of	 data	 took	 place	 via	 a	 pseudo	anonymised	online	questionnaire	from	each	BCSC.		Data	 capture	 therefore	 comprised	 two	 stages;	 initially	 from	 the	BCSS	database	and	 secondly	 from	 an	 online	 questionnaire	 completed	 at	 each	 of	 the	 Bowel	Cancer	Screening	Centres	which	could	be	delivered	to	me	via	an	online	account.	
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The	process	of	data	capture	using	these	two	mediums	is	outlined	in	the	following	sections.		
4.2.4	The	Bowel	Cancer	Screening	System	(BCSS)		BCSS	is	part	of	the	‘Open	Exeter’	suite	of	applications.	The	‘engine’	of	BCSS	is	an	oracle	 database.	 All	 of	 the	 system	 logic	 and	 processing	 is	 performed	 in	 oracle,	which	provides	results	to	the	Java	front	end	for	display	to	the	user.	Data	can	be	exported	to	a	Structured	Query	Language	server	to	allow	specific	queries	to	be	written.	Data	entered	into	BCSS	includes	patient	demographics	and	colonoscopy	results20.		Access	 to	 data	 stored	within	 BCSS	 is	 restricted.	 The	 BCSP	 evaluation	 group	 is	permitted	access	to	the	database	as	part	of	the	function	that	the	group	performs.	As	 previously	 described	 in	 section	 4.2.3,	 the	 BCSP	 evaluation	 group	 who	subsequently	permitted	access	 to	BCSS	had	sanctioned	 this	 research.	Professor	Rutter,	 as	 chair	 of	 the	 BCSP	 evaluation	 group	 and	 a	 co-supervisor	 of	 this	 MD	thesis,	 facilitated	 access	 to	 BCSS.	 Access	 to	 data	 within	 BCSS	 was	 provided	 in	conjunction	 with	 the	 NHSBCSP	 national	 office,	 which	 is	 part	 of	 Public	 Health	England	(PHE).		Data	entered	into	BCSS	includes	if	the	patient,	or	subject,	as	they	are	recorded	in	the	 database,	 had	 an	 endoscopic	 perforation	 recorded	 during	 their	 episode	 of	screening.	 The	 first	 stage	 in	me	 capturing	data	 for	 this	 study	was	 to	 email	 the	project	manager	at	the	NHS	Bowel	Cancer	Screening	Programme	National	Office.	
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I	wrote	an	email	 from	my	personal	NHS	mail	account	 to	Miss	Claire	Nickerson,	the	project	manager	at	the	NHSBCSP’s	national	office,	requesting	she	identify	all	the	subjects	recorded	as	having	an	endoscopic	perforation	in	the	BCSS	database.	Those	 subjects	 recorded	 as	 having	 an	 endoscopic	 perforation	 were	 identified	through	their	unique	subject	 identifier	and	their	unique	NHS	number.	The	NHS	number	was	classified	as	patient	identifiable	data	whereas	the	subject	identifier	was	a	pseudo	anonymised	 identifier	 that	could	only	be	accessed	through	BCSS.	Miss	Claire	Nickerson	replied	to	my	email	confirming	that	there	were	147	cases	of	 endoscopic	 perforation	 from	 the	 start	 of	 the	 BCSP	 on	 02/08/2006	 through	until	13/03/2014	recorded	on	BCSS.		So	that	I	would	be	able	to	identify	whom	these	patients	were,	I	then	sent	an	email	back	to	Miss	Claire	Nickerson	requesting	the	unique	subject	identifiers	and	NHS	numbers	 for	 these	patients.	 I	also	requested	an	 identifier	 for	 the	Bowel	Cancer	Screening	 Centre	 (BCSC)	 where	 the	 colonoscopic	 perforation	 had	 occurred	 so	that	 I	 knew	 the	 geographical	 location	 of	 these	perforation	 cases.	 The	BCSCs	 in	England	have	a	unique	screening	centre	code	numbered	from	BCS001	through	to	BCS062.	 (One	of	 the	BCSCs	 is	now	closed	hence	61	BCSCs	 in	 total).	Miss	Claire	Nickerson	 replied	 with	 the	 NHS	 numbers,	 subject	 identifiers	 and	 BCSC	 codes	meaning	I	had	completed	the	first	three	steps	in	data	capture	by	confirming	how	many	perforations,	who	the	perforation	cases	were	and	where	they	occurred.		I	 sent	 a	 third	 email	 to	 Miss	 Claire	 Nickerson	 requesting	 data	 relating	 to	 the	demographics	 of	 these	 subjects	 and	 the	 colonoscopy	 performed	 that	 was	associated	with	 perforation.	 The	 request	was	 split	 into	 three	 sections:	 subject	
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demographics,	 procedure	 details	 and	 polyp	 details.	 The	 subject	 demographics	included	the	subject	age	at	the	time	of	the	colonoscopic	perforation,	the	subject	sex	and	 the	 subject	ASA	physical	 status.	The	procedure	details	 requested	were	the	grade	of	bowel	preparation	quality,	the	date,	start	time	and	finish	time	of	the	colonoscopy.	Procedure	details	also	included	whether	polyps	had	been	resected	during	the	procedure	and	if	polypectomies	did	take	place,	the	number	of	polyps	that	 were	 resected.	 The	 final	 section	 related	 to	 details	 of	 the	 polyps	 resected	during	each	of	these	procedures	including	the	polyp	class,	the	polyp	location,	the	estimated	 endoscopic	 size	 of	 the	 polyp,	 the	 polyp	 therapy	modality,	 the	 polyp	therapy	device	and	the	polyp	therapy	success.			Miss	Claire	Nickerson,	replied	to	me	explaining	that	this	data	had	been	extracted	from	BCSS	in	three	separate	Microsoft	Excel	spread	sheets	under	the	workbook	titles	 ‘demographics’,	 ‘procedure	 details’	 and	 ‘polyp	 details’.	 Each	 spreadsheet	contained	the	subject	 identifier	with	one	of	 these	spreadsheets,	 ‘demographics’	also	 containing	 the	NHS	number	 and	BCSC	 code.	These	Microsoft	Excel	 spread	sheets	were	then	emailed	securely	to	me	via	NHS	mail.			
4.2.5	Bowel	Cancer	Screening	Centre	(BCSC)	contacts	
	In	 order	 to	 progress	 to	 the	 second	 stage	 of	 data	 capture	 that	 was	 outlined	 in	chapter	 4.2.3,	 I	 needed	 to	 contact	 each	 of	 the	 BCSCs	 where	 at	 least	 one	colonoscopic	 perforation	 had	 occurred.	 I	 again	 emailed	Miss	 Claire	 Nickerson,	project	 manager	 at	 the	 bowel	 cancer	 screening	 national	 office,	 requesting	 a	contacts	directory	for	each	of	the	Bowel	Cancer	Screening	Centres	(BCSCs).	The	
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directory	 included	 the	 email	 addresses	 and	 telephone	 numbers	 of	 the	 clinical	director,	programme	manager	and	lead	SSP	at	each	BCSC.			I	 then	designed	and	wrote	a	 ‘contacts’	Microsoft	Excel	spread	sheet	 for	each	of	the	 cases	of	 colonoscopic	perforation,	 detailing	 the	 subject	 identifier,	 the	BCSC	code,	the	name	of	the	BCSC,	the	name	of	the	clinical	director	of	the	BCSC	and	an	email	 address	 of	 the	 BCSC	 clinical	 director.	When	 this	 spread	 sheet	 had	 been	completed,	I	could	begin	the	second	stage	of	data	capture.		
4.2.6	Construction	of	a	questionnaire	for	data	capture	
	The	methodology	outlined	in	chapter	4.2.2	enabled	me	to	decide	the	key	themes	and	 stages	 of	 the	 ‘patient	 journey’	 surrounding	 colonoscopic	 perforation	 that	would	need	to	be	examined.	I	broke	the	journey	down	into	these	stages;	all	had	reasons	for	being	examined,	which	related	directly	to	the	aims	of	this	study.	The	sections	of	the	questionnaire	and	how	each	section	specifically	related	to	the	aims	of	this	study	described	in	chapter	4.1	are	listed	below:		Subject	Identifier	Medication:		The	use	of	antithrombotic	medication	and	corticosteroids	were	potentially	risk	factors	for	poorer	patient	outcomes	post	perforation.	Colonoscopy	Report:		To	 describe	 post	 perforation	 presentation,	 assessment,	 management	 and	outcomes	
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Representation	to	hospital:	To	 describe	 post	 perforation	 presentation,	 assessment,	 management	 and	outcomes	Time	 to	presentation	was	potentially	a	 risk	 factor	 for	poorer	patient	outcomes	post	perforation.	Admission	and	initial	observations:	To	 describe	 post	 perforation	 presentation,	 assessment,	 management	 and	outcomes	Initial	Management	To	 describe	 post	 perforation	 presentation,	 assessment,	 management	 and	outcomes	Time	 to	 commencing	 management	 was	 potentially	 a	 risk	 factor	 for	 poorer	patient	outcomes	post	perforation.	Initial	Investigations	To	 describe	 post	 perforation	 presentation,	 assessment,	 management	 and	outcomes	Surgery	To	determine	the	post	perforation	rates	of	surgery,	stoma	formation,	morbidity	and	mortality.	To	 describe	 post	 perforation	 presentation,	 assessment,	 management	 and	outcomes	Outcomes	To	 describe	 post	 perforation	 presentation,	 assessment,	 management	 and	outcomes	
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To	determine	the	post	perforation	rates	of	surgery,	stoma	formation,	morbidity	and	mortality.		The	 questionnaire	 listed	 questions	 in	 a	 structured,	 formal	 style.	 The	 full	questionnaire	can	be	found	in	the	appendix	of	this	thesis.	
	The	 full	 questionnaire	 was	 written	 in	 a	 Microsoft	 word	 document	 that	 was	printed	on	paper	for	piloting.	
	A	 pilot	 of	 the	 questionnaire	 took	 place	 at	 the	 Tees	 Bowel	 Cancer	 Screening	Centre	(BCSC).	I	used	the	case	notes	of	a	patient	who	had	suffered	a	colonoscopic	perforation	during	a	BCSP	colonoscopy	at	the	Tees	BCSC.	The	hospital	case	notes	from	North	Tees	&	Hartlepool	NHS	Foundation	Trust	were	 identified	using	 the	patient’s	NHS	number.	The	pilot	took	place	in	a	written	form	in	the	office	of	the	Tees	 BCSC.	 Specialist	 Screening	 Practitioner	 (SSP),	 Miss	 Emma	 Fenby,	 an	 SSP	who	 was	 employed	 at	 the	 Tees	 BCSC,	 and	 Miss	 Jestina	 Miles,	 a	 screening	colonoscopist	 employed	 at	 the	 Tees	 BCSC	 performed	 the	 pilot.	 The	 pilot	 took	approximately	 30	minutes	 to	 complete.	 No	 changes	 to	 the	 questionnaire	were	made	following	the	pilot.		
4.2.7	Questionnaire	Medium:	Bristol	Online	Surveys		Following	 the	 successful	 pilot	 of	 the	 questionnaire	 in	 paper	 medium,	 it	 was	entered	into	an	electronic	medium	so	that	it	could	be	easily	distributed	by	email	to	 the	BCSCs	 around	England	where	 at	 least	 one	 colonoscopic	 perforation	had	
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occurred.	 	 The	 electronic	 medium	 I	 used	 was	 with	 the	 internet	 based	 Bristol	online	surveys.	Durham	University	has	an	agreement	with	Bristol	online	surveys	allowing	its	students	and	staff	access.	I	created	the	online	survey	at	the	website	www.survey.bris.ac.uk.	The	questionnaire	was	entered	into	my	personal	account	under	the	survey	title	‘Perforations	in	the	Bowel	Cancer	Screening	Programme’.	I	typed	 each	 question	 individually	 into	 the	 survey	 and	 modified	 the	 survey	account	 so	 that	 the	 questionnaire	 would	 flow	 correctly	 depending	 on	 the	answers	that	had	been	entered.	The	questionnaire	was	confidential;	only	myself	and	 a	 learning	 resource	manager	 employed	 at	Durham	University,	Miss	 Emma	Crawford,	 were	 able	 to	 view	 it.	 Once	 all	 the	 questions	 had	 been	 entered,	 the	survey	was	launched	under	the	World	Wide	Web	address:			https://www.survey.bris.ac.uk/durham/perforations_in_the_bowel_cancer_screening_programme		The	 questionnaire	 in	 the	 online	 survey	medium	was	 launched	 in	 draft	 format	initially,	 ready	 for	 a	 further	 online	 pilot.	 The	 online	 pilot	 of	 the	 questionnaire	took	place	at	Tees	Bowel	Cancer	Screening	Centre	(BCSC).	I	used	the	case	notes	of	a	second	patient	who	had	suffered	a	colonoscopic	perforation	during	a	BCSP	colonoscopy	 at	 the	 Tees	 BCSC.	 The	 hospital	 case	 notes	 from	 North	 Tees	 &	Hartlepool	 NHS	 Foundation	 Trust	 were	 identified	 using	 the	 patient’s	 NHS	number.	 The	 pilot	 took	 place	 on	 a	 computer	 in	 the	 office	 of	 the	 Tees	 BCSC.	 A	screening	colonoscopist,	Miss	 Jestina	Miles,	who	 is	employed	at	 the	Tees	BCSC,	performed	 the	 online	 pilot.	 The	 pilot	 took	 approximately	 30	 minutes	 to	complete.	No	changes	to	the	questionnaire	were	made	following	the	pilot.	
	 95	
	Following	this	pilot,	the	electronic	questionnaire	was	ready	for	use	in	the	study.	It	 was	 launched	 ready	 for	 its	 online	 distribution.	 In	 order	 for	 the	 electronic	questionnaire	to	be	deployed	and	completed,	I	then	had	to	make	contact	with	all	the	BCSCs	in	England	where	at	least	one	perforation	had	occurred.		
4.2.8	Questionnaire	Location:	Bowel	Cancer	Screening	Centres	(BCSCs)		The	deployment	of	 the	online	questionnaire	 to	each	of	 the	BCSCs	 took	place	 in	three	stages.	Completion	of	the	online	questionnaire	required	a	named	person	at	each	BCSC	to	identify	and	review	the	medical	case	notes	of	each	patient.	In	order	to	do	this	they	required	the	NHS	number	of	each	particular	patient	that	had	been	provided	to	me	so	that	notes	could	be	requested	and	reviewed.		In	 order	 to	 provide	 the	 NHS	 number(s)	 of	 each	 of	 the	 respective	 perforation	cases,	a	secure	NHS	email	had	to	be	sent	between	NHS	email	accounts.	This	was	because	 the	NHS	number	 is	 patient	 identifiable	 data.	 The	NHS	 email	 system	 is	secure	and	protected	the	confidentiality	of	these	numbers.			As	 outlined	 in	 chapter	 4.2.5,	 the	 contacts	 for	 each	 BCSC	 where	 at	 least	 one	perforation	had	occurred	 comprised	 the	 clinical	director	of	 the	BCSC	and	 their	email	addresses.	Some	of	 the	BCSC	clinical	director’s	had	an	NHS	mail	account,	however,	the	majority	did	not.	Therefore,	an	initial	email	with	an	accompanying	letter	outlining	 the	study	and	 its	aims	was	sent	 to	each	BCSC	CD	requesting	an	
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NHS	mail	account	that	could	be	used.	The	accompanying	letter	that	was	emailed	can	be	found	in	the	appendix	of	this	thesis.		The	 majority	 of	 BCSC	 CDs	 replied	 directly	 to	 me	 with	 the	 specified	 NHS	mail	address.	 This	was	 an	NHS	 email	 address	 either	 of	 the	 BCSC	 CD	 themselves	 or	another	specified	contact	at	each	BCSC,	for	example,	the	programme	manager	or	a	 lead	 SSP.	 The	 NHS	 email	 addresses	 were	 then	 collated	 and	 added	 to	 the	Microsoft	Excel	spread	sheet	of	BCSC	contacts.		Two	 weeks	 following	 the	 first	 email	 sent,	 which	 is	 described	 above,	 I	 sent	 a	second	 NHS	 only	 email	 to	 the	 specified	 NHS	 email	 address	 of	 the	 specified	contact	at	each	BCSC.	This	NHS	email	contained	the	NHS	number	and	a	unique	subject	identification	number	of	the	patient	with	a	colonoscopic	perforation.	The	NHS	number	in	this	email	allowed	each	BCSC	to	request	the	specified	case	notes	for	the	patient.		A	 further	 two	 weeks	 following	 the	 second	 email,	 I	 sent	 a	 third	 email	 to	 each	specified	 NHS	 mail	 address	 with	 a	 link	 to	 the	 web	 address	 of	 the	 online	questionnaire.	 	 This	 email	 again	 reminded	 the	 specified	 contact	 at	 each	 of	 the	BCSCs	 to	 enter	 the	 unique	 subject	 identification	 number	 into	 the	 online	questionnaire,	it	being	non-patient	identifiable	data,	and	not	the	NHS	number	of	the	patient.		
4.2.9	Data	Review		
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The	questionnaire	within	the	online	account	remained	open	for	a	period	of	one	month	 initially,	while	responses	were	entered.	 I	 reviewed	the	response	rate	by	opening	 my	 account	 of	 the	 Bristol	 online	 surveys	 website.	 The	 account	 also	allowed	me	 to	 review	which	patient’s	 data	had	been	 entered.	 For	 those	BCSCs	who	 had	 not	 responded	 one	week	 before	 the	 end	 of	 this	 initial	 period	 of	 one	month,	a	reminder	email	to	complete	the	questionnaire	was	sent	to	the	specified	contact	at	each	of	the	BCSCs.		After	the	initial	period	of	one	month,	those	BCSCs	that	had	still	not	responded	at	that	 point	 were	 again	 sent	 an	 email	 reminding	 them	 to	 complete	 the	 online	questionnaire.	 The	 email	 stated	 the	 questionnaire	 would	 close	 one	 month	 on	from	 the	 point	 that	 the	 email	was	 sent	 so	 that	 a	 deadline	was	 set	 for	 them	 to	complete	this	request.	This	process	was	repeated	again	with	all	those	BCSCs	who	did	not	respond.			When	 a	 response	was	 not	 forthcoming	 for	 a	 particular	 subject	 identifier	 after	multiple	 attempts,	 this	 case	 was	 labelled	 a	 ‘non-responder’.	 Some	 BCSCs	provided	reasons	why	a	response	for	a	particular	subject	identifier	had	not	been	forthcoming.	For	example,	if	a	patient	had	been	admitted	to	a	trust	from	outside	the	BCSC	or	notes	could	not	be	found.			When	all	possible	responses	had	been	received,	the	data	from	the	questionnaire	was	 exported	 from	 the	 Bristol	 online	 survey	 account	 into	 a	 Microsoft	 Excel	spreadsheet.		
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4.2.10	Definitions	of	data	collected	
	A	 colonoscopic	 perforation	 was	 defined	 as	 a	 patient	 who	 had	 evidence	 of	 air,	luminal	contents	or	instrumentation	outside	the	gastrointestinal	tract	during	or	following	a	colonoscopy.		Diagnostic	 perforations	 were	 defined	 as	 colonoscopies	 where	 no	 tissue	 was	removed	from	the	colorectal	location	of	the	perforation,	tissue	was	removed	by	cold	biopsy	for	diagnostic	purposes	or	a	cold	biopsy	polypectomy	occurred	at	the	colorectal	location	of	the	perforation.		Therapeutic	perforations	were	defined	as	those	associated	any	of	 the	 following		therapeutic	devices:	 cold	 snare,	 hot	 snare,	 hot	 biopsy,	 argon	beam,	 endoscopic	knife,	injection,	heater	probe.		
4.2.11	Statistical	Analysis	
	The	Microsoft	 Excel	 spreadsheet	was	 imported	 into	 statistical	 package	 for	 the	social	 sciences	 (SPSS)	 version	 20	 for	 statistical	 analysis.	 Normally	 distributed	continuous	 variables	 were	 expressed	 as	 mean,	 non-normally	 distributed	continuous	 variables	 were	 expressed	 as	 median.	 Categorical	 variables	 were	expressed	as	a	percentage.	Pearson	chi-square	and	Fisher’s	exact	test	were	used	to	test	association	between	explanatory	and	outcome	variables	with	a	p	value	<	0.05	considered	to	be	significant.		
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4.3	Results	
	The	 results	 in	 this	 chapter	 are	 from	 colonoscopic	 data	 from	 the	 start	 of	 the	English	 National	 Health	 Service	 Bowel	 Cancer	 Screening	 Programme	 on	 the	02/08/2006	up	to	and	including	the	13/03/2014.	
	
4.3.1	Overall	colonoscopic	data	from	the	English	NHS	BCSP		
	The	 total	 number	 of	 colonoscopic	 procedures	 performed	 during	 this	 time	was	263,129.	 Of	 these	 263,129	 endoscopic	 procedures,	 159,301	 (60.5%)	 were	 in	male	patients	and	103,828	(39.5%)	in	female	patients.	The	age	of	these	patients	ranged	 from	 60-74	 years	 with	 a	 mean	 age	 of	 65.5.	 The	 American	 Society	 of	Anaesthesia	(ASA)	grade	was	1	(indicating	the	patient	was	fit)	in	77,536	(29.5%)	patients,	 2	 (indicating	 the	 patient	 had	 relevant	 disease)	 in	 141,492	 (53.8%)	patients,	 3	 (indicating	 the	 patient	 had	 restrictive	 disease)	 in	 19,998	 (7.6%)	patients,	4	(indicating	the	patient	had	life	threatening	disease)	in	903	(0.3%)	and	5	 (indicating	 they	were	moribund)	 in	9	 (0.003%)	patients.	The	ASA	grade	was	unknown	 in	 23,191	 (8.8%)	 patients.	 The	 bowel	 preparation	 quality	 of	 these	endoscopic	 procedures	 was	 adequate	 in	 89,032	 (33.8%)	 patients,	 good	 in	154,180	(58.5%)	patients,	poor	in	8,257	(3.1%)	patients	and	unknown	in	11,660	(4.4%)	patients.	
	
4.3.2	Colonoscopic	Perforations	in	the	English	NHS	BCSP		
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147	patients	were	recorded	as	having	endoscopic	perforation	of	the	colon	on	the	Bowel	 Cancer	 Screening	 System	 (BCSS).	 A	 perforation	 rate	 of	 0.06%	 was	therefore	calculated	as	follows:		147/263,129	=	0.06%		The	online	questionnaire	was	distributed	to	the	relevant	Bowel	Cancer	Screening	Centres	 (BCSCs)	 for	 all	 147	 patients.	 A	 response	 to	 online	 questionnaire	 was	received	 in	 117	 patients	 with	 limited	 data	 collected	 from	 BCSS	 on	 patient	presentation,	 assessment,	 management	 and	 outcome	 in	 the	 remaining	 30	patients.		
4.3.2.1	The	patients	with	colonoscopic	perforation	 for	whom	no	response	
to	the	online	questionnaire	was	received		Of	 the	 30	 patients	 for	 whom	 no	 response	 to	 the	 online	 questionnaire	 was	received,	24	(80%)	of	were	male	and	six	(20%)	were	 female.	Their	age	ranged	from	 60	 –	 74	 years	with	 a	mean	 age	 of	 66.07.	 The	 American	 Society	 of	 (ASA)	Anaesthesia	grade	was	1	 (indicating	 the	patient	was	 fit)	 in	6	 (20%)	patients,	2	(indicating	the	patient	had	relevant	disease)	in	21	(70%)	patients,	3	(indicating	the	 patient	 had	 restrictive	 disease)	 in	 2	 (6.7%)	 patients	 and	 unknown	 in	 1	patient.		During	the	colonoscopy	of	these	30	patients	the	bowel	preparation	quality	was	adequate	in	12	(40%)	patients,	good	in	15	(50%)	patients	and	poor	in	3	(10%)	
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patients.	 25	 (83.3%)	 of	 these	 patients	 had	 polyps	 resected.	 A	 diagnostic	perforation	 occurred	 in	 two	 patients,	 these	 being	 in	 the	 caecum	 and	 sigmoid	colon.	 A	 therapeutic	 perforation	 occurred	 in	 five	 patients.	 One	 of	 these	therapeutic	perforations	was	in	the	caecum,	three	were	in	the	sigmoid	colon	and	in	one	of	these	therapeutic	perforations	the	colorectal	location	of	the	perforation	was	 unclear.	 It	 was	 unclear	 in	 23	 of	 these	 30	 patients	 if	 a	 diagnostic	 or	therapeutic	perforation	had	occurred,	although	two	of	these	were	noted	to	be	in	the	sigmoid	colon.		Three	of	these	30	patients	were	admitted	to	hospital	immediately	following	the	colonoscopy.	Eight	were	discharged	and	then	re-presented	to	hospital,	of	which	four	were	documented	to	have	abdominal	pain.	Two	patients	were	not	admitted	to	hospital	but	were	reviewed	in	the	out	patient	department	following	computed	tomography	 (CT)	 scans	 showing	 radiological	 evidence	 of	 perforation.	 How	 the	patient	presented	was	unclear	in	the	remaining	17	patients.		Seven	of	 these	30	patients,	 for	whom	no	 response	 to	 our	 online	questionnaire	was	received,	had	surgery.	This	 included	 two	who	had	a	 right	hemi	colectomy,	one	with	 a	 sigmoid	 colectomy	and	one	a	hartmann’s	procedure.	The	operation	name	was	unknown	in	three	patients.	Four	patients	did	not	have	surgery	and	in	19	it	was	unclear	if	the	patient	had	surgery	or	not.	Two	of	these	30	patients	were	left	with	a	stoma	and	two	were	admitted	to	the	Intensive	Care	Unit	(ICU).		
4.3.2.2	The	patients	with	colonoscopic	perforation	for	whom	a	response	to	
the	online	questionnaire	was	received	
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	A	 response	 to	 the	 online	 questionnaire	 was	 received	 for	 117	 patients	 with	colonoscopic	perforation.	Of	these	117	patients,	68	(58.1%)	patients	were	male	and	 47	 (40.2%)	 patients	 were	 female.	 The	 patient	 sex	 was	 unknown	 in	 2	patients.	 Patient	 age	 ranged	 from	60	 –	 74	 years	with	 a	mean	 age	 of	 65.5.	 The	patient	 age	 was	 unknown	 in	 3	 patients.	 The	 American	 Society	 of	 Anaesthesia	(ASA)	 grade	 was	 1	 (indicating	 the	 patient	 was	 fit)	 in	 42	 (35.9%)	 patients,	 2	(indicating	 the	 patient	 had	 relevant	 disease)	 in	 63	 (53.8%)	 patients	 and	 3	(indicating	the	patient	had	restrictive	disease)	in	8	(6.8%)	patients.		During	the	colonoscopy	of	these	117	patients,	the	bowel	preparation	quality	was	good	 in	 67	 (57.3%)	 patients,	 adequate	 in	 46	 (39.3%)	 patients	 and	 poor	 in	 1	(0.9%)	 patient.	 The	 bowel	 preparation	 quality	was	 unknown	 in	 3	 patients.	 97	(82.9%)	of	the	patients	had	polyps	resected.		Of	the	117	perforations,	there	were	82	therapeutic	perforations	(70.1%)	and	22	diagnostic	 perforations	 (18.8%).	 In	13	 (11.1%)	 colonoscopies	 it	was	unclear	 if	any	therapy	had	taken	place	at	 the	colorectal	 location	of	 the	perforation	or	 the	colorectal	location	of	the	perforation	was	unknown.								
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Chart	1:	Bar	chart	of	all	perforations	by	colorectal	location	
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Chart	2:	Bar	chart	of	the	diagnostic	perforations	by	colorectal	location	
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Of	 12	 diagnostic	 perforations	 in	 the	 sigmoid	 colon,	 six	 (50%)	 also	 had	diverticular	 disease	 in	 the	 sigmoid	 colon. Of	 the	 263,129	 endoscopic	examinations	 during	 this	 study	 period,	 in	 80,023	 a	 diagnosis	 of	 diverticular	disease	was	noted,	a	rate	of	30.4%	overall.	Of	the	three	diagnostic	perforations	in	the	 rectum,	 the	 endoscopist	 had	 retroverted	 in	 the	 rectum	 in	 one	 (33.3%)	 of	these	 cases.	 Seven	 of	 the	 diagnostic	 perforations	 were	 at	 colorectal	 locations	where	 a	 biopsy	 had	 been	 performed	 for	 diagnostic	 purposes.	 Five	 of	 these	diagnostic	 biopsies	 were	 of	 a	 colorectal	 cancer.	 Four	 of	 these	 cancers	 were	associated	with	a	sub	clinical	computed	tomography	(CT)	detected	perforation. 	There	 were	 no	 significant	 associations	 between	 sex,	 age,	 ASA	 Grade,	 bowel	preparation	 quality,	 colorectal	 Location	 and	 a	 diagnostic	 or	 therapeutic	perforation	occurring	(p<0.05).	
 In	 15	 (12.8%)	 of	 patients	 the	 endoscopist	 had	 physically	 visualised	 the	perforation,	applying	endoclips	in	12	(10.2%).	Therefore,	endoclips	were	applied	in	 80%	 of	 perforations	 where	 the	 endoscopist	 had	 physically	 visualised	 the	perforation.	 	 The	 endoscopist	 had	 physically	 visualised	 the	 perforation	 by	visualising	a	tear	in	the	serosa	(n=6),	visualisation	of	an	extra	intestinal	structure	(n=3),	visualising	a	separation	of	muscle	fibres	(n=1),	visualising	a	defect	(n=3)	and	 seeing	 the	 endoscopic	 knife	 perforate	 the	 colon	 (n=1).	 In	 one	 of	 these	patients	it	was	unclear	how	the	endoscopist	had	visualised	the	perforation.	The	estimated	endoscopic	size	of	these	perforations	ranged	from	2	to	25mm	with	a	median	size	of	5.5mm.		
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	In	 the	12	patients	 in	whom	the	endoscopist	had	visualised	 the	perforation	and	endoclips	 were	 applied,	 10	 (83.3%)	 did	 not	 have	 surgery	 whereas	 2	 did,	however	 association	 between	 the	 use	 of	 endoclips	 and	 not	 having	 surgery	 did	not	reach	significance	(p<0.05).	
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Chart	3:	Flow	chart	representing	how	the	perforation	cases	presented											 								
					 							 									 		
Colonoscopic	Perforation	(n=117)	
Endoscopist	visualised	Perforation	(n=15)	
Represented	with	symptoms		(n=77)	
Asymptomatic-Endoscopist	Concern	(n=10)	
Discharged	following	Colonoscopy	(n=80)	
Admission	to	hospital	with	colonoscopic	perforation	(n=115)	
Admitted	immediately	following	colonoscopy	(n=11)	
Asymptomatic-Endoscopist	concern	(n=6)	
Endoclip(s)	Applied	(n=12)	
Asymptomatic	–	Social	Reasons	(n=1)	
Discharged	following	Colonoscopy	(n=1)	
Admitted	immediately	following	colonoscopy	(n=25)	
Symptomatic	with	Abdominal	Pain	(n=1)	
Symptomatic	with	Abdominal	Pain	(n=18)	
Not	Admitted		(n=2)	
Recalled	following	radiological	investigation		(n=2)	
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	Thirty-six	 of	 117	 (30.8%)	 patients	 were	 admitted	 to	 hospital	 immediately	following	 the	 completion	 of	 their	 colonoscopy.	 	 Of	 the	 36	patients	 admitted	 to	hospital	 immediately	 following	 completion	 of	 the	 colonoscopy,	 17	 were	asymptomatic	and	19	complained	of	symptoms.	The	asymptomatic	patients	were	admitted	 due	 to	 endoscopist	 suspicion	 of	 perforation	 (n=15),	 endoscopist	concern	 regarding	 bleeding	 (n=1)	 and	 for	 social	 reasons	 (n=1).	 The	 19	symptomatic	 patients	 all	 complained	 of	 abdominal	 pain	 with	 five	 also	complaining	of	abdominal	distension.	Of	these	19	patients	one	also	had	evidence	of	surgical	emphysema	in	their	neck	and	another	had	a	syncopal	episode.		Eighty-one	of	117	(69.2%)	colonoscopic	perforations	were	discharged	following	the	 completion	 of	 the	 colonoscopy.	 Two	 cases,	 both	 subclinical	 CT	 detected	perforations,	found	on	staging	scans	for	colorectal	cancers	were	not	admitted	to	hospital.	 A	 further	 two	 cases,	 both	 sub	 clinical	 CT	 detected	 perforations,	were	recalled	 to	 hospital	 following	 staging	 scans	 for	 colorectal	 cancer.	 77	 patients	represented	 to	 hospital	 with	 symptoms.	 In	 the	 majority	 of	 these,	 66	 of	 77	(85.7%),	the	presenting	complaint	was	abdominal	pain.	The	time	to	readmission	was	unclear	 in	 30	patients	 and	 in	51	patients	 the	median	 time	 to	 readmission	was	one	day	(range	0-8	days).			A	total	of	115	patients	were	admitted	to	hospital	with	colonoscopic	perforation.		When	 examining	 the	 time	 to	 presentation	 of	 diagnostic	 and	 therapeutic	perforations,	16	of	32	 (50%)	patients	with	a	 therapeutic	perforation,	 in	whom	
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time	 to	 presentation	was	 recorded	 presented	within	 the	 first	 24	 hours.	 Of	 the	remaining	 16	 patients	 with	 a	 therapeutic	 perforation,	 in	 whom	 time	 to	presentation	was	recorded,	six	(37.5%)	presented	at	one	day,	six	(37.5%)	at	two	days,	two	(6.3%)	at	4	days,	one	(3.1%)	at	six	days	and	one	(3.1%)	at	seven	days	post	 perforation.	 Of	 12	 diagnostic	 perforations,	 in	 whom	 time	 to	 presentation	was	recorded,	 five	(41.7%)	presented	within	the	 first	24	hours,	 three	(25%)	at	one	 day,	 one	 (8.3%)	 at	 four	 days,	 two	 (16.7%)	 at	 six	 days	 and	 one	 (8.3%)	 at	seven	days.	There	was	no	significant	difference	in	time	to	presentation	between	diagnostic	and	therapeutic	perforations	(p=0.362).			With	 regards	 to	 presenting	 complaint,	 there	 was	 no	 significant	 difference	 in	whether	a	diagnostic	or	therapeutic	perforation	presented	with	abdominal	pain	(p=0.768),	the	majority	of	diagnostic	perforations	in	whom	presenting	complaint	was	 recorded,	 15	 of	 20	 (75%)	 complaining	 of	 abdominal	 pain	 with	 61	 of	 78	(78.2%)	therapeutic	perforations	also	complaining	of	abdominal	pain.			
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Chart	 4:	 Histogram	 of	 time	 to	 presentation	 with	 symptoms	 from	
perforation	following	colonoscopy:	
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The	 initial	 observations	 recorded	 following	 admission	 to	hospital	were	patient	temperature,	 pulse	 rate,	 systolic	 blood	 pressure,	 diastolic	 blood	 pressure	 and	respiratory	 rate.	 Temperature	 was	 unclear	 in	 39	 (33.9%)	 patients	 with	 17	(14.7%)	 patients’	 being	 having	 pyrexia	 with	 a	 temperature	 of	 ≥ 38.0°C.	 59	(51.3%)	patients	initial	temperature	was	normal	at	35.1-37.9°C.	Pulse	rate	was	unclear	in	38	(32.5%)	patients,	with	62	(53%)	of	patients	having	a	pulse	<	100	beats	per	minute	and	17	(14.5%)	patients	pulse	being	tachycardic	at	>	100	beats	per	minute.	Respiratory	rate	was	unclear	 in	46	(40.0%)	patients	with	9	(7.8%)	patients’	 respiratory	 rate	 being	 >	 20	 breaths	 per	 minute	 and	 60	 (52.2%)	patients’	 respiratory	 rate	 being	 less	 than	 or	 equal	 to	 20	 breaths	 per	 minute.	Systolic	 blood	 pressure	 was	 unclear	 in	 37	 (32.2%)	 patients	 with	 57	 (73.1%)	patients	systolic	blood	pressure	being	>	120mmHg.	Diastolic	blood	pressure	was	also	 unclear	 in	 37	 (32.2%)	 patients	 with	 78	 (67.8%)	 patients	 diastolic	 blood	pressure	ranging	from	50-102mmHg.			When	examining	the	recorded	initial	observations	of	diagnostic	and	therapeutic	perforation,	 54	 therapeutic	 perforations	 and	 18	 diagnostic	 perforations	 had	there	initial	temperature	and	pulse	rate	recorded.	Five	of	18	(27.8%)	diagnostic	perforations	had	pyrexia	whereas	13	(72.2%)	were	apyrexial.	Of	54	therapeutic	perforations,	 44	 (81.5%)	 did	 not	 have	 pyrexia	 whereas	 10	 (18.5%)	 did.	 The	presence	 of	 pyrexia	 was	 not	 significantly	 associated	 with	 a	 diagnostic	 or	therapeutic	perforation	 (p=0.504).	 Similarly,	when	examining	 initial	pulse	 rate,	three	 of	 18	 (16.7%)	 diagnostic	 perforations	 had	 a	 tachycardia	 whereas	 15	(83.3%)	 did	 not.	 Thirteen	 of	 54	 (24.1%)	 therapeutic	 perforations	 had	tachycardia	 with	 41	 (75.9%)	 having	 a	 normal	 pulse	 rate.	 The	 presence	 of	 a	
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tachycardia	 was	 not	 significantly	 associated	 with	 diagnostic	 or	 therapeutic	perforations	 (p=0.745).	 In	 addition	a	 respiratory	 rate	>	20	breaths	per	minute	was	also	not	significantly	associated	with	a	diagnostic	or	therapeutic	perforation	(p=0.388).		
	The	 initial	 management	 recorded	 was	 if	 the	 patient	 was	 kept	 Nil	 By	 Mouth	(NBM),	 given	 intravenous	 (IV)	 fluids	 or	 intravenous	 (IV)	 antibiotics.	 It	 was	unclear	 if	 20	 (17.3%)	 patients	were	 kept	 NBM,	 12	 (10.4%)	 patients	were	 not	kept	 NBM	 whereas	 83	 (72.2%)	 patients	 were.	 Intravenous	 fluids	 were	commenced	 in	 90	 (78.3%)	 patients;	 it	 was	 unclear	 if	 intravenous	 fluids	 were	commenced	in	19	(16.5%)	of	patients.	Intravenous	antibiotics	were	commenced	in	 95	 (82.6%)	 patients;	 it	 was	 unclear	 in	 14	 (12.2%)	 patients	 if	 intravenous	fluids	had	been	commenced.		
	The	 initial	 investigation	 in	 these	115	patients	admitted	 to	hospital	 included	an	erect	 chest	 x-ray	 (CXR),	 abdominal	 x-ray	 (AXR)	or	 computed	 tomography	 (CT)	scan.	An	erect	chest	x-ray	(CXR)	was	performed	in	61	(53.1%)	patients	admitted	to	hospital.	The	CXR	was	reported	as	normal	in	29	(47.5%)	of	which	21	also	had	an	abdominal	x-ray	(AXR).	The	AXR	was	also	reported	as	normal	in	20	with	free	air	 in	 the	abdomen	 in	1	patient.	Of	 the	29	patients	with	a	normal	CXR,	21	also	had	a	CT	including	2	that	were	normal	but	19	showing	evidence	of	perforation.	The	 erect	 chest	 x-ray	 showed	 pneumoperitoneum	 in	 28	 (45.9%)	 patients.	 In	these	28,	13	also	had	an	abdominal	x-ray;	6	of	these	abdominal	x-ray’s	showed	no	evidence	of	perforation	with	7	showing	free	air	 in	the	abdomen.	13	of	these	patients	 with	 an	 erect	 chest	 x-ray	 showing	 pneumoperitoneum	 also	 had	 a	 CT	
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showing	 evidence	 of	 perforation.	 9	 patients	were	 taken	 straight	 to	 theatre	 for	surgery	on	basis	of	CXR	without	further	cross	sectional	imaging.	7	patients	went	onto	 have	 a	 CT	 before	 being	 taken	 to	 theatre	 for	 surgery.	 2	 patients	managed	conservatively	on	basis	of	CXR	 result	 alone.	The	CXR	 result	was	unknown	 in	4	patients.				An	 abdominal	 x-ray	 (AXR)	was	 performed	 in	 39	 of	 115	 (35.1%)	 patients.	 	 No	evidence	of	perforation	was	seen	in	28	(71.8%).	Of	these	28,	19	patients	also	had	a	CT.	The	CT	was	normal	in	1	patient	but	showed	evidence	of	perforation	in	18	patients.	 The	 AXR	 showed	 free	 air	 in	 the	 abdomen	 in	 10	 (25.6%)	 patients	 of	which	5	also	had	a	CT,	all	showing	evidence	of	perforation.	The	AXR	result	was	unknown	 in	 1	 patient.	 71	 of	 115	 (61.7%)	 patients	 had	 CT	 imaging	 following	admission.	 In	42	of	 the	71	 (59.1%)	patients	 the	CT	 showed	a	 small	 amount	 of	free	air	in	the	abdomen	with	29	(40.8%)	showing	a	large	amount	of	free	air.	Of	the	42	patients	with	a	small	amount	of	 free	air,	13	(30.9%)	had	surgery.	Of	29	patients	with	a	large	amount	of	free	on	CT,	17	(58.6%)	had	surgery	although	the	association	 between	 the	 amount	 of	 free	 air	 and	 having	 surgery	 did	 not	 reach	statistical	significance.	
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Chart	5:	Flow	chart	representing	the	management	of	the	perforation	cases	
that	were	admitted	to	hospital:					 	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	Surgery	(n	=	62)	 No	Surgery	(n=51)	
	Stoma	Formation		(n=30)	
	Unclear	if	Surgery	(n=2)	
Post	Perforation	Morbidity	(n=22)	 No	Post	Perforation	Morbidity	(n=93)	
Admission	to	hospital	with	colonoscopic	perforation	(n=115)	
	No	Stoma	Formation		(n=31)		Unclear	if	Stoma	(n=1)	
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	Fifty-one	 of	 115	 (44.3%)	 patients	 admitted	 to	 hospital	 did	 not	 have	 surgery.	None	 of	 these	 patients’	 admissions	 were	 associated	 with	 post	 perforation	morbidity	or	admission	to	the	intensive	care	unit.				Sixty-two	of	115	(53.9%)	patients	admitted	to	hospital	had	surgery.	In	16	of	62	patients	 (25.8%)	 the	 surgery	was	 commenced	during	normal	 surgical	working	hours	(08:00-17:00).	The	majority	of	operations,	43	(69.4%),	were	performed	by	consultant	surgeons.	35	of	62	(56.5%)	operations	were	performed	by	colorectal	surgeons.	 Seven	 laparoscopies	 occurred	 including	 simple	 closure	 of	 the	perforation	(n=4),	sigmoid	colectomy	(n=2)	and	an	appendicectomy	(n=1).	Five	of	the	seven	laparoscopies	were	performed	by	colorectal	surgeons	and	all	seven	were	performed	by	consultant	surgeons.	Nine	 laparoscopies	were	converted	 to	open	 laparotomies	 including	 a	 colonic	 resection	 and	 ileostomy	 (n=1),	 right	hemicolectomy	(n=4),	hartmann’s	procedure	(n=1),	peritoneal	lavage	(n=1)	and	simple	 closure	 of	 perforation	 (n=2).	 46	 open	 laparotomies	 were	 performed	including	 a	 simple	 closure	 of	 perforation	 (n=3),	 sigmoid	 colectomy	 &	 loop	ileostomy	 (n=1),	 hartmann’s	 procedure	 (n=11),	 over	 sew	 with	 defunctioning	loop	sigmoid	colostomy	(n=1),	right	hemicolectomy	(n=15),	total	colectomy	and	ileostomy	(n=2),	hartmann’s	procedure	with	extended	left	hemicolectomy	(n=1),	defunctioning	loop	colostomy	(n=3),	anterior	resection	with	defunctioning	loop	colostomy	(n=1),	exploratory	laparotomy	(n=1),	unknown	(n=2),	exteriorisation	of	 colon	 (n=1),	 anterior	 resection	 (n=1),	 simple	 closure	 of	 perforation	 with	sigmoid	 colectomy	 and	 covering	 ileostomy	 (n=1),	 limited	 left	 hemicolectomy	with	loop	ileostomy	(n=1)	and	sigmoid	loop	colostomy	(n=1).	
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	Seventeen	 of	 20	 (85.0%)	 diagnostic	 perforations	 admitted	 to	 hospital	 had	surgery,	 38	 of	 82	 (46.3%)	 of	 therapeutic	 perforations	 had	 surgery.	 In	 7	 of	those	patients	who	had	surgery	following	acute	admission,	it	was	unclear	if	a	diagnostic	 or	 therapeutic	 perforation	 had	 occurred.	 A	 diagnostic	 perforation	was	 significantly	 associated	 with	 the	 need	 for	 surgery	 compared	 with	 a	therapeutic	perforation	(p=0.002).	(RR:1.81,	95%	CI	1.34-2.43).			Of	 the	 15	 patients	 in	 whom	 the	 endoscopist	 had	 physically	 visualised	 the	perforation	at	 the	 time	of	perforation,	none	of	 the	six	perforations	 that	were	5mm	or	 less	 in	 size	had	 surgery;	 all	were	 therapeutic	 in	nature.	However	of	three	 greater	 than	 5mm	 in	 size,	 again,	 all	 therapeutic	 in	 nature,	 two	 had	surgery	though	this	association	did	not	reach	statistical	significance	(p=0.083).			Admission	 or	 discharge	 following	 colonoscopy	 (p=0.840)	 and	 time	 to	presentation	 (p=0.996)	 were	 not	 significantly	 associated	 with	 the	 patient	having	surgery.	When	examining	the	patient’s	 initial	presenting	complaint,	of	25	patients	who	did	not	complain	of	abdominal	pain,	17	(68%)	did	not	have	surgery	but	8	 (32%)	did.	Of	85	patients	 admitted	 to	hospital	 complaining	of	abdominal	pain,	52	(61.2%)	had	surgery	and	33	(38.8%)	did	not.	The	presence	of	 abdominal	 pain	 was	 therefore	 significantly	 associated	 with	 the	 patient	having	surgery	(p=0.012)	(RR:0.52,	95%	CI	0.29	–	0.95).		On	initial	observations	following	admission,	there	was	no	association	between	
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a	 patient	 being	 pyrexial	with	 a	 temperature	 of	≥ 38.0°C	 and	having	 surgery	(p=1.000).	Fourteen	of	62	(22.6%)	patients	who	had	surgery	had	a	tachycardia	at	initial	presentation.	In	15	of	62	(24.2%)	of	those	patients	who	had	surgery	the	 initial	pulse	was	unknown	and	 in	33	 (53.2%)	 the	pulse	 rate	was	normal	(60-100	bpm).	Of	the	51	patients	who	did	not	have	surgery,	in	19	(37.3%)	the	pulse	 rate	 was	 unknown,	 in	 3	 (5.9%)	 patients	 the	 patient	 was	 tachycardic	(pulse	>	100bpm)	and	in	29	(56.9%)	the	initial	pulse	rate	was	normal	(60-100	bpm).	 The	 presence	 of	 a	 tachycardia	 was	 significantly	 associated	 with	 a	patient	 having	 surgery	 (p=0.049)	 (RR:0.65	 95%	CI	 0.47-0.89).	 All	 9	 patients	with	 a	 respiratory	 rate	 of	 >	 20	 breaths	 per	 minute	 had	 surgery.	 32	 of	 62	(51.6%)	patients	who	had	surgery	had	a	respiratory	rate	of	less	than	or	equal	to	20	breaths	per	minute	and	in	21	of	62	(33.9%)	of	patients	who	had	surgery	the	 respiratory	 rate	 was	 unknown.	 A	 respiratory	 rate	 of	 greater	 than	 20	breaths	per	minute	was	 also	 significantly	 associated	with	 the	patient	 having	surgery	(p=0.009)	(RR:0.53,	95%	CI	0.42-0.68).		The	 operations	 in	 these	 62	 patients	 resulted	 in	 stomas	 being	 formed	 in	 30	patients.	Therefore,	48.3%	of	patients	having	surgery	left	hospital	with	a	stoma,	26.1%	of	all	perforations	admitted.						
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Chart	6:	Bar	chart	of	number	of	stomas	by	colorectal	location:	
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Of	30	patients	who	 left	 hospital	with	 a	 stoma,	 23	 (76.7%)	were	male	patients.	The	 sigmoid	 colon	 was	 the	 commonest	 colorectal	 location	 for	 a	 stoma	 to	 be	formed	 (n=18).	 Male	 sex	 (p=0.018)	 (RR:2.13,	 95%	 CI	 1.08	 –	 4.17)	 and	 a	colorectal	location	in	the	sigmoid	colon	when	compared	with	all	other	colorectal	locations	(p=0.001)	(RR:2.49,	95%	CI	1.46	–	4.25)	were	significantly	associated	with	stoma	formation.		Post	 perforation	 morbidity	 was	 defined	 as	 any	 patient	 who	 developed	 a	 post	operative	complication	or	new	diagnosis	during	their	in	patient	admission.	Only	those	 who	 had	 surgery	 developed	 post	 perforation	 morbidity.	 Twenty-two	patients	developed	a	 complication	or	new	diagnosis	post	perforation.	The	post	perforation	morbidity	rate	was	19.1%	per	total	number	of	perforations	admitted	to	 hospital	 and	 18.8%	 per	 number	 of	 perforations	 overall.	 The	 post	 operative	complications	 that	 contributed	 to	 this	 figure	 were	 renal	 failure	 (n=1),	respiratory	failure	(n=3),	wound	dehiscence	(n=2),	wound	infection	(n=6),	pelvic	collection	 (n=1),	 ileus	 (n=6),	 mucus	 plugging	 (n=1),	 reduced	 respiratory	 rate	(n=1),	 hospital	 acquired	 pneumonia	 (n=2),	 prolonged	 multifactorial	 ITU	 Stay	(n=1),	peritoneal	collection	(n=1),	 small	bowel	 ischaemia	(n=1),	pneumothorax	(n=1).	One	patient	had	both	wound	dehiscence	and	renal	failure.	One	patient	had	both	a	wound	infection	and	pelvic	collection	and	one	patient	mucus	plugging,	a	pneumothorax	 and	 small	 bowel	 ischaemia.	 Diagnostic	 Perforations	 (P=0.012)	(RR:	 2.84,	 95%	CI	 1.41-5.68)	 and	 Surgery	 (p<0.001)	 (RR:	 37.14,	 95%	CI	 2.31-597.70)	 were	 significantly	 associated	 with	 post	 perforation	 morbidity.	 	 The	surgery	 commencing	 in	 normal	 working	 hours	 (08:00-17:00)(p=0.681),	 the	surgeon	specialty	(p=1.000)	and	surgeon	grade	(p=0.734)	were	not	significantly	
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associated	 with	 post	 perforation	 morbidity.	 Of	 the	 40	 patients	 who	 did	 not	develop	post	perforation	morbidity	following	surgery,	the	majority,	23	(57.5%)	did	not	have	a	tachycardia	at	initial	presentation.	Eight	(20%)	did,	with	the	pulse	rate	being	unknown	in	9	(22.5%)	of	these	40	patients.	In	the	23	patients	who	had	surgery	 and	 developed	 post	 perforation	morbidity,	 11	 (47.8%)	 did	 not	 have	 a	tachycardia	at	presentation	and	5	(21.7%)	did	with	the	pulse	rate	being	unclear	in	seven	(30.4%).	The	presence	of	a	tachycardia	was	not	significantly	associated	with	post	perforation	morbidity	in	those	patients	having	surgery	(p=0.739).	
	Twenty-eight	patients	(24.3%)	were	admitted	to	the	Intensive	Care	Unit	or	High	Dependency	Unit.	In	all	of	these	cases	the	patient	had	just	had	surgery.	Number	of	nights	on	ITU/HDU	ranged	from	1	–	21	nights,	with	a	median	of	3	nights	stay	on	ITU.	In	all	115	patients	admitted	to	hospital,	the	length	of	hospital	stay	ranged	from	0	–	40	days	in	hospital	with	a	median	stay	of	6	days.		
	One	patient	 died	having	presented	with	 abdominal	 pain	 following	 a	diagnostic	colonoscopy	showing	diverticular	disease	in	the	sigmoid	colon.	The	patient	was	found	 to	 have	 a	 sigmoid	 perforation,	 had	 a	 Hartmann’s	 procedure	 and	 was	admitted	 to	 ITU.	 This	 patient	 subsequently	 developed	 complications	 post	operatively	 including	 mucus	 plugging,	 a	 pneumothorax	 and	 small	 bowel	ischaemia.	The	patient	died	6	days	following	admission.		
4.3.2.3	 Comparison	 of	 patients	 with	 colonoscopic	 perforation	 in	 whom	 a	
response	to	the	online	questionnaire	was	and	was	not	received.	
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To	 ensure	 that	 the	 117	 colonoscopic	 perforations,	 for	 whom	 I	 received	 a	response	 to	 the	 online	questionnaire,	 broadly	 represented	 the	 total	 number	of	147	perforations,	 five	variables	were	compared	between	 the	response	(n=117)	and	 the	 non	 response	 group	 (n=30).	 There	 were	 no	 significant	 differences	between	these	groups	in	whether	polyps	were	resected	(p=0.560),	the	colorectal	location	 of	 perforation	 (p=0.626),	 if	 a	 diagnostic	 or	 therapeutic	 perforation	occurred	(p=0.654),	 if	 the	patient	had	surgery	(p=0.754)	and	if	 the	patient	was	admitted	to	the	Intensive	Care	Unit	(p=0.082).	This	reassured	me	that	 the	data	received	in	the	response	group	was	not	skewed	in	any	way.	
	
4.4	Discussion	
	The	overall	perforation	rate	of	0.06%	reported	in	this	study	is	reassuring	when	compared	with	 other	 rates	 that	were	 described	 in	 chapter	 2.4.2	 of	 this	 thesis.	This	study	reports	a	 lower	perforation	rate	than	series	prior	to	1990	reporting	rates	of	0.12%	-	0.48%42	43.	This	study	is	one	of	the	largest	more	recent	series;	three	similarly	sized	series	published	since	2008	report	perforation	rates	of	0.04	–	0.08%	suggesting	that	the	figure	in	this	work	is	in	line	with	current	global	data2			
48	 49.	 The	 majority	 of	 perforations	 in	 my	 study	 occurred	 as	 a	 direct	 result	 of	therapy.	 These	 results	 are	 in	 contrast	 to	 the	 studies	 of	 Avgerinos	 et	 al.	 and	Korman	 et	 al.,	 both	 large	 studies	 of	 over	 100,000	 colonoscopies,	 that	 reported	diagnostic	 perforations	 to	 occur	 in	 greater	 number46	 47.	 Similarly	 Iqbal	 et	 al.	reported	56%	of	perforations	being	form	blunt	injuries	and	not	form	therapy48.	Although	Arora	et	al.	 reported	 fewer	diagnostic	perforations	(42%),	 this	 is	still	over	half	the	18.8%	diagnostic	perforations	reported	in	this	chapter2.	The	fewer	
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number	of	diagnostic	perforations	may	simply	reflect	the	fact	that	the	majority	of	procedures	 in	 the	 BCSP	 are	 therapeutic	 in	 nature	 but	 also	 suggests	 that	 the	quality	 of	 colonoscopy	 performed	 in	 the	 programme	 is	 high.	 The	 overall	therapeutic	perforation	rate	in	this	study	was	0.03%	and	diagnostic	perforation	rate	 was	 0.008%.	 The	 lower	 number	 of	 diagnostic	 perforations	 is	 reassuring	especially	when	 considering	 that	 in	 this	 study	 it	 is	 the	 diagnostic	 perforations	that	are	significantly	associated	with	the	need	for	surgery	and	post	perforation	morbidity.			The	 sigmoid	 colon	 (n=40)	 and	 caecum	 (n=22)	were	 the	 commonest	 colorectal	locations	of	perforation.	Twelve	(30%)	of	perforations	in	the	sigmoid	colon	were	diagnostic,	with	28	 (70%)	being	associated	with	polypectomy.	Similarly,	 in	 the	caecum	 6	 (27.3%)	 of	 the	 perforations	were	 diagnostic	 with	 16	 (72.7%)	 being	therapeutic	 in	 nature.	 The	 majority	 of	 perforations	 occurring	 in	 these	 two	colorectal	 locations	 is	 consistent	with	 the	 only	 other	 study	 of	 those	 reviewed,	reporting	outcomes	following	a	larger	(165)	number	of	perforations.	Iqbal	et	al.	reported	53%	of	perforations	occurring	in	the	sigmoid	colon	followed	by	24%	in	the	caecum48.	Data	in	this	chapter	reinforces	our	knowledge	of	the	mechanisms	associated	with	perforation.	 In	 the	BCSP,	 the	majority	of	 therapy	occurs	 in	 the	sigmoid	colon,	as	this	is	where	the	majority	of	polyps	are	found.	Similarly,	when	considering	 therapeutic	 polypectomy,	 it	 is	 the	 caecum	 that	 is	 significantly	associated	 with	 therapeutic	 perforation	 as	 reported	 by	 Rutter	 et	 al.39.	 One	hypothesis	for	this	is	the	thinness	of	the	caecal	wall	when	compared	with	other	colorectal	 locations.	 In	 this	 study	 I	 have	 been	 able	 to	 break	 down	 colorectal	location	 by	 diagnostic	 and	 therapeutic	 perforation.	 Again,	 the	 majority	 of	
	 123	
diagnostic	 perforations	 occurred	 in	 the	 sigmoid	 colon	 (n=12),	 30%	 of	 all	perforations	 in	 the	 sigmoid	 colon,	 followed	 by	 the	 caecum	 (n=6),	 27.3%	 of	 all	perforations	 in	 the	 caecum,	 which	 is	 consistent	 with	 our	 knowledge	 of	 the	mechanisms	 of	 diagnostic	 perforation	described	 in	 chapter	 2.4.4.	 Indeed	when	comparing	 the	 number	 of	 diagnostic	 perforations	 in	 the	 sigmoid	 colon	 where	diverticular	 disease	was	 also	 present	 to	 the	 number	 of	 endoscopic	 procedures	overall	where	diverticular	disease	was	found,	this	data	suggests	that	diverticular	disease	may	contribute	to	some	diagnostic	perforations.	This	may	be	due	to	the	intubation	 and	 perforation	 of	 a	 diverticulum	 itself	 or	 from	 mechanical	 forces	from	the	tip	or	shaft	of	the	scope	against	a	fixed	and/or	acutely	angled	sigmoid	colon	 where	 there	 is	 circular	 muscle	 hypertrophy	 secondary	 to	 diverticular	disease.	In	one	of	the	diagnostic	perforations	in	the	rectum	the	perforation	may	have	 been	 due	 to	 the	 force	 of	 retroverting	 the	 colonoscope	 tearing	 the	 rectal	wall.		Within	 the	 subgroup	 of	 diagnostic	 perforations	 in	 this	 study,	 four	 were	 in	asymptomatic	patients	and	were	detected	radiologically	on	staging	CT	scans	for	colorectal	cancer.	It	 is	perhaps	more	likely	though	that	these	perforations	were	due	 to	 the	 invasive	 nature	 of	 the	 cancer	 and	not	 any	 of	 the	 biopsies	 that	 took	place.	 In	 two	 of	 these	 patients	 the	TNM	 staging	was	 at	 least	 T4	 (T4N1M0	 and	T4N2M0),	which	would	be	consistent	with	these	cancers	penetrating	the	serosa,	and	 causing	perforation,	however,	 one	was	T3N0M0.	We	should	also	be	aware	that	 it	 is	 likely	 that	 these	 perforations	 will	 only	 ever	 be	 seen	 associated	 with	colorectal	cancer,	as	it	would	only	be	these	patients	that	have	a	staging	CT	scan	in	an	otherwise	asymptomatic	patient.	
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	The	number	of	perforations	physically	visualised	by	the	endoscopist	(12.8%)	in	this	 study	 is	 less	 than	 that	 described	 by	 other	 series	 which	 range	 from	 23-37.5%62	64.	The	median	size	of	perforation	from	my	data	was	5.5mm.	It	may	be	that	 the	 fewer	 number	 of	 perforations	 visualised	 in	 this	 study	 were	 due	 to	 a	smaller	perforation	 size	 although	 size	 isn’t	 specifically	mentioned	 in	 the	above	papers.	The	smaller	number	of	diagnostic	perforations	in	this	study	may	also	go	some	 way	 to	 explaining	 this	 as	 diagnostic	 perforations	 are	 more	 likely	 to	 be	larger	as	reported	by	Iqbal	et	al.	and	Dafnis	et	al.	147	38.	The	work	in	this	chapter	is	in	line	with	other	studies	that	the	majority	of	perforations	present	within	the	first	24	hours,	and	if	not	in	the	first	24	hours	then	at	least	within	48	hours.		Where	the	perforation	is	physically	visualised,	my	data	suggests	that	the	use	of	an	 endoclip	 to	 close	 the	 perforation	may	 improve	 patient	 outcomes.	 83.3%	 of	those	 perforations	 in	 whom	 the	 perforation	 was	 physically	 visualised	 by	 the	endoscopist	 and	 had	 endoclips	 applied	 were	 successfully	 mananged	endoscopically	 and	 conservatively	without	 the	 need	 for	 surgery,	 although	 this	association	didn’t	reach	statistical	significance.	This	figure	is	entirely	consistent	with	the	68-93%	of	patients	reported	as	being	successfully	managed	in	this	way	by	other	studies75	76	77	78.			My	work	has	highlighted	how	those	patients	who	were	managed	conservatively,	with	or	without	the	use	of	endoclips,	didn’t	develop	post	perforation	morbidity	or	 require	 intensive	 care	 admission.	 This,	 of	 course,	 reflects	 the	 fact	 that	perforations	who	have	surgery	are	likely	to	be	more	unwell	at	presentation,	due	
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to,	 for	 example,	 a	 greater	 degree	 of	 faecal	 peritonitis	 and	 haemodynamic	instability.	 These	 patients,	 are,	 therefore,	 perhaps	 more	 likely	 to	 have	 post	operative	 complications.	 However,	 it	 also	 follows	 that,	 where	 possible,	conservative	management	should	be	attempted.	My	data	has	showed	that	those	patients	 who	 have	 abdominal	 pain,	 with	 a	 respiratory	 rate	 of	 more	 than	 20	breaths	 per	 minute	 and	 a	 pulse	 rate	 of	 greater	 than	 100	 beats	 per	 minute	 at	initial	 presentation	were	more	 likely	 to	 have	 surgery.	 This	 gives	 a	 guide	 as	 to	when	medical	management	may	be	successful,	especially	if	an	endoclip	has	been	used	 to	 close	 the	 perforation.	 My	 data	 suggests	 that	 following	 perforation	 a	patient	without	abdominal	pain,	and/or	an	initial	pulse	rate	of	60	–	100	beats	per	minute	 and/or	 a	 respiratory	 rate	 of	 20	 breaths	 per	 minute	 or	 less	 may	 be	indicators	 for	medical	management.	 Indeed	 future	prospective	data	specifically	studying	the	presence	of	abdominal	pain,	the	respiratory	rate	and	the	pulse	rate	following	colonoscopic	perforation	may	add	weight	to	these	findings.		Uniquely,	I	have	been	able	to	report	the	initial	radiological	investigation	used	to	make	the	diagnosis	of	perforation.	This	confirms	how	the	clinician	should	not	be	reassured	by	a	normal	plain	erect	chest	x-ray	(CXR)	or	abdominal	x-ray	(AXR).	Of	29	patients	with	a	normal	CXR,	21	went	on	to	have	a	CT	abdomen	of	which	most	(90.5%)	showed	evidence	of	perforation.	Similarly,	of	the	39	patients	who	had	an	AXR,	28	showed	no	perforation	but	 in	 the	majority	of	 these	(64.3%)	there	was	evidence	of	perforation	on	CT.	Where	clinical	suspicion	of	perforation	is	high	the	clinician	will	usually	proceed	to	CT	even	after	a	normal	CXR,	however,	this	data	calls	into	question	the	relevance	of	doing	an	AXR	at	all.		
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Over	half	of	 the	admissions	 to	hospital	 in	 this	study	had	surgery,	an	 important	fact	 that	 can	 be	 used	 when	 consenting	 patients	 prior	 to	 future	 BCSP	colonoscopies.	 In	 addition,	 patient	 information	 documents	 can	 be	 amended	 to	reflect	the	potential	sequelae	of	perforation.	An	important	finding	of	this	work	is	that	the	diagnostic	perforations	are	significantly	associated	with	having	surgery	when	compared	with	therapeutic	perforations.	A	possible	explanation	lies	in	the	larger	 size	of	diagnostic	perforations,	 as	previously	 reported,	which	 result	 in	 a	greater	 degree	 of	 faecal	 contamination,	 peritonitis	 and	 haemodynamic	instability.		Unusually	 for	 other	 studies	 reporting	 outcomes	 following	 perforation,	 in	 this	chapter	I’ve	been	able	to	report	whether	surgery	was	commenced	during	normal	working	 hours,	 the	 grade	 of	 surgeon	 operating	 and	 the	 specialty	 of	 surgeon	operating	 (colorectal	 or	 non-colorectal	 surgeon).	 Operations	 appear	 to	 be	performed	 as	 the	 patient	 presents,	 25.8%	 being	 performed	Monday	 to	 Friday	from	08:00	to	17:00	hours.	When	considering	this	‘normal	working	hours’	period	being	45	hours	of	a	total	number	of	hours	in	the	week	of	168	hours,	the	25.8%	figure	 remains	 consistent	 with	 operations	 being	 performed	 around	 the	 clock.	Reassuringly	 consultant	 surgeons	 and	 colorectal	 surgeons	 performed	 the	greatest	 number	 of	 operations	 although	 none	 of	 these	 factors	 statistically	 had	any	impact	on	the	development	of	post	perforation	morbidity.	Of	note	was	that	the	 seven	 laparoscopies	 were	 only	 performed	 by	 consultant	 surgeons,	 the	majority	of	whom	(71.4%)	were	consultant	colorectal	surgeons.		
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Again,	 when	 considering	 the	 future	 consent	 process	 for	 patients	 attending	 for	colonoscopy	in	the	BCSP,	data	from	this	study	has	showed	that	if	surgery	occurs	post	perforation,	patients	have	an	approximately	50%	chance	of	leaving	hospital	with	 a	 stoma.	 This	 equates	 to	 over	 a	 quarter	 of	 patients	 admitted	 to	 hospital	overall.	 A	 patient	 is	more	 likely	 to	 be	 left	with	 a	 stoma	 following	 a	 diagnostic	perforation	 but	 it	 was	male	 sex	 and	 the	 sigmoid	 colon	 that	 were	 significantly	associated	with	stoma	formation.	A	possible	explanation	for	this	is	the	majority	of	perforations	in	the	sigmoid	colon	having	a	Hartmann’s	procedure,	particularly	in	 the	 case	 of	 the	 diagnostic	 perforations	 where	 there	 may	 be	 greater	 faecal	contamination.	With	 regard	 to	male	 sex,	 76.7%	 of	 the	 stomas	 formed	were	 in	males.	A	possible	explanation	 for	 this	may	be	a	subgroup	of	male	patients	who	have	 longer	sigmoid	colons	 that	are	more	 likely	 to	 loop	during	 intubation	with	consequent	 diagnostic	 perforation	 during	 intubation	 or	 loop	 resolution.	 In	addition	 eight	 of	 the	 23	 (34.8%)	male	 patients	who	 left	 hospital	with	 a	 stoma	also	 had	 diverticular	 disease	 at	 the	 colorectal	 location	 of	 perforation	 of	which	seven	were	in	the	sigmoid	colon.	In	all	30	patients	who	left	hospital	with	a	stoma	10	 (33.3%)	 also	 had	 diverticular	 disease	 at	 the	 colorectal	 location	 of	 the	perforation	compared	with	only	1	of	31	(3.2%)	who	had	diverticular	disease	at	the	colorectal	location	of	the	perforation	among	those	who	had	surgery	without	stoma	formation.		An	 important	 outcome	 to	 consider	 from	 this	 study	 is	 that	 only	 those	 patients	who	had	surgery	developed	post	perforation	morbidity	or	were	admitted	to	the	intensive	care	unit	(ICU).	For	reasons	explained	earlier,	this	may	reflect	the	fact	that	those	patients	who	had	surgery	were	likely	to	have	been	more	unstable	at	
	 128	
presentation	 and	 therefore	 more	 likely	 to	 develop	 post	 perforation	 morbidity	and	require	intensive	care	admission.	However,	it	is	also	reassuring	for	the	BCSP	that	those	patients	who	were	managed	without	having	surgery	recovered	well.	A	post	perforation	morbidity	rate	of	19.1%	in	patients	admitted	acutely	compares	favourably	 with	 other	 series	 both	 when	 considering	 morbidity	 following	 all	perforations	and	when	considering	morbidity	post	surgery	only.	Distinctively,	it	is	 the	 study	 in	 this	 chapter	 that	has	 reported	both	diagnostic	perforations	 and	surgery	 as	 being	 significantly	 associated	 with	 developing	 post	 perforation	morbidity.	 For	 the	 reasons	 reported	 above,	 diagnostic	 perforations	 appear	 to	carry	the	greatest	risk	of	the	patient	becoming	unstable	and	therefore	potentially	increasing	 the	 chances	 of	 them	 developing	 complications	 following	 surgery.	Although	any	death	associated	with	a	screening	investigation	is	disappointing	for	the	 screening	 programme,	 a	 post	 perforation	 mortality	 rate	 of	 0.87%	 does	compare	favourably	with	other	series	that	have	reported	mortality	both	overall	post	perforation	and	post	perforation	surgery.			
4.5	Conclusions	
	When	considering	my	intentions	of	writing	this	thesis,	the	study	in	this	chapter	has	 reassured	us	 that	 colonoscopic	perforations	 in	 the	English	NHSBCSP	occur	on	 an	 infrequent	 basis	 at	 similar	 rates	 to	 what	 occurs	 when	 colonoscopy	 is	performed	on	the	same	scale	elsewhere	in	the	world.			I	have	also	been	able	to	explore	the	impact	of	the	perforation	on	the	patient.	As	a	direct	result	of	this	study	we	now	know	that	98.2%	of	patients	with	perforation	
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were	 admitted	 to	 hospital	 and	 44.1%	 of	 admissions	 were	 admitted	 within	 48	hours	 of	 the	 colonoscopy.	 Data	 from	 those	 admissions	 shows	 that	 53.9%	 had	surgery,	 26.1%	 left	 hospital	with	 a	 stoma,	 19.1%	developed	 a	 complication	 or	new	diagnosis	while	in	hospital	and	24.3%	were	admitted	to	the	intensive	care	unit.	 Those	 that	 developed	 a	 complication	 or	 new	 diagnosis	 while	 in	 hospital	and/or	were	admitted	to	the	intensive	care	unit	did	so	only	after	having	surgery.	Unfortunately,	 one	 patient	 died	 following	 admission	 for	 a	 perforation.	Collectively,	all	these	facts	give	us	a	more	complete	understanding	of	the	impact	a	 colonoscopic	 perforation	 has	 on	 the	 patients	 involved.	 The	 data	 obtained	 in	this	 study	 also	means	 this	 can	 be	 presented	 to	 patients	 as	 part	 of	 the	 consent	process	 for	 future	 bowel	 cancer	 screening	 colonoscopies	 and	 may	 directly	impact	on	how	patients	perceive	the	benefit	and	risk	of	having	such	a	procedure.	Ultimately,	 it	 is	 the	 patient’s	 decision	 alone	 as	 to	 whether	 to	 proceed	 with	colonoscopic	examination	but	they	now	are	able	to	make	this	decision	on	a	more	informed	basis.		We	 are	 now	 also	more	 aware	 of	 type	 of	 perforation	 that	 is	 likely	 to	 result	 in	surgery	and	therefore	may	lead	stoma	formation,	post	perforation	morbidity	and	intensive	care	admission.	Diagnostic	perforations	are	significantly	more	likely	to	lead	to	this	chain	of	events.	Similarly,	stoma	formation	is	significantly	more	likely	to	occur	in	the	sigmoid	colon	than	any	other	colorectal	location	and	in	male,	not	female,	patients.			A	 third	 intention	 of	 this	 thesis	 specifically	 relating	 to	 this	 study	 was	 how	 to	improve	 the	 assessment	 and	management	 of	 colonoscopic	 perforation	 so	 that	
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the	patients	involved	have	the	best	possible	outcome.	We	now	know	that	those	patients	 that	 did	 not	 have	 surgery	 did	 not	 develop	 post	 perforation	morbidity	and	were	not	 admitted	 to	 intensive	 care	 .	 This	may	 simply	 reflect	patients	not	needing	surgery	being	more	stable	at	presentation.	However,	 it	 is	 important	 to	emphasize	 these	 patients	 have	 good	 outcomes.	 This	 chapter	 has	 showed	potential	 indicators	 for	 where	 non	 surgical	 management	 may	 be	 used	 in	 the	future.	The	use	of	endoclips	results,	in	most	cases,	in	the	patient	avoiding	surgery	and	these	should	be	considered	and	used	if	the	endoscopist	physically	visualises	the	perforation.	This	is	particularly	in	the	context	of	a	perforation	of	5mm	or	less	in	size.	Similarly,	 if	a	patient	does	not	have	abdominal	pain,	has	a	normal	pulse	rate	of	60	–	100	beats	per	minute	and	a	respiratory	rate	of	20	breaths	per	minute	or	 less	 following	 confirmation	 of	 a	 perforation,	 these	 are	 all	 indicators	 for	managing	 them	 non	 surgically	 Although	 the	 conservative	 management	 of	perforation	 is	 likely	 to	 produce	 a	 more	 desirable	 outcome	 for	 patient	 and	clinician,	 these	decisions,	as	always	must	be	 taken	by	 the	assessing	clinician	 in	the	context	of	the	clinical	situation	that	is	in	front	of	them.	
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Chapter	5	
	
Colonoscopists’	 narratives	 of	 a	 colonoscopy	 associated	 with	 a	 colorectal	
perforation	
	
5.1	Aims	
	1.	To	identify	‘human’	and	‘environmental’	factors	that	may	be	associated	with	a	colonoscopic	perforation.	2.	To	explore	how	colonoscopists	react	to	performing	a	colonoscopy	associated	with	a	colorectal	perforation.	
	
5.2	Methods	
	
5.2.1	The	qualitative	research	approach	
	Two	 of	 my	 intentions	 in	 writing	 this	 thesis	 related	 to	 the	 colonoscopist	 who	performs	the	colonoscopy	associated	with	an	adverse	event.	I	planned	to	explore	the	 impact	 of	 the	 adverse	 event	 on	 the	 colonoscopist	 and	 provide	 a	 reference	point	of	such	experiences	so	that	other	colonoscopists	could	refer	to	them	should	they	encounter	such	an	event	 in	the	 future.	As	previously	stated	 in	chapter	3,	 I	also	 intended	 to	 identify	 risk	 factors	 for	 colonoscopic	 adverse	 events.	 My	examination	 of	 these	 adverse	 events	 comprised	 not	 only	 a	 review	 of	 relevant	literature,	but	also	my	own	experience	of	witnessing	the	 involvement	of	others	with	colonoscopic	adverse	events	and	conversations	with	colleagues	about	such	
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cases.	It	was	apparent	from	this	examination	that	not	all	these	risk	factors	could	be	 determined	 from	 quantitative	 data.	 Some	 of	 these	 factors	 would	 not	 be	documented	on	endoscopy	reports,	medical	notes	or	entered	 into	databases.	 In	order	 to	 achieve	 these	 aims	 I	 would	 need	 to	 speak	 directly	 to	 those	colonoscopists	 who	 had	 performed	 colonoscopies	 associated	 with	 adverse	events.	 I	 therefore	 designed	 this	 qualitative	 research	 study	 surrounding	colonoscopists’	experience	of	colonoscopic	perforation.		Qualitative	 research	 stems	 from	 a	 number	 of	 disciplines	 including	 philosophy,	social	 psychology,	 sociology	 and	 anthropology.	 It	 seeks	 to	 determine	 the	perspective	 of	 an	 individual	 or	 group.	 The	 advantages	 of	 qualitative	 research	include	that	it	permits	a	personal	involvement	with	participants	in	their	natural	setting	 allowing	 an	 in	 depth	 engagement.	 This	 can	 result	 in	 a	 rich	 detailed	understanding	of	an	issue.	Qualitative	research	can	generate	new	theory,	deepen	knowledge	and	illuminate	the	findings	of	quantitative	research148.		In	determining	the	impact	of	a	colonoscopic	perforation	on	a	colonoscopist	and	evaluating	how	the	colonoscopist	subsequently	reacts,	 I	 identified	an	issue	that	required	 further	 exploration.	 This	 study	 provided	 colonoscopists	 the	opportunity	to	share	their	experiences148.			The	study	also	used	qualitative	research	to	identify	factors	that	could	not	easily	be	 measured.	 Such	 factors	 included	 the	 identification	 of	 risk	 factors	 for	perforation	 other	 than	 those	 that	 had	 been	 established	 quantitatively.	 For	 the	purposes	 of	 this	 study	 these	 factors	were	 termed	 ‘human’	 and	 ‘environmental’	
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factors148.	 ‘Human’	 factors	 relate	 to	 the	 thoughts,	 feelings	 and	 emotions	 of	 the	colonoscopist	 at	 the	 time	 of	 the	 colonoscopy	 associated	 with	 the	 perforation.	‘Environmental’	factors	relate	to	the	setting	of	the	colonoscopy	and	the	situation	the	colonoscopist	was	in.		There	 are	 six	 main	 qualitative	 research	 methodologies:	 case	 study,	phenomenology,	 grounded	 theory,	 ethnography,	 narrative	 research	 and	 realist	evaluation.		Case	study	is	‘an	empirical	enquiry	that	investigates	a	contemporary	phenomenon	within	its	real	life	context,	especially	when	the	boundaries	between	phenomenon	 and	 context	 are	 not	 clearly	 evident’	 and	 it	 ‘relies	 on	 multiple	sources	 of	 evidence’149.	 Phenomenology	 describes	 the	 lived	 experience	 of	 a	phenomenon	and	can	be	described	as	an	‘object’	of	human	experience.	Grounded	theory	 aims	 to	 move	 beyond	 description	 to	 generate	 a	 theory;	 an	 analytical	schema	of	a	social	process	or	interaction.	Ethnography	is	the	study	of	a	culture	or	subculture	 and	 is	 concerned	 with	 the	 insiders’	 view	 of	 their	 world.	 Narrative	research	is	concerned	with	how	a	narrative	is	told,	why	it	is	told	in	a	particular	way	 and	 the	 forms	of	 telling	 rather	 than	 their	 content.	 Realist	 Evaluation	 asks	‘What	 works	 for	 whom,	 in	 what	 circumstances	 and	 in	 what	 respects,	 and	how?’150		
5.2.2	Phenomenology	
	Of	 the	 six	 qualitative	 research	 methodologies	 outlined	 above,	 I	 used	phenomenology	 in	 this	study.	Phenomenology	aims	 to	develop	a	description	of	shared	 experiences,	 which	 includes	 both	 perceptions	 about	 what	 was	
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experienced	as	well	as	how	it	was	experienced.	Phenomenology	is	based	on	the	work	 of	 the	 mathematician,	 Edmund	 Husserl	 (1859-1938)	 and	 was	 later	developed	 by	 Heidegger	 and	 Satre.	 There	 are	 four	 basic	 tenets	 of	phenomenology.			1.	The	pursuit	of	wisdom;	to	advance	our	understanding	of	the	meaning	of	being	human.		2.	A	philosophy	without	presuppositions;	bracketing	or	putting	aside	one’s	own	beliefs	and	suppositions	about	the	phenomena.		3.	The	intentionality	of	consciousness,	relates	to	the	individual	understanding	of	reality	by	virtue	of	consciousness.	4.	Refusal	of	 the	 subject-object	dichotomy;	 the	 reality	of	 an	object	 is	perceived	within	the	meaning	of	an	individual’s	experience.		There	are	broadly	three	types	of	phenomenology:	hermeneutic	phenomenology,	transcendental	 phenomenology	 and	 interpretative	 phenomenological	 analysis	(IPA).	 Hermeneutic	 phenomenology	 usually	 refers	 to	 the	 interpretation	 of	 the	texts	 of	 life.	 Transcendental	 phenomenology	 is	 that	 in	 which	 everything	 is	perceived	 freshly,	 as	 if	 for	 the	 first	 time.	 IPA	 combines	 these	 two	 types	 of	phenomenology.	Using	IPA	the	researcher	begins	as	a	naive	observer	and	moves	through	 a	 process	 of	 sense	 making	 towards	 a	 more	 questioning	 and	 analytic	framework.		I	 used	 phenomenology	 for	 this	 study	 because	 I	 aimed	 to	 explore	 a	 lived	experience,	 the	 reaction	 of	 a	 colonoscopist,	 to	 a	 phenomenon,	 a	 colonoscopic	
	 135	
perforation.	 I	also	 intended	to	explore	 the	common	meaning	of	a	phenomenon,	the	colonoscopic	perforation,	among	a	group	of	 individuals,	 the	colonoscopists,	all	of	whom	had	experienced	that	phenomenon148.			
5.2.1	Study	Protocol	and	Supporting	Documents		Following	the	identification	of	an	appropriate	qualitative	research	methodology	and	establishing	 the	aims	of	 the	study,	 I	drafted	and	 finalised	a	 research	study	protocol.	The	protocol	had	several	specific	sections.	It	began	with	the	details	of	the	 researchers,	 which	 were	 myself,	 and	 the	 supervisors	 of	 this	 thesis.	 The	background	to	 the	study	 included	the	 literature	reviewed	 in	chapter	2.7	of	 this	thesis	 surrounding	 adverse	 events	 and	 the	 colonoscopist.	 A	 lay	 summary	was	provided	 along	 with	 the	 study	 hypothesis,	 its	 aims	 and	 a	 description	 of	 the	methodology.	 How	 potential	 participants	 would	 be	 recruited,	 including	 the	inclusion	and	exclusion	criteria,	was	also	described.	The	research	study	protocol	went	 on	 to	 give	 details	 of	 how	 consent	 would	 be	 obtained,	 how	 the	confidentiality	 of	 participants	 would	 be	 maintained	 and	 how	 data	 generated	from	 the	 study	 would	 be	 managed.	 Ethical	 considerations	 and	 where	 ethical	approval	was	 sought	was	 also	 described.	 The	 protocol	 finished	with	 details	 of	where	a	peer	review	was	sought	and	details	of	how	results	from	the	study	would	be	disseminated.		After	completing	the	study	protocol,	I	devised	and	wrote	an	interview	guide.	The	guide	comprised	a	series	of	questions	grouped	in	specific	sections	that	I	felt	gave	me	 the	 basis	 from	 which	 I	 would	 be	 able	 to	 achieve	 the	 aims	 of	 the	 study.	 I	
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devised	the	questions	in	the	guide	based	on	several	distinct	processes.	Initially,	they	 came	 from	my	 own	 thoughts	 and	 feelings	 of	 what	 I	 considered	 could	 be	potential	 ‘human’	 and	 ‘environmental’	 factors	 surrounding	 colonoscopic	perforation	and	how	I	might	react	to	a	colonoscopic	perforation	should	it	happen	in	 my	 own	 practise.	 Secondly,	 they	 came	 from	 personal	 observations	 and	discussions	with	colleagues	surrounding	previous	perforation	cases.	Thirdly,	the	literature	 reviewed	 in	 chapter	 2.7	 of	 this	 thesis	 provided	 a	 basis	 for	 exploring	how	a	colonoscopist	may	react	to	a	perforation.	Questions	in	the	interview	guide	were	 grouped	 under	 the	 sections:	 participant	 demographics,	 colonoscopy	experience,	event	details,	immediate	reaction,	professional	and	personal	reaction	and	subsequent	practice.	The	interview	guide	can	be	found	in	chapter	10	of	this	thesis.		A	 participant	 information	 sheet	 (PIS)	 that	 would	 be	 used	 for	 distribution	 to	potential	participants	in	the	study	was	also	then	written.	This	document	was	in	a	question	and	answer	 format,	 the	questions	being	ones	that	 I	 felt	gave	potential	participants	a	broad	understanding	of	why	I	designed	this	research	study	and	its	aims.	The	design	and	content	of	 the	PIS	was	based	on	 similar	documents	used	previously	 by	 qualitative	 researchers	within	 Durham	University	 for	 interview-based	studies.			In	addition	to	the	PIS,	I	wrote	a	consent	form	for	participants	to	sign	confirming	and	documenting	their	desire	to	take	part	in	the	study.	The	consent	form	was	in	the	format	of	a	series	of	statements	relating	to	the	study,	with	a	yes/no	tick	box	next	to	each	statement	and	a	space	for	the	participant	to	sign	the	form.		
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5.2.2	Peer	Review	
	When	 the	 study	 protocol	 and	 the	 supporting	 documents	 described	 had	 been	completed,	I	requested	a	peer	review	of	the	study	be	performed.	The	comments	made	by	the	peer	reviewer,	focusing	mainly	on	improving	the	general	clarity	of	study	 protocol	 and	 the	 rationale	 for	 the	 proposed	 research	 were	 then	incorporated	into	a	final	version	of	the	study	protocol	prior	to	its	submission	for	ethical	approval.		
5.2.3	Ethics	
	Ethical	approval	was	sought	and	granted	from	the	Durham	University,	School	of	Medicine,	Pharmacy	&	Health	Ethics	Sub-Committee.	The	Ethics	Sub-Committee	reviewed	the	study	protocol	in	addition	to	other	supporting	documents	relating	to	the	study.			
5.2.4	Participant	Recruitment	
	Once	 I	 had	gained	ethical	 approval	 for	 the	 study	 to	 start,	 I	wrote	 an	 invitation	letter	that	briefly	outlined	the	research	study,	why	I	had	designed	it,	and	its	aims.	I	 attached	 this	 letter	 to	an	email	 and	emailed	 it,	 via	NHS	mail,	 to	all	 the	Bowel	Cancer	 Screening	 Programme	 colonoscopists	 based	 at	 the	 five	 Bowel	 Cancer	Screening	 Centres	 in	 the	 North	 East	 of	 England	 and	 North	 Cumbria.	 The	invitation	 letter	 was	 also	 then	 emailed	 to	 all	 consultant	 gastroenterologists	
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employed	in	NHS	trusts	 in	the	Northern	Deanery	(now	Health	Education	North	East)	of	England	excluding	those	BCSP	colonoscopists	already	emailed.	The	letter	can	 be	 found	 in	 the	 Chapter	 10	 of	 this	 thesis.	 I	 received	 eleven	 replies	 to	 the	email	 from	participants	 indicating	 their	willingness	 to	 take	part,	 including	 one	consultant	 surgeon,	 three	 nurse	 endoscopists	 and	 seven	 consultant	gastroenterologists.	 Those	 colonoscopists	 who	 replied	 to	 the	 email	 and	 were	willing	 to	 be	 participants	 in	 the	 study	were	 emailed	 a	 participant	 information	sheet	and	a	study	consent	form.	A	date	and	time	for	the	interview	to	take	place	was	 arranged	 via	 email	 correspondence	 directly	 with	 the	 participant	 or	 with	their	secretary.	The	consent	form	was	signed	by	the	participant	and	then	either	emailed	or	posted	back	to	me	prior	to	commencing	the	interview.			
5.2.5	Interviews	
	Eleven	interviews	were	performed	during	October	and	November	of	2014,	each	at	the	base	hospital	of	the	participant.	The	interviews	took	place	in	rooms	with	only	the	participant	and	myself	present.	Only	one	specific	perforation	case	was	discussed	 during	 each	 interview.	 Where	 the	 colonoscopist	 had	 two	 or	 more	colonoscopic	 perforation	 cases	 during	 their	 practice,	 the	 colonoscopist	 chose	which	 perforation	 case	 they	 wanted	 to	 discuss	 prior	 to	 the	 interview.	 The	interviews	were	conducted	anonymously	and	were	voice	recorded.			Each	interview	was	semi	structured	using	the	interview	guide	for	reference.	The	semi-structured	 nature	 of	 the	 interviews	 allowed	me	 to	 explore,	 in	 depth,	 the	perforation	 case	 and	 allowed	 participants	 to	 introduce	 issues	 that	 were	
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important	to	them.	They	also	gave	me	the	flexibility	to	pursue	issues	when	they	appeared	to	be	important	to	the	participant	or	merit	more	exploration.			
5.2.6	Data	Analysis		When	 all	 eleven	 interviews	 had	 been	 completed,	 I	 used	 the	 process	 of	‘framework’	 to	 analyse	 the	 data	 produced151.	 I	 personally	 transcribed	 the	interview	 recordings	 on	 to	 eleven	 separate	 Microsoft	 word	 documents.	 Each	transcription	was	given	a	code	from	C1	to	C11	representing	the	interviews	in	the	order	 in	 which	 they	 took	 place	 from	 colonoscopist	 number	 1	 (C1)	 to	colonoscopist	number	11	 (C11).	Transcription	of	 the	 interviews	allowed	me	 to	begin	 the	process	 of	 ‘framework’	 by	 ‘familiarising’	myself	with	 the	data.	While	transcribing	 and	 ‘familiarising’	 myself	 with	 the	 data,	 I	 began	 to	 consciously	develop	a	‘thematic	framework’.	The	‘thematic	framework’	was	developed	by	the	process	of	‘abstraction	and	conceptualisation’151.			When	all	 the	 interviews	were	 transcribed	 I	 identified	 the	 ‘key	 issues,	 concepts	and	 themes’.	 These	 were	 identified	 by	 drawing	 upon	 ‘priori	 issues,	 emergent	issues	 and	 analytical	 themes	 arising	 from	 the	 recurrence	 or	 patterning	 of	 the	particular	 experiences’	 of	 the	 colonoscopists.	 I	 used	 this	 process	 to	 identify	different	 ‘key	 issues,	 concepts	 and	 themes’	 that	 arose	 from	 the	 range	 of	colonoscopists	that	were	interviewed151.			I	 continued	 the	 process	 of	 ‘framework’	 by	 ‘indexing’.	 This	 was	 where	 the	‘thematic	framework’	was	applied	to	data	in	its	textual	form.	I	recorded	the	index	
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references	 on	 the	margins	 of	 each	 transcript	 by	 a	 numerical	 system	 that	 links	back	 to	 the	 index.	After	 ‘indexing’,	 I	 ‘charted’	 the	data.	Data	was	 lifted	 from	 its	original	context	and	rearranged	according	to	the	appropriate	thematic	reference.	This	‘chart’	was	arranged	with	headings	drawn	from	the	thematic	framework	or	the	 ‘priori’	 issues.	 The	 final	 part	 of	 the	 data	 analysis	 involved	 ‘mapping	 and	interpretation’.		Once	all	the	data	has	been	charted,	the	key	characteristics	of	the	data	 were	 mapped	 and	 interpreted	 as	 a	 whole	 in	 order	 to	 answer	 the	 study	aims151.			
5.3	Results	
	Data	obtained	from	the	interviews	were	divided	into	two	main	sections	in	order	to	 answer	 the	 aims	 of	 this	 study.	 Firstly,	 this	 related	 to	 the	 reaction	 of	 the	colonoscopist	to	the	perforation	and,	secondly,	the	‘human’	and	‘environmental’	factors	associated	with	perforation.	Within	the	first	of	these,	a	difference	in	the	reactions	 between	 the	 three	 types	 of	 professionals	 that	 were	 interviewed	emerged	 and	 I	 have	 therefore	described	 this	 separately	 in	 section	5.3.2	 of	 this	chapter.	
	The	 interviews	 among	 the	 eleven	 colonoscopists	 related	 to	 perforation	 cases	from	different	periods	of	time	prior	to	the	interview.	These	time	periods	ranged	from	four	months	to	approximately	20	years	prior	to	the	interview.	Despite	the	differences	in	time	periods,	in	all	eleven	cases	the	participant	was	clearly	able	to	recall	the	perforation	case	and	their	feelings	surrounding	it.	Evidence	of	how	the	
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clarity	of	memory	remained	with	 the	participant	can	be	 found	 in	 the	 following	extracts:		
‘Yes,	I	can	very	much	remember	what	happened’	(C1)	
‘I	still	think	about	it,	I	still	remember	the	case	quite	well,	and	I	would	think	that	
almost	everyone	you	speak	to,	who	has	damaged	somebody	that	way	will	
remember	it	quite	well’	(C9)	
‘When	you’ve	had	something	like	that	happen	it	actually	sticks	with	you	for	a	lot	
longer	than	that.	Even	now,	when	I’m	colonoscoping,	I’m	always	aware;	things	like	
that	stick	with	you.’	(C10)		The	clarity	of	memory	of	the	case	along	with	the	quotes	listed	above	suggests	the	perforation	 case	 had	 a	 deep	 psychological	 impact	 on	 the	 colonoscopist.	 The	stages	of	the	reaction	are	described	in	the	following	section.		
5.3.1	The	Colonoscopists’	Reaction	
	The	thematic	 framework	produced	from	the	data	relating	to	the	colonoscopists	reaction	 to	 the	 perforation	 comprised	 four	 distinct	 themes	 and	 stages	 to	 their	reaction.	These	are	based	on	the	stages	of	reaction	identified	by	Scott	et	al.,	Luu	et	al.	and	Ullstrom	et	al.	in	their	studies141,145,144.		‘The	 Realisation’	 comprises	 the	 period	 in	 the	 minutes	 and	 hours	 after	 the	colonoscopist	has	realised	a	perforation	occurred	and	involves	a	range	of	strong	and	powerful	emotions.	
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		‘Into	the	Mirror’	then	transpired	over	the	following	days	when	the	colonoscopist	experienced	feelings	of	personal	responsibility,	self	blame	and	vulnerability.			
‘Acceptance	and	Refocus’	followed	in	the	subsequent	days	and	weeks	where	the	colonoscopist,	 with	 support,	 recommenced	 performing	 colonoscopy,	 accepted	that	 the	 perforation	 occurred	 and	 was	 able	 to	 refocus	 on	 their	 personal	 and	professional	life.		Finally,	 there	 is	 a	 period	of	 	 ‘Reflection	and	Learning’;	 the	 colonoscopists	 looks	back	on	the	case,	learns	from	it	and	applies	that	to	the	their	future	practice.		
5.3.1.1	‘The	Realisation’		A	 range	 of	 strong	 and	 powerful	 feeling	 and	 emotions	were	 evident	 during	 the	
‘The	 Realisation’	 comprising	 in	 the	 participants	 own	 words	 disbelief,	 shock,	sickness,	emptiness,	horror,	terror,	fear	and	annoyance.			
‘Disbelief	initially,	Oh	My	God,	that	can’t	be	what	I	think	it	is’	(C3)	
‘I	think	complete	dismay…I	couldn’t	believe	it.	Oh…is	it	really?	...I	think	dismayed’	(C4)		
‘it	was	quite	shocking….shocked,	really	shocked’	(C8)		
‘I	felt	sick	inside	knowing	I	had	done	that’	(C1)	
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‘The	thought	that	I	had	done	this	was	just	awful,	it	really,	I	wouldn’t	wish	it	on	
anybody	to	feel	like	that’	(C1)	
‘Sinking,	gut	wrenching	feeling’	(C8)		
‘I	felt	empty,	because	I	knew	it	had	perforated’	(C2)	
‘I	think	I	felt	a	little	bit	hollow	inside’	(C2)		
‘It	was	pretty	horrific	and	obviously	you	feel	absolutely	awful’	(C3)	
‘Horror,	immediate	terror,	extreme	fear’	(C11)		
‘I	was	just	in	tears,	I	took	myself	away	and	had	a	bit	of	a	weep’	(C11)	
‘I	was	distraught	for	the	rest	of	the	day.	I	was	wiped	out	with	it,	with	the	adrenaline	
and	everything.	I	was	in	tears	all	day	really’	(C11)		
‘Annoyed’	(C7)	
‘Little	bit	annoyed	with	myself’	(C9)		
5.3.1.2	‘Into	the	Mirror’	
	After	 ‘The	Realisation’,	 in	 the	 days	 following	 the	 perforation,	 the	 colonoscopist	may	 have	 started	 to	 look	 ‘Into	 the	Mirror’	and	 take	 personal	 ownership	 of	 the	perforation	case,	feel	personally	responsible	for	it	and	blame	him	or	herself.		
‘You	feel	very	responsible	for	it,	as	though	it’s	your	perforation’	(C1)	
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‘I	suppose	you	blame	yourself	a	little	bit	when	you	do	that,	I	was	asking	why	did	I	
do	that?’	(C4)	
‘It	was	almost	certainly	me	that	caused	his	demise’	(C8)	
‘It	just	sinks	in	even	more	that	you’ve	caused	harm	to	somebody’	(C1)	
‘It	made	me	feel	that	I	was	to	blame’	(C11)	
‘I	really	felt	very	bad	and	guilty	that	I’d	inflicted	that	on	the	patient’	(C1)		Within	 this	 period	 of	 looking	 ‘Into	 the	 Mirror’	 the	 colonoscopist	 may	 be	embarrassed,	 question	 himself	 or	 herself	 and	 feel	 vulnerable	 about	 their	 own	position.	This	was	highlighted	in	comments	such	as	those	below:		
‘There	is	a	hesitancy	in	seeking	the	support	of	your	colleagues,	because	you	think,	
they	might	think	you’re	not	good	enough.’	(C2)	
‘But	you	probably	feel	a	bit	embarrassed,	I	suppose,	and	probably	a	bit…you	don’t	
want	to	share	things	with	people	because	it	doesn’t	feel	good’	(C3)	
‘Especially	when	you’re	starting	out,	particularly	when	you’re	a	consultant,	
consultants	tend	to	have	that	‘Oh	my	god,	I’ve	got	to	be	able	to	do	this	and	do	it	on	
my	own’	(C7)	
‘I	hadn’t	had	that	sort	of	severity	of	complication,	I	was	only	2	years	into	my	
consultant	post	so	yeah	you	feel	pretty	vulnerable’	(C8)	
‘I’m	less	than	a	year	into	a	consultant	post	and	I’ve	managed	to	perforate	a	colon	
inside’	(C9)	
‘I	hadn’t	built	up	enough	base	of	safely	done	difficult	things	to	feel….someone	might	
come	down	on	me	like	a	tonne	of	bricks’	(C9)		
	 145	
Two	of	the	colonoscopists	interviewed	specifically	described	emotion	in	the	days	following	the	perforation	case	relating	to	decisions	that	were	made	regarding	the	patient’s	subsequent	care	and	management.	 In	both	cases	 the	patient	died	as	a	consequence	of	complications	secondary	to	the	perforation.	Both	colonoscopists	were	 gastroenterologists	 and	 the	 patients’	 care	 had	 subsequently	 been	 taken	over	by	surgeons.	Neither	colonoscopist	had	been	involved	in	decisions	relating	to	the	patients’	management	and	subsequent	care.		
‘Angry.	I	felt	a	bit	let	down.	I	also	felt	a	little	bit	disappointed	that	I	wasn’t	involved	
in	the	decision	making….I	was	part	of	the	patient’s	deterioration,	the	procedure	
was	part	of	the	patient’s	deterioration.	I	felt	the	least	they	could	have	done	was	
involve	me	in	the	decision-making.	I	felt	a	bit	let	down	by	that.’	(C4)		
‘I	was	upset	because	I	wasn’t	involved	in	the	decision	making’	(C8)		
5.3.1.3	‘Acceptance	and	Refocus’		In	 the	 days	 and	 weeks	 after	 this	 period	 of	 looking	 ‘Into	 the	 Mirror’,	 the	colonoscopist	 started	 to	 re-commence	 colonoscopy	 practice,	 accept	 that	 the	perforation	occurred	and	was	able	to	refocus	on	their	personal	and	professional	life.	 I	 have	 named	 this	 period	 of	 their	 reaction	 ‘Acceptance	 and	Refocus’.	 With	regards	to	performing	colonoscopy	again,	colonoscopists	described	a	heightened	anxiety,	nervousness	and	even	terror	when	starting	their	next	colonoscopy	after	the	perforation	case:	
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‘I	was	very	nervous	initially	about	doing	colonoscopy	again,	I	kind	of	thought	to	
myself,	did	I	really	want	to	be	doing	colonoscopy,	because	this	is	what	can	happen’	(C1)	
‘I	was	very	very	nervous	especially	the	first	time	I	took	a	polyp	off’	(C1)	
‘If	there	had	been	another	list…to	do	that	afternoon,	I	don’t	think	I	would	have	been	
able	to	do	it.	Because	I	don’t	think	I	would	have	picked	up	another	colonoscope	as	if	
nothing	had	happened.	So,	I	don’t	think	I	would	have	been	able	to	do	another	list	
straight	away’	(C2)	
	‘The	next	time	you	do	anything	you’re	slightly….	you’re	slightly	weary	and	
apprehensive’	(C7)	
‘Terrified.	Largely	because	I	couldn’t	rationalise	to	myself	doing	anything	
significantly	different’	(C9)	
‘Certainly	for	a	while	afterwards	you	feel	a	little	apprehensive,	certainly	a	little	
more	attuned	to	what	you’re	doing’	(C10)		However,	 these	 feeling	 were	 balanced	 by	 the	 determination	 of	 some	 of	 the	colonoscopists	to	persevere	and	not	stop	doing	colonoscopy:		
‘but	I	don’t	recall	thinking	of	hanging	my	scope	up	and	I	don’t	recall	thinking	of	
necessarily	stopping	EMR’	(C8)	
‘but	I’ve	never	wanted	to	give	up’	(C11)		After	re-commencing	practice,	 the	colonoscopists	accepted	 that	 the	perforation	case	had	occurred	and	moved	on	with	their	personal	and	professional	lives.	Part	
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of	this	process	was	aided	by	the	support	of	other	colleagues;	the	majority	of	the	participants	recalled	how	the	support	of	colleagues	played	a	large	part	in	this:		
‘I	got	a	lot	of	support	from	people	who	I	didn’t	think	I	would	at	the	time’	(C1)	
‘I	think	I	got	enough	support	from	my	fellow	endoscopist	colleagues’	(C1)		
‘I	got	a	lot	of	support	from	other	endoscopists…it	helped	me	to	get	over	it	and	get	
on’	(C1)	
‘the	organisation	was	extremely	supportive,	we	went	through	a	Root	Cause	
Analysis,	and	I	did	feel	very	supported	by	that…I’m	incredibly	grateful	to	my	
organisation	because	it	was	very	open,	it	wasn’t	a	blame	thing’	(C8)	
‘I	actually	do	find	it	supportive	to	actually	go	back	over	a	case	and	analyse	what	
went	wrong’	(C6)		The	 phase	 of	 acceptance	 revolved	 around	 the	 individual’s	 realisation	 that	perforation	is	inevitable	when	doing	colonoscopy:		
‘We	know	perforations	happen	and	it’s	happened’	(C3)	
‘If	you	don’t	have	enough	complications,	you’re	probably	not	doing	enough	work’	(C7)	
	‘That’s	the	cost	you	pay	for	doing	business	to	a	certain	extent.	You	can’t	make	
everybody	better.	You	just	have	to	try	and	organise	the	net	gain	in	the	process’	(C9)	
‘If	you	do	enough	colonoscopy,	you	will	perforate	somebody’	(C9)	
‘You	have	to	accommodate	to	it	because	you’re	going	to	kill	somebody’	(C9)	
‘Complications	happen,	one	is	always	careful,	but	complications	happen	and	will	
continue	to	happen’	(C2)	
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	After	starting	to	do	colonoscopy	again	and	going	through	the	acceptance	phase,	some	 of	 the	 colonoscopists	 described	 how	 they	were	 able	 to	 ‘refocus’	 in	 both	their	personal	and	professional	lives:		
‘In	my	own	mind	I	just	came	to	terms	with	it	and	got	on	with	it’	
‘That	terror	has	eased	off’	(C11)	
‘I	did	take	a	little	while,	but	I	think	once	I	started	to	get	back	into	doing	
colonoscopy	again	and	got	my	first	polypectomy	out	the	way	again,	I	was	fine’	(C1)		
5.3.1.4	‘Reflection	and	Learning’		The	final	stage	in	the	colonoscopists’	reaction	to	a	colonoscopic	perforation	came	in	 the	months	 and	 even	 years	 following	 the	 event.	 The	 colonoscopist	 had	 the	opportunity	to	learn	from	the	case,	reflect	on	what	they	could	have	differently	or	better	and	then	apply	that	to	their	future	practice	going	forward.	In	some	cases	that	reflection	and	 learning	may	still	be	being	applied	 to	 the	present	day.	Most	colonoscopists	 expressed	 how	 much	 they	 had	 learnt	 from	 the	 case	 and	 how	much	it	had	aided	their	professional	development.		
‘Whenever	you	have	a	complication,	you	try	to	re-evaluate	your	practice	don’t	you?’	(C6)	
‘The	important	thing	is	to	go	back,	reflect	on	it,	think	things	through	and	there’s	
always	one	little	issue,	one	thing	where	you	think,	ah,	I	could	have	done	that	a	bit	
better’	(C7)	
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‘It	was	a	tremendous	learning	thing,	and…in	retrospect…’	(C8)		This	 reflection	 and	 learning	 was	 then	 taken	 forward	 into	 the	 colonoscopists’	subsequent	 practice.	 Most	 colonoscopists	 expressed	 how	 the	 case	 had	 made	them	more	cautious	during	the	procedure:		
	‘I’m	a	bit	more	cautious	with	the	diathermy	but	I	think	mainly	I’m	just	more	
cautious	in	my	positioning’	(C6)	
‘definitely	now	I	would	have	approached	it	with	much	more	caution’	(C8)	
‘I’m	maybe	more	aware	of	quality	of	tissue.	I’m	maybe	more	likely	to	stop’	(C9)	
‘I	think	I	treated	colonoscopy	far	more	seriously	than	I	had	perhaps	before’	(C10)		The	caecum	was	identified	as	a	high	risk	colorectal	location	for	perforations	and	one	 case	 had	 changed	 a	 colonoscopists	 practice	 when	 performing	 endoscopic	mucosal	resection	polypectomy	in	the	caecum:		
‘I’m	incredibly	careful	in	the	caecum	these	days’	(C8)	
‘Now	I’m	much	more	aware	of	the	risk	of	caecal	perforations’	(C8)	
‘now	I	would	have	put	loads	more	clips	on,	and	now	I,	my	practice	is	to	pretty	much	
clip	everything	I	take	off	in	the	caecum.	I	leave	a	long	line	of	clips’	(C8)			When	 specifically	 referring	 to	 patients’	 symptoms	 and	 communication	 with	patients	following	a	colonoscopy,	changes	to	management	strategies	as	a	result	of	the	perforation	case	were	also	evident:	
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‘I	think,	now	I	would	be	much	more	careful	about	those	signs’	(C8)	
‘What	I	do	now	for	all	EMRs,	I	give	my	telephone	number,	my	mobile	telephone	
number	and	I	give	it	to	them	and	I	say,	look,	I	want	you	to	call	me	if	there’s	any	
problem’	(C8)		
5.3.2	 The	 differences	 in	 colonoscopist	 reaction	 between	 specialties	 and	
professions	
	A	theme	that	emerged	during	the	course	of	the	interviews	and	data	analysis	was	the	 differences	 in	 reaction	 between	 the	 specialties	 and	 professions	 among	 the	colonoscopists.	 There	 were	 three	 groups	 of	 professional	 interviewed;	 nurse	endoscopist,	medical	gastroenterologist	and	surgeon.		All	 three	 of	 the	 nurse	 endoscopists	 interviewed	 spoke	 of	 how	 they	 felt	 the	perforation	 case	 had	 a	 more	 severe	 impact	 on	 them	 than	 they	 suspected	 the	same	event	would	have	on	a	medical	or	surgical	endoscopist.			
‘I	think,	this	is	going	to	sound	horrible,	but	I	think	medical	people	are	more	used	to	
things	going	wrong,	whereas,	coming	from	a	nursing	background,	I	was	the	only	
nurse	at	the	time	in	the	trust	doing	colonoscopy,	that	was	how	I	found	it	difficult.	
My	nursing	colleagues	could	say	one	thing	but	it	didn’t	really	mean	an	awful	lot	
because	I	could	tell	they	couldn’t	exactly	tell	how	I	was	feeling’	(C1)	
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‘Nurse	endoscopists	particularly,	I	think,	are	prone	to	crises	of	confidence,	more	so	
than	consultants	who	have	to	learn	to	be	very	confident	don’t	they?	But	nurses	I	
think	are	a	bit	more	prone	to	it	so	I’d	probably	be	quite	supportive	of	a	nurse	
endoscopist	and	just	check	they	were	ok,	you	know,	and	bolster	their	confidence	
about	the	good	things	they’ve	done.’	(C6)	
	
‘Because	I	have	a	feeling	that….I	do	think,	I’m	not	sure	if	I’m	right	or	not,	but	I	do	
think	that	nurses	feel	it	more	because	we	probably	don’t	have	the	confidence	that	
medical	staff	do	in	actually	doing	things.	We’re	perhaps	more	used	to	‘alleviating	
discomfort’,	I’m	not	saying	medical	staff	don’t	do	that,	don’t	get	me	wrong’	(C11)		The	reactions	of	 the	nurse	endoscopists	can	be	contrasted	with	 the	reaction	of	the	surgeon	who	was	interviewed:		
‘I	suppose	surgical	endoscopists	have	a	slightly	different	perspective.	We’re	always	
doing	procedures	that	quite	commonly	result	in	serious	complications	so	from	a	
mental	point	of	view	I	guess	it’s	less	of	a	big	deal’	(C5)	
	
‘You	can’t	be	a	colorectal	surgeon	without	being	able	to	cope	that	some	of	these	
patients	may	have	bad	complications.	Some	will	even	die	as	a	result	of	
complications.	If	you	had	great	difficulty	dealing	with	that	without	more	support	
than	you	would	get	from	colleagues	and	family,	I	think	you	would	probably	be	in	
the	wrong	job.’	(C5)		
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5.3.3	 Human	 &	 environmental	 Factors	 associated	 with	 colonoscopic	
perforation	
	
5.3.3.1	Human	factors	
	Two	 distinct	 ‘human’	 factors	 associated	 with	 perforation	 emerged	 from	 the	analysis	of	data,	which	were	fatigue	and	expectation.			One	 colonoscopist	 described	 how	 the	 perforation	 case	 had	 occurred	 when	 he	was	 tired	 at	 the	 end	 of	 an	 all	 day	 endoscopy	 list.	 He	 felt	 that	 fatigue	 had	contributed	somewhat	to	the	perforation:		
‘It	was	towards	the	end	of	a	busy	therapeutic	list,	a	therapeutic	all	day	list’	
‘I	suspect	it	probably	does	contribute	to	a	certain	extent	to	the	decision	making’	
‘probably	at	the	time	I	thought	my	brain’s	tired	here’	(C7)		Another	colonoscopist	reported	how,	although	he	was	aware	of	the	indication	for	the	 colonoscopy	 being	 an	 endoscopic	 mucosal	 resection	 of	 a	 large	 polyp,	 the	procedure	 hadn’t	 been	 what	 he	 was	 expecting;	 there	 was	 a	 larger	 number	 of	polyps	 in	 addition	 requiring	 polypectomy	 than	 he	 expected	 which	 altered	 the	procedure	both	in	terms	of	timescale	and	workload:		
‘probably	the	significant	thing	that	happened	was	that	there	was	quite	a	lot	of	
polyps	to	take	off.	Erm….and,	I	think,	it	would	be	fair	to	say……	it	was	a	bit	of	a	
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struggle,	erm,	to…….it	was	slightly	more	than	I	was	expecting.	It	was	more	than	I	
was	expecting.’	(C8)	
‘I	didn’t	want	to	repeat	the	procedure	so	that	was	a	slightly	distorting	thing’	(C8)		
5.3.3.2	Environmental	factors	
	Two	 distinct	 ‘environmental’	 factors	 also	 emerged	 from	 the	 data,	 which	 were	time	and	equipment.			One	of	the	colonoscopists	described	how	he	felt	time	was	the	major	contributing	factor	to	the	perforation:		
‘The	list	had	already	started	late,	I	forget	for	what	reason….	I	was	a	little	bit	
anxious	about	the	fact	that	time	was	ticking	on.	So,	to	speed	things	up	I…	started	
snapping	off	some	of	these	polyps	and	one	or	two	were	a	bit	bigger	and	I	put	the	
diathermy	on	and	I	did	some	hot	snaring,	perhaps	with	a	little	bit	more	haste	than	I	
would	normally.	Perhaps	because	of	that	not	using	submucosal	injection	for	cases	
where	I	would	have	probably	used	it	for	cases	where	I	would	have	had	more	time.’	(C5)	
	
‘I’m	annoyed	with	this	one	because	I	suspect	it	was	probably	an	avoidable	
perforation	if	we	had	done	the	procedure	with	a	bit	more	time.	Without	the	time	
pressure	we	probably	wouldn’t	have	had	that	complication.’	(C5)		
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Another	colonoscopist	reported	an	issue	with	the	diathermy	equipment	during	a	polypectomy	associated	with	a	perforation,	which	may	have	been	a	contributory	factor:		 ‘There	was	a	problem	with	the	diathermy	equipment,	it	wasn’t	really	cutting,	so	
half	way	through	the	polypectomy	we	had	to	switch	the	diathermy	machine	over.	It	
did	cut	through,	and	at	the	end	I	was	concerned	there	might	be	a	bit	too	much	burn	
there.’	(C6)	
	
‘At	the	time	I	was	using	endocut,	150	blend	2,	but	it	wasn’t	cutting	at	all.	If	
anything	it	seemed	to	be	more	coaging	than	cutting.	We	just	weren’t	making	any	
progress,	we	just	weren’t	cutting	through	at	all	and	as	soon	as	we	changed	
equipment	we	cut	straight	through.’	(C6)		
5.4	Discussion	
	Despite	differences	in	timescale	between	when	the	perforation	had	occurred	and	the	 interview	 taking	 place,	 all	 eleven	 colonoscopists	 that	 participated	 in	 the	study	were	clearly	able	to	recall,	 in	detail,	 the	perforation	case.	They	were	also	able	 to	 remember,	 precisely,	 the	 events	 surrounding	 the	 case	 and	 their	subsequent	 reaction.	 I	 found	 no	 evidence	 that	 the	 recall	 of	 the	 case	 was	influenced	by	the	amount	of	time	since	the	perforation.	This	suggests	that	such	cases	are	deeply	imbedded	in	the	memory	of	a	colonoscopist	and	the	case	has	a	deep	psychological	impact	on	them.		
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The	 reactions	of	all	 the	colonoscopists	 could	be	grouped	 in	 to	 the	 four	distinct	stages	described	which	followed	on	from	each	other	in	time.	The	exact	timings	of	these	stages,	the	emotions	within	each	stage	and	the	extent	of	the	impact	on	the	colonoscopist	varied,	however,	depending	on	several	factors.			‘The	 Realisation’	 begins	 when	 the	 colonoscopist	 realises	 a	 perforation	 had	occurred	and	may	last	minutes	or	hours.	This	most	closely	resembles	the	‘chaos	and	accident	response’	described	by	Scott	et	al.,	‘the	kick’	described	by	Luu	et	al.	and	 the	 ‘emotional	 reactions’	 described	by	Ullstrom	et	 al.	 141,145,144.	 Scott	 et	 al.	specifically	 describes	 ‘chaotic	 and	 confusing	 scenarios	 of	 internal	 and	 external	turmoil’.	How	the	colonoscopists	came	to	realise	that	a	perforation	had	occurred	varied	depending	on	how	the	perforation	had	presented.	This	lead	to	differences	in	 the	 emotions	 expressed	 during	 ‘The	Realisation’.	 Two	 of	 the	 colonoscopists	who	visualised	the	perforation	by	visualising	an	extra	intestinal	structure	during	the	 colonoscopy	 specifically	 described	 ‘disbelief’	 and	 ‘horror’	 whereas	 a	colonoscopist	 who	 heard	 that	 the	 patient	 had	 a	 perforation	 from	 a	 colleague	some	days	after	they	performed	the	colonoscopy	described	‘shock’.	Similarly,	the	experience	 and	 profession	 of	 the	 colonoscopist	 may	 have	 influenced	 the	reaction;	 a	 senior	 consultant	 gastroenterologist	 specifically	 described	 feeling	‘annoyed’	 upon	 realising	 a	 perforation	 had	 occurred,	 another	 junior	 nurse	endoscopist	described	being	‘upset’.			The	feelings	expressed	by	the	colonoscopists	when	looking	 ‘Into	the	Mirror’	are	similar	 to	 those	described	by	 Scott	 et	 al.	 during	 ‘Intrusive	Reflections’.	 I	 found	that	the	feelings	of	vulnerability,	however,	 fitted	better	with	 ‘Into	the	Mirror’	as	
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colonoscopists	 were	 thinking	 about	 themselves.	 Scott	 at	 al.’s	 study	 described	similar	 feelings	 of	 vulnerability	 during	 the	 fourth	 reaction	 stage	 of	 their	 study	‘enduring	the	inquisition’	and	similar	emotions	were	present	during	Ullstrom	et	al.’s	 ‘professional	 performance	 and	 self	 confidence’.	 Where	 two	 of	 the	colonoscopists	 in	 this	 study	were	 unique	 during	 this	 stage	was	 the	 anger	 and	upset	 they	 felt	 at	 not	 being	 involved	 in	 decisions	 relating	 to	 the	 patient’s	subsequent	care.		The	majority	of	the	colonoscopists	felt	well	supported	by	their	colleagues	and/or	organisation	in	the	aftermath	of	the	perforation	and	spoke	of	how	much	this	had	helped	 them,	 particularly	 during	 the	 stage	 of	 ‘Acceptance	 and	 Refocus’.	 The	support	 described	 by	 colonoscopists	 is	 mirrored	 by	 the	 stage	 of	 ‘restoring	personal	 integrity’	 described	 by	 Scott	 et	 al.	 in	 their	 study	 which	 involved	 the	victim	 ‘seeking	 support	 from	 an	 individual	 from	 whom	 they	 had	 a	 trusting	relationship	such	as	a	colleague,	supervisor,	personal	 friend	or	 family	member’	and	the	stage	of	‘obtaining	emotional	first	aid’	where	the	victim	sought	emotional	support141.	 Luu	 et	 al.	 also	 described	 such	 actions	 during	 ‘the	 recovery’	 and	Ullstrom	et	al.	 reported	how	peer	support	had	been	crucial145,144.	 Interestingly,	one	 junior	 nurse	 colonoscopist	 didn’t	 feel	 well	 supported	 following	 the	perforation	 case	 and	 made	 reference	 to	 a	 ‘macho’	 environment	 among	 other	endoscopists	 in	 their	 department.	 It	 was	 apparent	 to	 me	 that	 the	 support	 of	colleagues	is	vital	in	helping	colonoscopists	through	the	stage	of	‘Acceptance	and	
Refocus’,	 especially	 in	 the	 case	 of	 nurse	 colonoscopists	 and	 junior	 medical	colonoscopists.	One	colonoscopist	reported	how	they	wouldn’t	have	been	able	to	carry	on	doing	the	endoscopy	list	after	they	had	realised	that	a	perforation	had	
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occurred	during	the	colonoscopy	and	may	have	even	struggled	to	carry	on	doing	them	 later	 that	 week.	 This	 evidence	 leads	 me	 to	 conclude	 that	 following	 a	colonoscopic	 perforation	 the	 support	 of	 colleagues	 is	 vital	 in	 helping	 the	colonoscopist	 through	 the	 stages	 of	 reaction.	 I	 would	 also	 recommend	 that	colleagues	within	an	organisation	should,	at	the	very	least,	offer	to	sit	down	and	discuss	 the	 case	 with	 the	 colonoscopist	 affected	 by	 the	 perforation	 and	 be	prepared	and	willing	to	take	over	the	remaining	cases	on	their	 list,	should	 ‘The	
Realisation’	start	during	a	colonoscopy,	and	even	take	over	their	lists	in	the	days	and	week	after	 the	perforation	case	 if	needs	be.	The	presence	of	a	colleague	 in	the	 endoscopy	 room	 may	 also	 help,	 during,	 for	 example,	 a	 subsequent	polypectomy	 in	 alleviating	 some	 of	 the	 emotions	 that	 the	 colonoscopists	described	when	starting	to	perform	colonoscopy	and	polypectomy	again.			A	 paradox	 of	 the	 stages	 of	 reaction	 is	 that	 even	 though	 there	 are	 numerous	strong	emotions	felt	during	‘The	Realisation’,	there	is	always	the	acceptance	that	perforation	 is	 an	 inevitable	 consequence	 of	 performing	 colonoscopy.	However,	this	acceptance	doesn’t	appear	to	diminish	the	emotion	felt	at	any	point.			The	lessons	learnt	from	the	perforation	case	and	new	practices	brought	about	as	a	 result	 of	 the	 case	 reported	 by	 the	 colonoscopists	 during	 ‘Reflection	 and	
Learning’	 are	 parallel	 to	 those	 feelings	 reported	 during	 the	 ‘thriving’	 stage	 of	‘moving	on’	by	Scott	et	al.	and	‘the	recovery’	by	Luu	et	al.141,145.	The	caecum	was	identified	 qualitatively	 from	 this	 study	 as	 a	 high	 risk	 colorectal	 location	 for	perforation;	 one	 of	 the	 colonoscopists	 described	 higher	 caution	 when	performing	 therapy	 in	 the	 caecum	and	 routinely	using	endoclips	 following	any	
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endoscopic	 mucosal	 resection	 of	 polyps	 in	 the	 caecum	 as	 a	 result	 of	 the	perforation	 case	 discussed.	 This	 complements	 the	 quantitative	 studies	suggesting	 caecal	 location	 is	 a	 risk	 factor	 for	 perforation	 that	 have	 been	described	in	chapter	2.5	of	this	thesis.			It	is	not	only	during	the	colonoscopy	but	also	in	its	aftermath	where	changes	in	a	colonoscopists’	practice	have	resulted	as	a	consequence	of	the	perforation	case.	One	 of	 the	 colonoscopists,	 who	 reported	 distress	 at	 not	 being	 involved	 in	subsequent	decision	making	regarding	a	patients	care	post	perforation,	reported	how,	now,	they	always	give	their	mobile	telephone	number	to	a	patient	following	a	 high	 risk	 procedure	 and	 ask	 the	 patient	 to	 call	 them	 first	 if	 they	 develop	abdominal	 pain	 or	 feel	 unwell.	 This	meant	 they	 could	 be	 fully	 involved	 in	 the	patient’s	 care	 and	avoid	 some	of	 the	 events	 and	emotions	 that	were	described	during	‘Into	the	Mirror’.		The	 interviews	 implied	 that	 the	 perforation	 case	 may	 have	 had	 less	 of	 a	psychological	 impact	 on	 those	 professionals	 who	 are	 used	 to	 working	 with	greater	 clinical	 risk	 during	 their	 day-to-day	 practice.	 The	 nurse	 endoscopists	interviewed	perceived	the	perforation	case	had	a	greater	impact	on	them	than	it	would	 do	 on	 medical	 or	 surgical	 endoscopists.	 When	 I	 explored	 this	 further,	reasons	 offered	 were	 the	 relatively	 small	 numbers	 of	 nurse	 endoscopists	 that	performed	colonoscopy	during	its	infancy,	the	unfamiliarity	with	adverse	events	of	this	severity	during	their	nursing	careers	and	a	general	 lack	of	confidence	in	their	abilities.	 	One	of	 the	nurse	colonoscopists	alluded	to	the	fact	 that	because	she	was	 a	 female,	 the	 case	may	 have	 had	 a	 greater	 impact	 on	 her	 than	would	
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have	done	on	a	male,	potentially	indicating	colonoscopist	sex	bears	an	influence	on	the	psychological	impact	of	the	perforation	case.	Given	the	increasing	need	for	colonoscopy	and	colonoscopists	coupled	with	a	desire	for	greater	cost	saving	in	the	 NHS,	 it	 is	 likely	 that	 nurse	 endoscopists	 will	 have	 a	 greater	 role	 in	colonoscopy	 service	 provision	 than	 ever	 before.	 It	 is	 therefore	 vital	 that	 the	medical	 and	 surgical	 colonoscopists	 are	 aware	 of	 the	 potential	 greater	psychological	 impact	 perforation	 cases	 may	 have	 on	 nurse	 endoscopists,	particularly	in	relation	to	the	support	required	during	‘Acceptance	and	Refocus’,	and	that	they	are	prepared	and	willing	to	offer	the	necessary	support.		One	of	the	prior	issues	I	wanted	to	explore	in	this	study	was	that	a	change	in	endoscopic	environment	or	performing	a	colonoscopy	in	a	different	environment	to	which	the	colonoscopist	was	used	to	may	be	a	risk	factor	for	colonoscopic	perforation.	I	am	aware	that	my	own	personal	colonoscopic	performance	deteriorated	following	a	change	in	endoscopic	environment.	Although	I	asked	each	participant	about	this	issue	neither	of	these	potential	‘environmental’	factors	were	relevant	to	the	perforation	cases	discussed.	Time	and	equipment	failure	were	identified	as	‘environmental’	factors	associated	with	perforation	in	this	study.	These	associations	should	be	kept	in	mind	by	colonoscopists	in	the	future.	Similarly,	the	two	‘human’	factors	identified	associated	with	perforation,	fatigue	and	expectation,	should	also	be	kept	in	mind	when	performing	colonoscopy.		One	 limitation	of	 this	study	was	the	relatively	small	numbers	of	colonoscopists	that	 were	 interviewed,	 particularly	 when	 this	 is	 broken	 down	 by	 specialty.	
	 160	
However,	 because	 of	 time	 and	 travel	 constraints	 this	 study	 only	 took	 place	within	 Health	 Education	 North	 East.	 There	 are	 seven	 NHS	 trusts	 within	 this	region.	When	 the	 pool	 of	 independent	 colonoscopists	within	 these	 trusts,	who	may	have	experience	of	a	perforation	is	considered,	along	with	the	fact	that	not	every	 colonoscopist	may	wish	 to	 discuss	 their	 experiences	 of	 such	 an	 emotive	subject	 with	 a	 trainee	 in	 the	 region,	 eleven	 interviews	 provided	 a	 reasonable	response	and	an	accurate	representation	of	experience.			
5.5	Conclusions	
	Two	 of	 my	 intentions	 in	 writing	 this	 thesis	 were	 to	 minimise	 the	 risk	 of	colonoscopic	adverse	events,	 including	perforation,	and	improve	its	assessment	and	management.			As	a	direct	result	of	this	study,	we	have	qualitative	evidence	of	the	caecum	being	a	 high-risk	 colorectal	 location	 for	 perforation.	 Colonoscopist	 caution	 in	 the	caecum	and	the	routine	use	of	endoclips	following	endoscopic	mucosal	resection	of	large	polyps	in	the	caecum	may,	therefore,	minimise	perforation	risk.	My	data	suggests	 that	 not	 performing	 a	 colonoscopy	 when	 there	 is	 significant	 time	pressure	or	colonoscopist	fatigue	may	also	minimise	perforation	risk.	Similarly,	the	regular	and	thorough	checking	of	diathermy	equipment	prior	to	commencing	colonoscopy	 may	 be	 helpful	 as	 would	 bringing	 a	 patient	 back	 for	 a	 second	procedure	should	the	number	of	polypectomies	required	and	time	to	do	them	in	during	the	colonoscopy	be	far	greater	than	expected.		
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When	considering	the	assessment	and	management	of	colonoscopic	perforation	we	 now	 have	 qualitative	 evidence	 of	 how	 this	 could	 be	 improved.	 A	 specific	named	 contact	 point	 and	 person	 for	 a	 patient	 should	 they	 develop	 symptoms	following	 a	 colonoscopy	 may	 help	 in	 managing	 their	 perforation	 most	appropriately.	 Similarly,	 clinician	 caution	 with	 subtle	 abdominal	 signs	 in	 the	aftermath	of	high	risk	procedures	may	improve	outcomes.		A	further	intention	of	writing	this	thesis	was	to	explore	the	impact	of	an	adverse	event,	including	perforation,	on	a	colonoscopist	and	to	provide	a	reference	point	that	all	colonoscopists	could	use	and	relate	to	should	they	encounter	an	adverse	event	associated	with	a	colonoscopy	they	perform	in	the	future.	This	qualitative	study	 has	 revealed	 what	 a	 colonoscopist	 may	 experience	 following	 such	 an	event,	 the	 emotions	 they	 may	 feel	 and	 the	 effect	 the	 case	 may	 have	 on	 their	personal	and	professional	lives.				This	 work	 has	 led	 me	 to	 conclude	 that	 the	 support	 of	 colleagues	 is	 vital	 in	helping	a	colonoscopist	through	the	stages	of	response.	I	believe	that	colleagues	should	offer	 to	discuss	 the	perforation	case	with	the	colonoscopist	and	offer	 to	take	over/buddy	up	on	the	endoscopy	list	where	the	perforation	occurs	or	their	colleagues’	subsequent	endoscopy	lists	if	needs	be.	It	may	be	preferable	if	such	a	colleague	 had	 been	 specifically	 identified	 prior	 to	 the	 perforation	 occurring.	Indeed	this	work	supports	the	concept	of	all	colonoscopists	having	a	designated	‘mentor’.	Mentoring	 is	well	 established	 in	 other	 healthcare	 settings;	 a	 ‘mentor’	may	 be	 defined	 as	 ‘a	 trusted	 counsellor	 or	 guide’.	Mentoring	may	 be	 a	 formal	process,	 involving	 a	 designated	 named	 person	 being	 allocated	 to	 the	
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colonoscopist	 or	 done	 informally	 involving,	 for	 example,	 opportunistic	discussions	 with	 peers	 and	 colleagues.	 The	 English	 NHS	 BCSP	 has	 recently	introduced	 a	 mentoring	 programme	 for	 screening	 colonoscopists.	 	 The	 BCSP	mentor	has	responsibilities	including	the	support	of	a	colonoscopist	through	the	accreditation	process	 for	Bowel	Cancer	Screening,	supporting	newly	accredited	colonoscopists	 in	their	new	role	and,	 importantly,	supporting	the	colonoscopist	after	any	adverse	event152.			Such	a	system	of	mentoring	being	used	in	the	symptomatic	colonoscopy	service	too,	 would,	 based	 on	 the	 evidence	 in	 this	 chapter,	 be	 to	 the	 benefit	 of	 all	colonoscopists	following	a	perforation.	If	the	mentor	had	already	been	identified,	with	 the	 chance	 for	 a	 relationship	 to	 build,	 the	 colonoscopist	 who	 is	 involved	with	the	perforation	may	be	more	willing	to	seek	their	mentor’s	support	both	at	the	time	of	the	perforation	and	in	its	aftermath.	That	colonoscopist	may	request	the	presence	of	the	mentor	during	their	subsequent	lists.	For	this	to	happen	the	mentor	 would	 need	 to	 be	 available	 when	 the	 mentee	 colonoscopist	 was	performing	 colonoscopy,	 therefore	 services	 scheduling	 mentor	 and	 mentee	colonoscopy	lists	separately	would	be	an	important	requirement	of	this	process.		I	hope	this	work	can	be	used	as	a	reference	point	so	that	colonoscopists	can	be	better	prepared	for	and	better	manage	their	feelings,	emotions	and	performance	in	 the	 aftermath	of	 a	perforation.	The	 intention	of	 this	point	 of	 reference	 is	 so	future	perforations	will	not	be	to	the	detriment	of	a	colonoscopist’s	performance.		
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Chapter	6	
	
Post	Polypectomy	Bleeding	(PPB)	
	
6.1	Aims	
	The	 following	 aims	 relate	 to	 post	 polypectomy	bleeding	within	 the	North	 East	region	 of	 the	 English	 National	 Health	 Service	 Bowel	 Cancer	 Screening	Programme	only.	
	1.	To	determine	the	rate	of	post	polypectomy	bleeding.	2.	To	determine	the	rate	of	post	polypectomy	bleeding	broken	down	by	its	grade	of	severity.	3.	 To	 describe	 post	 polypectomy	 bleeding	 presentation,	 management	 and	outcomes.	4.	To	explore	the	factors	that	contribute	to	a	post	polypectomy	bleed’s	grade	of	severity.		
6.2	Methods	
	
6.2.1	English	National	Health	Service	Bowel	Cancer	Screening	Programme	
Regions	
	Endoscopic	 procedures	 in	 the	 English	 National	 Health	 Service	 Bowel	 Cancer	Screening	 Programme	 are	 performed	 at	 61	 Joint	 Advisory	 Group	 on	
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Gastrointestinal	 Endoscopy	 (JAG)	 approved	 Bowel	 Cancer	 Screening	 Centres	(BCSCs).	These	are	divided	by	geographical	 location	 into	 five	different	 regions:	Midlands	&	North	West,	Southern,	London,	Eastern	and	North	East.	Each	region	has	a	regional	quality	assurance	lead	clinician,	part	of	whose	responsibility	it	is	to	review	any	adverse	event	that	occurs	at	a	BCSC	within	that	region.	Each	BCSC	has	a	clinical	director	who	is	responsible	for	that	BCSC.			
6.2.2	 English	 National	 Health	 Service	 (NHS)	 Bowel	 Cancer	 Screening	
Programme	 (BCSP)	 ‘Adverse	 Incident	 Alert	 to	 National	 Office’	 Forms	 and	
‘Clinical	Director	Reports’		A	 patient	 who	 attends	 for	 an	 endoscopic	 procedure	 as	 part	 of	 the	 English	National	 Health	 Service	 Bowel	 Cancer	 Screening	 Programme	 is	 contacted	 by	telephone	 24	 hours	 after	 the	 procedure	 by	 a	 Specialist	 Screening	 Practitioner	who	was	present	during	 the	procedure.	During	 the	 telephone	conversation	 the	SSP	 specifically	 asks	 the	 patient	 about	 the	 presence	 of	 symptoms,	 including	bleeding	 per	 rectum	 or	 other	 symptoms	 of	 PPB,	 following	 the	 procedure.	Patients	 also	 receive	 a	 questionnaire	 through	 the	 post	 from	 the	 Bowel	 Cancer	Screening	Centre	at	30	days	post	procedure.	The	patient	is	asked	to	complete	the	questionnaire	and	return	it	to	the	BCSC.	Questions	specifically	relate	to	whether	an	 adverse	 event,	 including	 bleeding,	 has	 occurred	 with	 further	 details	 of	 the	event	and	its	impact	on	the	patient.	If	a	patient	does	re	present	with	bleeding	per	rectum	 following	 polypectomy,	 for	 the	 most	 part	 this	 will	 be	 to	 the	 hospital	where	the	colonoscopy	occurred.	In	addition	patients	are	also	specifically	asked	to	 contact	 the	 BCSP	 team	 should	 they	 develop	 symptoms.	 These	 methods	 of	
	 165	
contacting	or	being	contacted	by	the	patient	following	their	procedure	form	part	of	the	process	by	which	the	BCSP	is	alerted	to	an	adverse	event,	including	PPB.		If	an	adverse	event	does	occur,	data	on	the	adverse	event	is	recorded	by	the	SSP	electronically	 on	 a	 specific	 form,	 the	 ‘adverse	 incident	 alert	 to	 national	 office’	form.	This	form	is	e-mailed	to	the	BCSP	national	office.	The	form	is	also	e-mailed	to	 the	 regional	 quality	 assurance	 lead	 clinician	 for	 the	 BCSP	 region	where	 the	adverse	event	occurred.	Each	adverse	event	is	subject	to	a	formal	report	by	the	clinical	director	of	the	BCSC	where	the	adverse	event	occurred;	this	report	is	also	e-mailed	to	the	regional	quality	assurance	lead	clinician.		
6.2.3	The	North	East	Region	of	 the	English	National	Health	Service	Bowel	
Cancer	Screening	Programme		The	 North	 East	 Region	 of	 the	 English	 National	 Health	 Service	 Bowel	 Cancer	Screening	 Programme	 was	 the	 setting	 for	 this	 study.	 Professor	 Rutter,	 as	regional	 quality	 assurance	 lead	 clinician	 for	 the	North	East	 region	of	 the	BCSP	had	 reviewed	 and	 collected	 both	 the	 ‘adverse	 incident	 alert	 to	 national	 office’	forms	and	the	‘clinical	director	reports’	for	all	the	cases	of	bleeding	that	had	been	reported	as	an	adverse	event	 from	four	Bowel	Cancer	Screening	Centres	 in	 the	North	East	region	and	a	further	BCSC,	South	Yorkshire	and	Bassetlaw.	Professor	Rutter	 as	 regional	 quality	 assurance	 lead	 clinician	 also	 covered	 this	BCSC.	The	five	 BCSCs	were	 North	 of	 Tyne	 BCSC,	 South	 of	 Tyne	 BCSC,	 Tees	 BCSC,	 County	Durham	&	Darlington	BCSC	and	South	Yorkshire	&	Bassetlaw	BCSC.	The	cases	of	bleeding	reported	as	being	adverse	events	were	from	the	06/12/2010	up	to	and	
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including	 the	15/07/2014.	Professor	Rutter,	as	co-supervisor	of	 this	MD	thesis	provided	 me	 with	 these	 documents	 that	 contained	 the	 data	 required	 for	 this	study.			
6.2.4	Review	of	Bowel	Cancer	Screening	Programme	‘adverse	incident	alert	
to	national	office’	forms	and	‘clinical	director	reports’	
	I	 reviewed	all	of	 the	completed	 ‘adverse	 incident	alert	 to	national	office’	 forms	and	‘clinical	director	reports’	that	had	been	provided	to	me	by	Professor	Rutter.	No	patient	identifiable	data	was	entered	onto	these	forms.		The	 ‘adverse	 incident	 alert	 to	 national	 office’	 form	 comprises	 several	 sections	each	containing	data	relating	to	the	adverse	event.	The	contact	details	of	who	has	completed	 the	 form	 and	 the	 site	 within	 the	 Bowel	 Cancer	 Screening	 Centre	where	the	adverse	event	occurred	are	completed	first.	This	is	followed	by	a	tick	box	of	the	category	of	the	 incident;	 the	category	being	either	an	incident	at	the	BCSP	 hub	 or	 an	 incident	 at	 the	 BCSC	 or	 screening	 site.	 A	 free	 text	 box	with	 a	‘description	of	the	incident	including	date	and	time’	is	then	completed,	followed	by	 a	 free	 text	 box	 of	 the	 ‘immediate	 action	 taken’	 and	 finally	 a	 free	 text	 of	 a	description	of	the	‘possible	impact’	on	the	patient.		The	 ‘clinical	 director	 reports’	 are	 entered	 into	 an	 electronic	 form	with	 several	sections	for	free	text.	These	sections	include	(1)	the	date	of	the	procedure	(2)	a	description	 of	 risk	 factors/events/therapy	 with	 dates	 (3)	 interventional	procedures/surgery	 with	 dates	 (4)	 where	 relevant,	 kit	 used	 and	 diathermy	
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settings	(5)	outcome	(6)	stratification	of	severity	(as	per	BCSP	QA	guidelines	for	colonoscopy	document)	(7)	attribution	of	event	(as	per	BCSP	QA	guidelines	 for	colonoscopy	 document)	 (8)	 learning	 points	 and	 actions	 taken	 if	 any	 and	 (9)	confirmation	the	event	has	been	recorded	on	the	BCSS.		
6.2.5	Constructing	the	post	polypectomy	bleeding	database	
	As	 I	 reviewed	 the	 forms	 that	 are	detailed	 in	 chapter	6.2.4,	 I	 entered	data	 from	them	into	a	Microsoft	Excel	spread	sheet.	Each	pair	of	‘adverse	incident	alert	to	national	office’	forms	and	‘clinical	director	reports’	was	given	a	number	from	2	-	78	identifying	it	as	a	case	of	bleeding	as	an	adverse	event	in	my	database.			Each	case	of	bleeding	was	entered	into	a	different	row	in	the	spread	sheet	with	different	columns	in	the	spread	sheet	relating	to	the	patient,	the	endoscopy,	the	polypectomy,	 how	 the	 patient	 presented,	 their	 subsequent	 management	 and	outcome.	 The	 columns	 were	 divided	 into:	 (1)	 the	 date	 the	 colonoscopy	associated	 with	 bleeding	 took	 place	 	 (2)	 if	 the	 patient	 was	 taking	 any	antithrombotic	 medication	 (3)	 the	 name	 and	 dose	 of	 the	 antithrombotic	medication	(4)	how	many	polyps	were	resected	(5)	the	polyp	location	(6)	polyp	class	 (7)	 estimated	 endoscopic	 polyp	 size	 (8)	 polyp	 therapy	 (9)	 polyp	 therapy	device	 (10)	 endoscopic	 therapy	 given	 during	 the	 procedure	 (11)	 if	 the	 patient	was	 admitted	 or	 discharged	 following	 the	 procedure	 (12)	 the	 date	 of	representation	 with	 symptoms	 from	 bleeding	 (13)	 the	 number	 of	 days	 to	representation	with	bleeding	(14)	the	presenting	complaint	of	the	bleeding	(15)	if	 intravenous	 fluids	 and	 blood	were	 administrated	 (16)	 if	 a	 repeat	 endoscopy	
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took	 place	 (17)	 the	 date	 of	 the	 endoscopy	 (18)	 the	 endoscopic	 therapy	performed	 at	 repeat	 endoscopy	 (19)	 if	 surgery	 occurred	 (20)	 the	 name	 of	 the	operation	 if	 surgery	did	 take	place	 (21)	 the	date	 the	operation	was	performed	(22)	 the	 diagnosis	 (23)	 the	 date	 of	 discharge	 (24)	 the	 number	 of	 days	 an	inpatient	and	(25)	the	severity	grading	of	the	bleeding.			When	all	columns	and	rows	and	had	a	value	assigned	to	them	the	construction	of	the	post	polypectomy	bleeding	database	was	complete.		
6.2.6	 Overall	 endoscopic	 data	 for	 the	 North	 East	 Region	 of	 the	 English	
National	Health	Service	Bowel	Cancer	Screening	Programme	
	The	final	part	of	 the	methodology	I	used	for	this	study	was	contacting	the	NHS	BCSP	national	 office	 for	 the	 overall	 endoscopic	 data	 relating	 to	 the	North	 East	Region	of	the	NHS	BCSP.	I	emailed	a	project	manager	at	the	NHS	Bowel	Cancer	Screening	Programme	national	office	requesting	this	data.	I	wrote	an	email	from	my	personal	NHS	mail	account	to	Miss	Claire	Nickerson,	the	project	manager	at	the	 NHS	 BCSP’s	 national	 office,	 requesting	 she	 identify	 the	 total	 number	 of	endoscopic	 procedures	 and	 the	 total	 number	 of	 polypectomies	 that	 had	 been	performed	in	the	North	East	Region	of	the	NHS	BCSP	from	the	06/12/2010	up	to	and	 including	 the	 15/07/2014.	 The	 project	 manager,	 Miss	 Claire	 Nickerson,	interrogated	 the	Bowel	Cancer	 Screening	System	 to	 acquire	 this	data	 and	 then	emailed	the	figures	back	to	me.		
6.2.7	Note	on	peri	procedure	bleeding		
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	Peri	 procedure	 bleeding	 was	 defined	 as	 that	 occurring	 immediately	 following	polypectomy,	 controlled	 during	 the	 colonoscopy	 and	 not	 preventing	 its	completion.	 The	 vast	 majority	 of	 cases	 of	 peri	 procedure	 bleeding	 would	 not,	therefore,	 be	 reported	 as	 being	 an	 adverse	 event	 and	 would	 not	 have	 been	included	in	the	dataset	used	in	this	study.	Peri	procedure	bleeding	was,	however,	reported	as	an	adverse	event	and	therefore	included	in	the	dataset	used	in	this	study	 when	 a	 patient	 was	 admitted	 to	 hospital	 following	 completion	 of	 the	colonoscopy	for	a	period	of	observation.	Where	cases	of	peri	procedure	bleeding	such	as	this	were	identified,	they	were	separated	from	those	of	post	polypectomy	bleeding.	
	
6.2.8	Statistical	Analysis	
	The	 Microsoft	 Excel	 spreadsheet	 that	 I	 had	 produced	 was	 uploaded	 into	statistical	package	for	the	social	sciences	version	20	for	data	analysis.	Normally	distributed	 continuous	 variables	 were	 expressed	 as	 mean,	 with	 non-normally	distributed	 continuous	 variables	 expressed	 as	 median.	 Categorical	 variables	were	expressed	as	a	percentage.	Pearson	chi-square	and	Fisher’s	exact	test	were	used	 to	 test	 association	 between	 explanatory	 and	 outcome	 variables	 with	 a	 p	value	<	0.05	considered	to	be	significant.		
6.3	Results	
	
6.3.1	Overall	endoscopic	data	from	the	study	population	
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	Data	was	collected	from	five	of	eight	Bowel	Cancer	Screening	Centres	within	the	North	 East	 Region	 of	 the	 Bowel	 Cancer	 Screening	 Programme.	 The	 five	 BCSCs	were	 North	 of	 Tyne	 BCSC,	 South	 of	 Tyne	 BCSC,	 Tees	 BCSC,	 County	 Durham	&	Darlington	 BCSC	 and	 South	 Yorkshire	 &	 Bassetlaw	 BCSC.	 The	 total	 population	recorded	by	Clinical	 Commissioning	Groups	 as	 being	 registered	with	 a	 general	practitioner	 within	 the	 geographical	 areas	 covered	 by	 these	 BCSCs	 was	4,191,507.	All	60-74	year	olds	within	this	population	were	sent	an	invitation	to	take	part	in	the	Bowel	Cancer	Screening	Programme	with	a	Faecal	Occult	Blood	Test.	
	During	the	period	of	this	study	period	1,293,672	Faecal	Occult	Blood	Tests	were	distributed	 of	 which	 784,359	 were	 returned.	 13,869	 FOBTs	 were	 abnormal	leading	 to	 11,564	 patients	 attending	 for	 a	 colonoscopy.	 15,285	 colonoscopies	were	 subsequently	 performed,	 a	 mean	 of	 1.3	 per	 subject.	 These	 15,285	colonoscopies	led	to	23,766	polypectomies.		76	cases	of	bleeding	recorded	as	being	an	adverse	event	were	identified.	Of	the	76	 cases	 of	 bleeding	 identified,	 four	 of	 these	 cases	 sought	 consultation	 from	bleeding	post	procedure	due	to	bleeding	haemorrhoids	following	colonoscopies	where	no	polypectomies	had	taken	place.	Two	of	 the	cases	sought	consultation	post	 procedure	 from	 bleeding	 thought	 secondary	 to	 the	 colonoscopy	 and/or	bowel	 preparation	 and	 not	 from	 polypectomies.	 All	 six	 of	 these	 cases	 were	excluded	from	the	analysis.		
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Two	 cases	 of	 peri	 procedure	 bleeding	 immediately	 following	 polypectomy,	controlled	 during	 the	 procedure	 and	 not	 preventing	 its	 completion,	 were	subsequently	 admitted	 to	 hospital	 for	 observation.	 Therefore,	 they	 can	 be	considered	within	the	BCSP	definition	of	bleeding	as	an	adverse	event.	However,	for	the	reasons	explained	in	6.2.7,	these	cases	were	separated	from	those	of	post	polypectomy	bleeding.		68	cases	of	post	polypectomy	bleeding	therefore	remained	with	the	rates	of	PPB	calculated	below:		PPB	rate	per	colonoscopy	=	68/15,285	x	100	=	0.44%	PPB	rate	per	polypectomy	=	68/23,766	x	100	=	0.29%		
6.3.2	Peri	procedure	bleeding		
	A	patient	who	underwent	colonoscopy	with	a	hot	snare	polypectomy	of	a	15mm	sigmoid	 pedunculated	 polyp	 had	 peri	 procedure	 bleeding	 controlled	 with	adrenaline	injection	and	four	endoclips.		A	second	patient	with	atrial	fibrillation	had	warfarin	stopped	five	days	prior	to	the	colonoscopy.	Three	polypectomies	of	three	sessile	polyps	took	place,	two	in	the	caecum	of	7mm	and	2mm	respectively	with	a	3rd	25mm	polyp	in	the	sigmoid.	Two	endoclips	were	required	to	control	haemorrhage	 from	 the	 sigmoid	polyp.	Both	patients	were	 admitted	 to	hospital	for	observation	and	discharged	24	hours	later.		
6.3.3	Post	polypectomy	bleeding	(PPB)	
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	12	of	68	(17.6%)	patients	with	PPB	were	known	to	have	co-morbidity	including	four	 with	 atrial	 fibrillation.	 The	 four	 patients	 with	 atrial	 fibrillation	 also	 had	additional	 co-morbidity	 including	 hypertension	 (n=1),	 chronic	 obstructive	pulmonary	 disease	 (n=1),	 a	 permanent	 pacemaker	 (n=1)	 and	 a	 previous	transient	 ischaemic	 attack	 (n=1).	 Other	 patients	 with	 co-morbidity	 included	diabetes	mellitus	&	previous	stroke	(n=1),	previous	deep	vein	thrombosis	(DVT)	and	pulmonary	embolism	(PE)	(n=1),	hypertension	&	gout	(n=1),	hypertension	&	previous	TIA	(n=1),	COPD	&	Coagulopathy	(n=1),	previous	TIA	(n=1),	Idiopathic	thrombocytopenic	purpura	(n=1)	and	haemophilia	(n=1).		13	 of	 68	 (19.1%)	patients	with	 PPB	were	 taking	 antithrombotic	medication	 at	the	 time	 of	 colonoscopy	 and	 polypectomy	 including	 aspirin	 (n=11)	 (warfarin	stopped	 five	 days	 pre	 procedure	 in	 two	 of	 these,	 one	 also	 took	 dipyridamole),	clopidogrel	(n=1)	(the	patient	decided	to	continue	clopidogrel	with	appropriate	consent)	 and	 warfarin	 (n=1)	 (the	 patient	 decided	 to	 continue	 warfarin	 with	appropriate	 consent).	Three	of	68	 (4.4%)	patients	had	 stopped	antithrombotic	medication	 prior	 to	 the	 colonoscopy	 including	warfarin	 (n=2)	 and	 clopidogrel	(n=1).	Six	of	68	(8.8%)	patients	stopped	warfarin	five	days	prior	to	colonoscopy	and	were	commenced	on	low	molecular	weight	heparin	(LMWH)	two	days	after	stopping	warfarin	with	omission	of	LMWH	on	day	of	the	colonoscopy.	Although	19.1%	 of	 patients	 with	 PPB	 were	 taking	 antithrombotic	 medication	 it	 was	unclear	how	this	compared	with	the	overall	use	of	antithrombotic	medication	in	the	BCSP.			
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Analysis	 of	 single	 polypectomies	 enabled	 accurate	 attribution	 of	 the	 post	polypectomy	 bleeding	 to	 the	 single	 polyp.	 PPB	 was	 associated	 with	 a	 single	polypectomy	in	22	of	68	(31.9%)	of	patients.	Multiple	polypectomies	took	place	in	46	(67.6%)	of	patients.	
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Chart	1:	Bar	chart	of	post	polypectomy	bleeding	polyp	location	for	single	
polypectomy	procedures	split	by	bleed	severity	
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Chart	2:	Bar	chart	of	post	polypectomy	bleeding	polyp	class	for	single	
polypectomy	procedures	split	by	bleed	severity		
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Of	 the	 single	 polypectomy	 procedures	 associated	 with	 PPB,	 three	 of	 the	polypectomies	were	 in	 the	 caecum:	 a	 30mm	 laterally	 spreading	 tumour	 of	 the	non	granular	type	resected	by	endoscopic	mucosal	resection,	hot	snare	and	using	argon	 plasma	 coagulation,	 a	 10mm	pedunculated	 polyp	 resected	 by	 hot	 snare,	(adrenaline	injection	was	used	peri	procedure	on	this	polyp)	and	a	5mm	sessile	polyp.	Two	laterally	spreading	tumours	of	the	granular	type	were	resected	from	the	 ascending	 colon	 were	 associated	 with	 PPB.	 These	 were	 of	 27	 and	 50mm	respectively,	resected	by	EMR	and	hot	snare	with	APC	used	on	the	27mm	polyp.	A	25mm	LST-NG	resected	 from	the	hepatic	 flexure	by	EMR,	hot	snare	and	APC	was	also	associated	with	PPB.	There	were	seven	single	polypectomies	associated	with	PPB	in	the	sigmoid	colon,	four	were	pedunculated	polyps	ranging	from	11	–	50mm.	Two	endoclips	were	applied	peri	procedure	to	the	largest	of	these.	Two	polyps	 were	 semi	 pedunculated	 of	 18	 and	 27mm	 respectively.	 Adrenaline	injection	 was	 used	 peri	 procedure	 on	 the	 27mm	 polyp.	 Of	 eight	 single	polypectomies	 in	the	rectum,	three	were	 laterally	spreading	tumours	of	40mm,	50mm	and	 75mm	 in	 size.	 Five	were	 sessile	 polyps	 ranging	 from	6	 –	 45mm	 in	size.	 Two	 of	 these	 sessile	 polyps	 in	 the	 rectum,	 both	 of	 10mm,	 had	 endoclips	applied	peri	procedure	and	on	one	adrenaline	injection	was	used.	How	this	data	relating	 to	 single	 polypectomy	 location,	 polyp	 size	 and	 polyp	 morphology	compared	 with	 procedures	 on	 patients	 who	 did	 not	 have	 post	 polypectomy	bleeding	was	unclear	as	this	data	wasn’t	available	for	use	in	this	study.		In	 one	 of	 68	 patients,	 the	 time	 to	 presentation	 was	 not	 documented.	 Time	 to	presentation	 ranged	 from	 the	 same	 day	 of	 the	 colonoscopy	 to	 19	 days	 post	procedure	with	a	median	time	to	presentation	of	four	days.		
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Chart	3:	Histogram	of	number	of	days	to	presentation	with	minor	severity	
Post	Polypectomy	Bleeding	
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Chart	4:	Histogram	of	number	of	days	to	presentation	with	intermediate	
severity	Post	Polypectomy	Bleeding	
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67	 patients	 presented	 with	 bleeding	 per	 rectum.	 One	 patient	 presented	 with	melaena	six	days	following	a	5mm	polypectomy	in	the	caecum.	Of	the	67	patients	presenting	with	bleeding	per	rectum,	six	of	67	(9.0%)	patients	had	symptoms	or	signs	 reflecting	 haemodynamic	 changes	 including:	 syncope	 (n=2),	 dizziness	(n=1),	lightheadedness	(n=1),	hypotension	(n=1),	syncope	&	hypotension	(n=1).	Four	 patients	 also	 complained	 of	 abdominal	 pain	 in	 addition	 to	 bleeding	 per	rectum.			16	of	68	(23.5%)	cases	of	post	polypectomy	bleeding	had	medical	management	comprising	a	blood	 transfusion	and/or	 intravenous	 fluids,	 fresh	 frozen	plasma,	tranexamic	 acid,	 factor	 V111	 and	 oral	 iron.	Nine	 of	 68	 (13.2%)	 patients	 had	 a	blood	 transfusion.	 Repeat	 endoscopy	 was	 performed	 in	 19	 of	 68	 (27.9%)	patients	 and	 in	 seven	 of	 68	 (10.3%)	 patients	 therapy	 was	 given	 at	 repeat	endoscopy.	Therapy	given	to	control	bleeding	included	application	of	endoclips,	adrenaline	 injection	 or	 both.	 In	 one	 patient	 an	 endoloop	 was	 applied	 to	 the	remaining	stalk	 following	a	polypectomy	of	a	20mm	pedunculated	polyp	 in	 the	sigmoid.	One	of	 the	68	cases	of	PPB	underwent	surgery.	This	was	due	to	rectal	bleeding	following	an	EMR	with	APC	to	a	50mm	LST	in	the	rectum.	The	patient	presented	 six	 days	 following	 the	 colonoscopy	 and	 had	 four	 units	 of	 blood	transfused.	 A	 subsequent	 Examination	 Under	 Anaesthesia	 and	 suture	 of	 the	bleeding	point	was	performed.	It	was	unclear	if	this	surgery	had	occurred	out	of	normal	working	hours	without	access	to	an	endoscopist.			In	patient	hospital	 stay	 ranged	 from	0	–	6	days	with	a	median	hospital	 stay	of	
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two	 days.	 There	 was	 no	 mortality	 associated	 with	 these	 cases	 of	 post	polypectomy	bleeding.	One	patient	required	a	second	admission	having	initially	presented	 6	 hours	 following	 a	 colonoscopy	 during	 which	 a	 total	 of	 8	polypectomies	were	performed	from	the	caecum,	transverse	and	sigmoid	colon.	They	 presented	with	 bleeding	 per	 rectum	 and	were	 transfused	 a	 total	 of	 nine	units	 blood.	 At	 repeat	 colonoscopy	 adrenaline	 was	 injected	 at	 the	 transverse	colon.		The	patient	was	discharged	after	24	hours	but	re-presented	a	further	24	hours	 later	 with	 bleeding	 per	 rectum.	 They	 had	 a	 CT	 angiography	 with	radiological	embolization	of	an	 ileocolic	vessel	and	remained	an	 inpatient	 for	a	further	3	days.			
6.3.4	Post	polypectomy	bleeding	by	grade	of	severity		PPB	was	graded	by	severity	into	major,	intermediate	or	minor	bleeding	using	the	NHS	 BCSP	 framework	 based	 on	 the	 American	 Society	 for	 Gastrointestinal	Endoscopy	(ASGE)	grading	system4	26.	There	were	 two	cases	of	major	bleeding	(2.9%	of	post	polypectomy	bleeds)	equating	to	a	rate	of	0.01%	of	major	bleeding	per	 colonoscopy.	 Intermediate	 bleeding	 occurred	 in	 29	 cases	 (42.6%	 of	 post	polypectomy	 bleeds)	 a	 rate	 of	 0.19%	 per	 colonoscopy	 and	 minor	 bleeding	occurred	 in	37	 cases	 (54.4%	of	post	polypectomy	bleeds),	 a	 rate	of	 0.24%	per	colonoscopy.	 This	 cannot	 be	 compared	 to	 the	 current	 BCSP	 individual	performance	 standard	 for	 PPB	 of	 less	 than	 0.01%	 per	 colonoscopy	 where	polypectomy	occurred	as	this	data	equates	with	all	colonoscopies.			
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Chart	4:	Pie	chart	representing	breakdown	of	cases	of	post	polypectomy	
bleeding	by	grade	of	severity			
														
Minor	Intermediate	Major	
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The	criteria	 for	how	each	case	of	PPB	met	their	specific	grading	of	severity	are	outlined	below:		
Table	1:	Criteria	for	meeting	major	post	polypectomy	bleeding	by	case			
Cases	 Surgery	 Unplanned	
admission	or	
prolongation	of	
hospital	stay	for	>	
10	nights	
ITU	Admission	>	
1night	
1	 X	 	 	1	 	 	 X			Median	Time	to	presentation	of	major	post	polypectomy	bleeding	was	3.5	days	(range	1-6	days).	Median	hospital	stay	of	major	post	polypectomy	bleeding	was	3	days	(range	2-4	days).		
Table	2:	Criteria	for	meeting	Intermediate	post	polypectomy	bleeding	by	
case:		
Cases	 Hgb	
Drop	
≥	2g	
Transfusion	 4	-	10	
nights	
Endoscopy	
		
Therapy	
at	
Endoscopy	
Radiology	
Intervention	
9	 	 	 	 X	 	 	6	 X	 	 	 	 	 	4	 	 	 	 X	 X	 	1	 X	 	 X	 	 	 	2	 X	 	 	 X	 	 	2	 X	 X	 	 X	 X	 	1	 X	 X	 X	 X	 X	 	1	 X	 X	 X	 	 	 	2	 X	 X	 	 	 	 	1	 X	 X	 	 X	 	 X	
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The	median	time	to	presentation	of	intermediate	PPB	was	4.5	days	(range	0-19	days).	Median	in	patient	stay	of	intermediate	PPB	was	2	days	(range	0-6	days).	In	19	 cases	 of	 intermediate	 post	 polypectomy	 bleeding	 a	 repeat	 endoscopy	 was	performed.	 In	 seven	 of	 these	 examinations	 endoscopic	 therapy	was	 applied	 at	repeat	 endoscopy.	 When	 examining	 factors	 associated	 with	 the	 need	 for	endoscopic	 therapy	 in	 this	 group	 of	 patients	 in	 whom	 a	 repeat	 endoscopic	examination	was	performed,	42.8%	of	those	that	had	repeat	endoscopic	therapy	had	 a	 haemoglobin	 drop	 greater	 than	 or	 equal	 to	 2g/dL	 and	 had	 a	 blood	transfusion.	Only	 25%	of	 those	 that	 did	not	 have	 therapy	 at	 repeat	 endoscopy	had	a	haemoglobin	drop	greater	than	or	equal	to	2g/dL	and	only	8%	had	a	blood	transfusion.	 Neither	 a	 haemoglobin	 drop	 greater	 than	 or	 equal	 to	 2g/dL	(p=0.617)	nor	having	a	blood	transfusion	(p=0.117)	were	significant	predictors	of	the	need	for	endoscopic	therapy.		
Table	3:	Criteria	for	meeting	minor	post	polypectomy	bleeding	by	case:		
Cases	 Unplanned	post	
procedure	medical	
consultation	 Unplanned	admission	or	prolongation	of	hospital	stay	for	≤	3	nights	24	 X	 	13	 X	 X	
		The	median	time	to	presentation	of	minor	PPB	was	3.5	days	(range	0	–	10	days).	Five	patients	stayed	in	hospital	for	more	than	one	night.		
6.3.5	Factors	associated	with	major	and	intermediate	severity	post	
polypectomy	bleeding	
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	Factors	that	were	explored	as	potential	predictors	of	major	and	intermediate	severity	PPB	were	the	presence	of	co-morbidity	and	the	use	of	antithrombotic	medication.	Six	of	37	(16.2%)	minor	severity	bleeds	had	co-morbidity	and	nine	of	37	(24.3%)	were	taking	anti	thrombotic	medication	at	the	time	of	polypectomy.	This	compared	with	six	of	31	(19.4%)	intermediate	and	major	severity	bleeds	that	had	co-morbidity	and	13	of	31	(41.9%)	intermediate	and	major	severity	bleeds	that	were	taking	antithrombotic	medication.	Neither	the	presence	of	co-morbidity	(p=0.760)	nor	the	use	of	anti	thrombotic	medication	(p=0.193)	were	significantly	associated	with	these	more	severe	PPB	sub	groups	of	major	and	intermediate	severity	PPB.			Explanatory	variables	among	single	polypectomy	procedures	examined	were	polyp	location,	polyp	size	and	polyp	class.	Of	11	minor	severity	post	polypectomy	bleeds	associated	with	single	polypectomy	procedures,	three	(27.3%)	were	in	the	caecum,	five	(45.5%)	were	in	the	rectum	and	three	(27.3%)	were	in	the	sigmoid	colon.	Four	were	associated	with	sessile	polypectomies,	two	with	pedunculated	polypectomies,	one	with	a	sub-pedunculated	polypectomy	and	three	with	Laterally	Spreading	Tumours	(LSTs).	One	polyp	class	was	not	recorded.	Size	of	polyp	associated	with	minor	severity	PPB	ranged	from	5mm	to	75mm	with	a	median	size	of	polyp	of	15mm.	Of	11	intermediate	and	major	severity	risk	post	polypectomy	bleeds	associated	with	single	polypectomy	procedures,	three	(27.3%)	were	in	the	rectum,	four	(36.4%)	were	in	the	sigmoid	colon,	two	(18.2%)	were	in	the	ascending	colon,	one	(9.1%)	was	at	the	hepatic	flexure	and	in	one	the	colorectal	location	of	the	polypectomy	was	not	recorded.	
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Three	of	11	(27.3%)	polyps	were	sessile,	three	(27.3%)	were	pedunculated,	one	(9.1%)	was	semi	pedunculated	and	four	(36.4%)	were	LSTs.	Polyp	size	ranged	from	9mm	to	50mm	with	a	median	size	of	polyp	of	25mm.	Neither	polyp	location	(p=0.177),	polyp	size	(p=0.239)	and	polyp	class	(p=0.720)	were	predictive	of	intermediate	or	major	severity	PPB.		
6.4	Discussion	
	Although	the	number	of	colonoscopies	(15,285)	reported	 in	 this	study	 is	 lower	than	other	similar	recent	series	reporting	PPB,	we	can	be	reassured	that	the	rate	of	PPB	per	colonoscopy	(0.44%)	in	this	study	is	in	line	with	the	rates	described	in	 chapter	 2.5.2	 of	 this	 thesis.	 In	 this	 study	 I	 have	 reported	 PPB	 rate	 per	polypectomy	which	at	0.23%	is	lower	than	the	1.06%	reported	by	Macrae	et	al.43.	The	majority	 of	 studies	 only	 give	 a	 rate	 of	 PPB	per	 colonoscopy	 and	 therefore	reliably	 comparing	 rate	 per	 polypectomy	 is	 difficult.	 However,	 data	 from	 this	study	provides	us	with	the	evidence	that	polypectomy	is	performed	safely	in	the	English	NHS	BCSP	and	 the	 rates	 of	 PPB	are	 comparable	 to	 colonoscopy	 that	 is	performed	worldwide.		Although	 the	 lack	 of	 data	 from	 a	 control	 group	 in	 this	 study	 prevented	 me	exploring	whether	 the	presence	of	 co-morbidity	 and	 the	use	of	 antithrombotic	medication	are	risk	factors	for	PPB,	just	under	one	fifth	of	patients	with	PPB	had	co-morbidity	 and/or	 were	 taking	 anti	 thrombotic	 medication	 at	 the	 time	 of	colonoscopy	and	polypectomy.				
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The	 median	 time	 to	 presentation	 of	 these	 post	 polypectomy	 bleeds	 was	 four	days,	one	less	than	the	five	days	reported	by	Sorbi	et	al.	with	the	range	of	time	to	presentation	extending	to	19	days	post	polypectomy,	2	more	than	that	described	in	 Sorbi	 et	 al.’s	 study98.	 Unlike	 some	 studies,	 I	 have	 presented	 time	 to	presentation	 in	 all	 patients	 showing	 that	 the	 majority	 of	 post	 polypectomy	bleeds	presented	within	the	first	48	hours	post	polypectomy.	This	better	informs	us	 of	 when	 to	 contact	 patients	 in	 the	 aftermath	 of	 a	 polypectomy.	 Specialist	Screening	 Practitioners	 currently	 contact	 patients	 at	 24	 hours	 post	 procedure,	however,	 using	 a	48	hour	 cut	 off	 for	 checking	 for	bleeding	per	 rectum	may	be	more	 helpful	 than	 the	 current	 24	 hour	 period.	 In	 Sorbi	 et	 al.’s	 descriptive	analysis,	 43%	 of	 patients	 had	 signs	 of	 haemodynamic	 compromise	 compared	with	only	9%	 in	my	 study98.	 This,	 reassuringly,	 suggests	 that	 the	bleeds	 in	my	study	 were	 less	 severe,	 re-affirmed	 with	 the	 data	 from	 the	 grading	 of	 PPB	severity.		Only	13.2%	of	the	patients	with	PPB	required	a	blood	transfusion	compared	with	the	25%	described	by	Rosen	et	al.,	92.3%	described	by	Gibbs	et	al.	and	54.2%	by	Sorbi	et	al.96	 97	 98.	Again,	 these	 figures	add	weight	 to	 the	 fact	 that	 the	bleeds	 in	this	 study	were	 not	 as	 severe	 as	 other	 similar	 series	 and	 reassure	 us	 that	 the	extent	to	which	patient	safety	is	compromised	by	PPB	in	the	English	NHS	BCSP	is	minimal.			27.9%	of	post	polypectomy	bleeds	in	my	study	had	a	repeat	endoscopy,	however,	endoscopic	 therapy	was	 given	 in	 10.2%	of	 all	 bleeds.	 A	 repeat	 diagnostic	 only	endoscopic	examination	was	performed	 in	17.7%	of	 cases.	Although	ultimately	
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the	 judgement	 on	 who	 has	 a	 repeat	 endoscopic	 examination	 is	 down	 to	 the	assessing	 clinician,	 it	 would	 appear	 from	 my	 data	 that	 some	 endoscopic	examinations	 are	 performed	 needlessly	 and	 could	 be	 avoided.	How	 to	 identify	who	requires	a	repeat	endoscopic	examination	is	an	important	question	and	this	remains	unclear	from	my	study	as	neither	a	drop	in	haemoglobin	greater	than	or	equal	to	two	grams	per	demi	litre	or	having	a	blood	transfusion	were	significant	predictors	of	having	endoscopic	therapy.	A	larger	series	may	help	in	answering	this	question.		Importantly	 there	 were	 no	 complications	 or	 deaths	 associated	 with	 the	admissions	 of	 PPB	 which	 again	 reflects	 favourably	 on	 how	 PPB	 has	 been	managed	in	this	study.	One	patient	had	surgery	in	order	to	control	PPB	which	is	in	 line	 with	 the	 one	 patient	 having	 surgical	 intervention	 described	 in	 other	series38	101	107.	This	operation	was	an	examination	under	anaesthesia	and	suture	of	 the	 post	 polypectomy	 bleeding	 point	 rather	 than	 a	 colonic	 resection	 as	described	in	other	series.	One	limitation	of	the	methodology	I	used	to	collect	data	was	 that	 the	 exact	 time	 of	 presentation	wasn’t	 documented	 in	 the	majority	 of	cases.	 It	 is	 therefore	unclear	 if	 the	one	patient	who	had	surgery	had	presented	out	of	normal	working	hours	when	there	wasn’t	access	either	to	the	endoscopist	who	 had	 performed	 the	 polypectomy	 or	 an	 on	 call	 endoscopist.	 It	 would	 be	suprising	 if	 haemostasis	 in	 this	 particular	 case	 could	 not	 have	 been	 achieved	endoscopically.	 It	may	have	been	that	 the	 initial	assessing	clinician(s)	only	had	access	to	a	surgical	team	hence	the	patient	having	surgery.	This	potential	chain	of	 events	 raises	questions	 regarding	 the	advice	given	 to	patients	 about	who	 to	contact	 should	 they	 develop	 bleeding	 per	 rectum	 following	 polypectomy	 and	
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who	the	assessing	clinician(s)	should	communicate	with	in	these	circumstances.	For	example,	a	patient	 is	advised	to	contact	a	member	of	the	BCSP	if	 they	have	any	 bleeding	 per	 rectum	 that	 concerns	 them	post	 procedure.	 This	may	 not	 be	possible	out	of	current	normal	working	hours	leading	to	the	patient	contacting	a	general	practitioner	or	presenting	 to	 an	Accident	&	Emergency	department.	 In	this	scenario,	if	out	of	hours	intervention	was	felt	to	be	required	by	the	presence	of,	 for	 example,	 continuing	 bleeding,	 haemodynamic	 compromise	 or	 a	 drop	 in	haemoglobin	of	over	2g/dL	 then	a	conversation	with	an	on	call	 endoscopist	or	gastroenterologist	would	be	an	appropriate	first	port	of	call.	If	this	service	wasn’t	available,	only	then	involving	the	on	call	surgical	team	may	be	appropriate.	As	a	result	of	this	particular	patient	having	surgery	this	post	polypectomy	bleed	was	graded	 as	 severe	 but	 potentially	 this	 categorization	 could	 have	 been	 avoided.	Unlike	 the	 studies	 by	 Rosen	 et	 al.	 and	 Sorbi	 et	 al.	 none	 of	 the	 patients	 in	 this	study	required	a	colectomy	96	98.			Only	 one	 patient	 presented	 for	 a	 second	 time	 with	 bleeding	 per	 rectum	 and	required	 radiological	 management	 in	 the	 form	 of	 computed	 tomography	angiography	 and	 embolization.	 The	 use	 of	 this	 technique	 to	 control	 PPB	 is	limited	 to	 isolated	 case	 reports	 so	 comparison	 of	 this	management	 strategy	 in	the	 context	 of	 this	 retrospective	 observational	 case	 series	 is	 difficult.	 Although	data	 regarding	 length	 of	 hospital	 stay	 form	 other	 studies	 is	 scarce,	 a	 median	hospital	 stay	 of	 two	 days	 in	 this	 study	 again	 reflects	 favourably	 on	 both	 the	severity	of	PPB	and	how	it	was	managed.	This	figure	was	a	median	one	day	less	than	that	reported	by	Sorbi	et	al.98.	The	longest	a	patient	remained	in	hospital	for	
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was	six	days,	much	less	than	that	reported	by	Inoue	et	al.	but	two	days	more	than	by	Singh	et	al.124	125.		The	 work	 in	 this	 chapter	 is	 distinctive	 as	 it	 has	 graded	 post	 polypectomy	bleeding	 by	 severity	 as	 per	 the	 English	 NHS	 BCSP’s	 adverse	 events	 severity	grading	 framework,	 based	 on	 the	 American	 Society	 of	 Gastrointestinal	Endoscopy’s	 grading	 system26	 4.	 My	 data	 has	 suggested	 the	 post	 polypectomy	bleeds	studied	were	not	as	severe	as	those	in	other	series.	This	was	confirmed	by	the	 application	 of	 the	 severity	 grading	 criteria	 with	 over	 half	 of	 these	 bleeds	being	of	minor	severity	and	 therefore	clinically	 insignificant.	Only	 two	patients	had	 a	 severe	 post	 polypectomy	 bleed,	 one	 of	 these	 because	 of	 having	 surgery,	which,	as	explained	above,	may	have	been	avoidable.	Of	 those	patients	with	an	intermediate	severity	post	polypectomy	bleed,	the	majority	were	graded	as	such	because	of	having	a	 repeat	 endoscopic	procedure	even	 though	no	 therapy	was	required.	A	limitation	of	my	dataset	was	that	I	could	only	test	haemoglobin	drop	over	two	grams	per	demilitre	and	whether	the	patient	had	a	transfusion	or	not	as	explanatory	variables	predicting	the	need	 for	endoscopic	 therapy,	neither	of	which	 were	 significant	 predictors.	 A	 more	 detailed	 dataset	 including,	 for	example,	admission	pulse	and	blood	pressure	or	the	volume	of	blood	passed	may	better	predict	the	need	for	endoscopic	therapy	and	is	a	specific	point	for	further	research.	As	 expected	 the	major	 severity	 bleeds	were	 in	 hospital	 for	 a	median	one	day	 longer	 and	presented	a	median	one	day	 sooner	 than	 the	 intermediate	severity	bleeds.		
	 190	
Another	limitation	of	this	dataset	was	the	small	numbers	of	single	polypectomy	procedures	 that	 took	 place.	When	 predicting	 factors	 associated	with	 the	more	severe	PPB	sub	groups	of	major	and	intermediate	severity	bleeding	using	single	polypectomy	 procedures,	 which	 enabled	 accurate	 attribution	 of	 the	 single	polypectomy	 to	 the	 bleed,	 none	 of	 the	 explanatory	 variables	 were	 significant.	Partly,	 this	 is	 due	 to	 the	 small	 numbers	 involved	 and	 has	 to	 be	 taken	 in	 the	context	of	national	data	from	the	English	NHS	BCSP	which	has	showed	polyp	size	and	a	location	of	a	polyp	in	the	caecum	as	significant	predictors	of	PPB.		
6.5	Conclusions	
	The	 data	 reported	 in	 this	 chapter	 reassures	 us	 that	 the	 frequency	with	which	post	polypectomy	bleeding	occurs	when	measured	per	colonoscopy	is	similar	to	that	 occurring	 globally	 when	 colonoscopy	 and	 polypectomy	 is	 performed	 in	similar	 numbers.	 In	 addition,	 less	 than	 half	 of	 the	 bleeds	 studied	 would	 be	considered	to	be	clinically	significant	bleeds;	an	important	statistic	in	this	work.		When	considering	the	impact	of	PPB	on	the	patients	involved	there	appear	to	be	less	 serious	 consequences	when	 compared	 to	perforation.	 64.7%	of	 these	post	polypectomy	bleeds	were	admitted	to	hospital.	There	were	no	complications	or	deaths	following	PPB.	Surgery	was	required	in	only	one	patient	as	was	the	case	with	intensive	care	admission.			This	work	has	raised	specific	points	about	how	the	assessment	and	management	of	 PPB	 could	 be	 improved.	 We	 now	 know	 that	 the	 majority	 of	 these	 post	
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polypectomy	bleeds	presented	within	48	hours	and,	therefore,	ensuring	there	is	access	to	either	the	colonoscopist	who	performed	the	initial	procedure	or	an	on	call	 endoscopist	with	whom	 the	 case	 can	be	discussed	during	 this	 time	period	may	 prevent	 unnecessary	 intervention.	 Alternatively,	 performing	 high	 risk	procedures	Monday	to	Wednesday	only	would	be	a	method	of	ensuring	access	to	the	appropriate	personnel	in	the	event	of	PPB.	A	post	procedure	SSP	phone	call	at	 48	 hours	 rather	 than	 24	 hours	 to	 the	 patient	 may	 help	 in	 facilitating	 this.	Similarly,	 this	data	 suggests	 that	 the	majority	of	 repeat	endoscopic	procedures	are	performed	needlessly	and	could	be	avoided.	Predicting	those	patients	whose	bleeding	does	not	require	any	intervention	will	therefore	be	an	important	focus	of	future	research.		
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Chapter	7	
	
Post	Colonoscopy	Colorectal	Cancer	(PCCRC)	
	
7.1	Aims	
	The	following	aims	relate	to	Post	Colonoscopy	Colorectal	Cancer	(PCCRC)	within	the	English	National	Health	Service	Bowel	Cancer	Screening	Programme	only.	
	1.	To	establish	the	overall	rate	of	PCCRC.	2.	To	establish	the	rate	of	PCCRC	for	individual	years.	3.	To	explore	if	and	how	the	PCCRC	rate	changes	over	time.		
7.2	Methods	
	
7.2.1	Calculation	of	Post	Colonoscopy	Colorectal	Cancer	(PCCRC)	Rate	
	The	 first	 stage	 in	 achieving	 the	 aims	 of	 this	 study	 was	 to	 establish	 the	methodology	for	calculating	PCCRC	rate.	As	has	been	described	in	chapter	2.6	of	this	 thesis	 there	 is	no	standardised	definition	or	 formula	 for	calculating	PCCRC	rate.	 The	 English	 National	 Health	 Service	 Bowel	 Cancer	 Screening	 Programme	has	 adopted	 a	 novel	 method	 of	 PCCRC	 rate	 calculation,	 using	 the	 number	 of	colonoscopies	 diagnosing	 a	 cancer	 rather	 than	 cancers	 in	 its	 numerator	 and	denominator.	 The	 reasoning	 for	 this	 is	 that	 using	 colonoscopies	 in	 the	 rate	calculation	best	enables	us	 to	express	 to	patients	 the	chances	of	a	colonoscopy	
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either	 missing	 or	 not	 preventing	 against	 the	 development	 of	 a	 cancer.	 This	methodology	was	proposed	and	used	by	Morris	et	al.	 to	determine	PCCRC	rate	from	symptomatic	patients	in	England	using	data	from	the	National	Cancer	Data	Repository126.		In	order	to	calculate	PCCRC	rate	using	this	method	we	require	a	numerator	and	denominator.	To	provide	 the	numerator	and	denominator	we	have	 to	consider	two	distinct	types	of	colonoscopy;	a	colonoscopy	that	detects	a	colorectal	cancer,	which	I	refer	to	as	‘true	positive	colonoscopy’	and	a	second	type	of	colonoscopy,	on	a	patient	that	doesn’t	detect	a	cancer	but	when	cancer	subsequently	develops	in	 that	 patient,	 termed	 a	 ‘false	 negative	 colonoscopy’.	 Importantly,	 there	 is	 a	finite	 period	 of	 time	 after	 the	 false	 negative	 colonoscopy	 for	 the	 PCCRC	 to	develop.	 I	 used	a	period	of	3	 years	 after	 the	 false	negative	 colonoscopy	 in	 this	study.	 To	 calculate	 overall	 PCCRC	 rate	 I	 then	 used	 the	 formula	 false	 negative	colonoscopies	/	(false	negative	colonoscopies	+	true	positive	colonoscopies).	
	
7.2.2	Calculation	of	Post	Colonoscopy	Colorectal	Cancer	(PCCRC)	rate	for	an	
individual	year	
	Aims	 two	 and	 three	 of	 this	 study	 required	 a	 calculation	 of	 PCCRC	 rate	 for	 an	individual	year	in	the	NHS	BCSP.	In	order	to	do	this	calculation	I	again	used	the	two	 categories	 of	 colonoscopy	described,	 true	 positive	 colonoscopies	 and	 false	negative	 colonoscopies.	 However,	 on	 this	 occasion	we	 consider	 them	 to	 occur	during	one	 and	not	multiple	 years.	 For	 example	 if	we	wish	 to	 calculate	PCCRC	rate	for	the	year	x	we	use	the	formula:	false	negative	colonoscopies	during	year	
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x/(false	 negative	 colonoscopies	 during	 year	 x	 +	 true	 positive	 Colonoscopies	during	year	x).	For	this	calculation	I	again	used	a	3	year	cut	off	period	after	the	year	 x	 for	 the	 colorectal	 cancer	 to	 develop	 in	 those	 subjects	 who	 had	 a	 false	negative	colonoscopy.		
7.2.3	The	Bowel	Cancer	Screening	System	(BCSS)	
	The	 internet	 based	 database	 of	 the	 English	 NHS	 BCSP,	 the	 Bowel	 Cancer	Screening	System,	again	provided	 the	data	required	 to	achieve	 the	aims	of	 this	study	 using	 the	methodology	 outlined	 above.	 Details	 of	 BCSS	 can	 be	 found	 in	chapter	 4	 of	 this	 thesis.	 Access	 to	 BCSS	was	 facilitated	 by	 Professor	 Rutter,	 as	chair	of	the	English	NHS	BCSP	evaluation	group	and	co-supervisor	of	this	thesis.			I	wrote	and	sent	an	email	to	Miss	Claire	Nickerson,	project	manager	at	the	Bowel	Cancer	Screening	Programme	national	office.	The	email	outlined	 the	 study	and	the	 data	 that	would	 be	 required	 in	 order	 to	 achieve	 its	 aims.	 I	 requested	 data	from	BCSS	on	all	the	subjects’	screening	episodes	that	were	recorded	as	having	a	diagnosis	 of	 colorectal	 cancer	 from	 the	 start	 of	 the	 English	 NHS	 BCSP	 on	 the	02/08/2006	 up	 to	 and	 including	 the	 31/12/2013.	 Where	 a	 subject	 with	 a	diagnosis	of	colorectal	cancer	had	been	through	a	previous	episode	of	screening	and	had	a	colonoscopy	during	that	episode	I	also	requested	data	relating	to	that	episode	of	screening.		For	 those	 subjects	 recorded	 as	 having	 a	 diagnosis	 of	 colorectal	 cancer	 I	requested	 data	 on	 several	 variables	 relating	 to	 the	 subject	 and	 that	 specific	
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screening	 episode.	 These	 included	 (1)	 a	 unique	 subject	 identifier	 (2)	 the	 start	date	of	the	screening	episode	(3)	the	type	of	colorectal	 investigation	that	made	the	diagnosis	of	colorectal	cancer	(patients	in	the	BCSP	may	be	investigated	not	only	with	a	colonoscopy,	but	also	with	a	Virtual	CT	Colonoscopy,	CT	Abdomen	or	Barium	 Enema)	 and	 (4)	 the	 date	 of	 the	 colorectal	 investigation(s)	 during	 the	episode	 of	 screening.	 For	 those	 subjects	 diagnosed	with	 colorectal	 cancer	who	had	 previously	 been	 through	 one	 or	 more	 episodes	 of	 screening	 prior	 to	 the	episode	where	cancer	was	diagnosed,	data	was	also	requested	relating	 to	 their	previous	 episode(s)	 of	 screening.	 Data	 from	 this	 episode(s)	 related	 to	 the	following	 variables:	 (5)	 a	 unique	 subject	 identifier	 (6)	 the	 start	 date	 of	 the	screening	 episode	 (7)	 the	 type	 of	 colorectal	 investigation(s)	 that	 took	 place	during	the	episode(s)	and	(8)	the	date	of	this	colorectal	investigation(s).		Miss	Claire	Nickerson,	project	manager	at	the	BCSP	national	office,	received	this	email	and	then	wrote	a	query	to	extract	all	of	this	data	from	BCSS.	The	data	was	then	emailed	back	to	me	securely	via	NHS	mail.	The	data	was	provided	in	three	Microsoft	Excel	spreadsheets;	 the	first	two	of	these	spreadsheets	related	to	the	subjects’	 episodes	 of	 screening	 where	 cancer	 was	 diagnosed.	 Variables	 1-4	 as	listed	above	were	entered	 into	 the	columns	with	data	 for	each	subject	 in	rows.	The	 third	 spreadsheet	 related	 to	 the	 subjects	 previous	 episode(s)	 of	 screening	with	variables	5-8	entered	into	columns	with	data	for	each	subject	entered	into	each	row.		
7.2.4	Analysis	of	Microsoft	Excel	spreadsheets		
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I	 used	 the	 first	 two	of	 these	 spreadsheets	 containing	variables	1-4	 to	 calculate	the	 number	 of	 true	 positive	 colonoscopies.	 During	 this	 process	 those	 subjects	who	 had	 multiple	 investigations	 during	 the	 episode	 of	 screening	 diagnosing	colorectal	 cancer	 were	 identified.	 A	 true	 positive	 colonoscopy	 was	 deemed	 to	have	occurred	if	a	colonoscopy	was	the	most	recent	investigation	in	that	episode	of	screening.	If	a	colonoscopy	and	a	radiological	investigation	had	taken	place	on	the	 same	day,	 the	 colonoscopy	 ‘gave	way’	 to	 the	 radiological	 investigation	 and	wasn’t	considered	a	true	positive	colonoscopy	on	the	basis	that	the	endoscopist	would	have	 requested	a	 same	day	 radiological	 investigation	because	he	or	 she	felt	there	was	an	issue	with	completeness	of	examination	of	the	colon.			I	 then	 calculated	 the	 number	 of	 false	 negative	 colonoscopies	 by	 reviewing	 the	third	 of	 these	 spreadsheets.	 Where	 a	 subject	 had	 undergone	 multiple	investigations	during	one	or	more	episodes	of	screening	prior	to	the	episode	of	screening	 diagnosing	 colorectal	 cancer,	 a	 false	 negative	 colonoscopy	 was	recorded	if	 it	was	the	most	recent	full	colorectal	 investigation	in	the	episode	of	screening	immediately	prior	to	the	episode	of	screening	diagnosing	cancer.				These	 steps	 were	 repeated	 with	 respect	 to	 each	 year	 from	 2006-2013.	 Those	cancers	 that	 had	 presented	 more	 than	 3	 years	 after	 the	 false	 negative	colonoscopy	were	 then	excluded	 form	 the	analysis	 to	give	 the	 true	PCCRC	rate	for	 the	4	year	 time	period	 from	2006	 to	2010	and	 the	 true	annual	PCCRC	rate	each	year	from	2006	to	2010.	PCCRC	rate	was	expressed	as	a	percentage.		
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7.3	Results	
	Results	are	presented	in	the	following	tables	and	graphs:		
Table	1:	Complete	breakdown	of	true	positive	colonoscopies	and	false	
negative	colonoscopies	from	2006	-	2013		
Year	of	
Investigation	
True	Positive	
Colonoscopies	
False	Negative	
Colonoscopies	2006	 39	 1	2007	 574	 13	2008	 1683	 43	2009	 2314	 56	2010	 3195	 70	2011	 3433	 35	2012	 3311	 14	2013	 3027	 0		
Table	2:	PCCRC	Results	by	year	of	colonoscopy	(2006-2010)	with	3	years	
follow	up	
	
Year	of	
Colonoscopy	
True	Positive	
Colonoscopies		
False	Negative	
Colonoscopies		
To	year	
end		
PCCRC	
Rate	2006	 39	 1	 2009	 2.50%	2007	 574	 7	 2010	 1.20%	2008	 1683	 36	 2011	 2.09%	2009	 2314	 53	 2012	 2.24%	2010	 3195	 70	 2013	 2.14%	
Total	 7805	 167	 	 2.09%	
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7.4	Discussion	
	Table	 1	 shows	 the	 complete	 breakdown	 of	 true	 positive	 and	 false	 negative	colonoscopies	 during	 this	 study	 period.	 However,	 this	 table	 cannot	 be	 used	 to	calculate	PCCRC	 rate	 as	 different	 periods	 of	 follow	up	 are	 in	 use	 following	 the	false	negative	colonoscopy.	For	example,	 the	period	of	 follow	up	after	 the	 false	negative	colonoscopy	in	2006	would	be	seven	years	whereas	for	2012	it	would	be	 one	 year.	 The	 table	 shows	how	 the	 number	 of	 false	 negative	 colonoscopies	starts	to	decrease	after	2011	as	there	hasn’t	been	sufficient	time	allowed	for	the	colorectal	cancers	to	present	after	the	false	negative	colonoscopy	takes	place.			Table	 2	 and	 graph	 1	 presents	 this	 data	 uniformly,	 as	 for	 each	 year	 rate	 is	calculated	 with	 a	 three	 year	 period	 of	 follow	 up	 after	 the	 false	 negative	colonoscopy.	 This	 gives	 an	 overall	 PCCRC	 rate	 of	 2.09%.	When	 examining	 the	annual	rate	calculation,	the	numbers	of	false	negative	colonoscopies	in	2006	and	2007	 are	 small	 and	 therefore	 it	 is	 difficult	 to	 draw	 any	 firm	 conclusions	 from	them.	 However,	 having	 increased	 from	 2007,	 PCCRC	 rate	 plateaus	 at	 over	 2%	from	the	years	2008	–	2010.	This,	perhaps,	gives	a	more	accurate	representation	of	PCCRC	rate.		Graph	 2	 allows	 visualisation	 of	 when	 post	 colonoscopy	 colorectal	 cancers	 are	presenting	following	the	false	negative	colonoscopy.	Again,	because	of	the	small	number	 of	 false	 negative	 colonoscopies,	 one	 in	 2006	 and	 seven	 in	 2007,	 it	 is	difficult	 to	 draw	 any	 conclusions	 from	 the	 data	 for	 these	 two	 years.	 However,	from	2008	to	2010	there	is	a	steady	increase	to	2	years	follow	up	then	a	much	
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sharper	rise	to	3	years	follow	up,	suggesting	most	PCCRCs	present	2	to	3	years	following	the	false	negative	colonoscopy.		It	 is	 important	 to	 point	 out	 that	 the	 overall	 figure	 of	 2.09%	 underestimates	PCCRC	rate	as	it	doesn’t	include	data	from	interval	cancers	that	have	presented	symptomatically	external	to	the	BCSP.	This	was	a	major	limitation	of	the	study	in	this	chapter.	However,	despite	the	omission	of	this	data	this	figure	is	still	lower	than	the	PCCRC	rate	of	8.6%	reported	by	Morris	et	al.	 from	cancers	presenting	symptomatically	 in	 England	 from	2001	 to	 2007.	 Indeed	 in	Morris	 et	 al’s	 study	annual	 rate	 fell	 year	 on	 year	 from	 10.2%	 in	 2001	 to	 6.2%	 in	 2007,	 perhaps	reflecting	an	improvement	in	colonoscopy	quality	during	this	time126.	The	figure	of	 6.2%	 is	 perhaps	 most	 relevant	 to	 the	 data	 in	 this	 chapter	 in	 terms	 of	 the	similar	time	scale	involved.	Despite	the	rates	reported	in	this	chapter	not	seeing	the	 year	 on	 year	 decrease	 in	 PCCRC	 rate	 and	 the	 annual	 rate	 remaining	 fairly	static	 at	 between	 2.09	 –	 2.24%,	 even	 with	 the	 addition	 of	 data	 from	 interval	cancers,	I	would	expect	PCCRC	rate	to	be	below	the	6.2%	reported	by	Morris	et	al.	from	2007.	This	could	be	interpreted	as	showing	a	higher	level	of	quality	and	safety	 to	 BCSP	 colonoscopy	 when	 compared	 with	 the	 symptomatic	 service	 in	England126.	
	It	 is	 difficult	 to	 compare	 my	 results	 with	 other	 studies	 published	 globally	reporting	 PCCRC	 rate	 as	 most	 have	 used	 different	 formulae	 to	 calculate	 rate	involving	using	cancers	as	opposed	to	colonoscopies	in	the	denominator.	Morris	et	al.	showed	how	PCCRC	rate	can	vary	when	applying	their	dataset	to	methods	used	by	Singh	et	al.,	Cooper	et	al.,	Bressler	et	al.	and	Le	Clerq	et	al.	hence	proving	
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the	 point	 that	 clarity	 and	 consistency	 of	 methodology	 is	 paramount	 when	researching	PCCRC126	153	134	131	129.	Further	population	based	studies	using	this	methodology	 for	PCCRC	 rate	 calculation	 are	 required	before	 a	 fair	 comparison	can	be	made	with	the	data	in	this	chapter.	
	
7.5	Conclusions	
	As	 a	 result	 of	 this	 study	 the	 English	 NHS	 BCSP	 can	 now	 report	 to	 patients	attending	 for	 colonoscopy	 that	 the	 chances	 of	 the	 colonoscopy	missing	 or	 not	preventing	 against	 the	 development	 of	 cancer	 is	 approximately	 2%.	 When	considering	PCCRC	as	an	adverse	event	this	 is	an	 important	measure	of	quality	and	safety	in	the	programme.		The	PCCRC	 rate	 of	 2.09%	 reported	 in	 this	 chapter	 under	 reports	 the	 true	 rate	because	of	a	 lack	of	data	on	interval	cancers.	Even	with	the	addition	of	 interval	cancer	data	the	true	rate	is	likely	to	be	lower	than	that	seen	in	the	symptomatic	service	in	England.		
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Chapter	8	
	
Discussion	&	Conclusions	
	
8.1	Overall	Headlines	
	My	 first	 intention	 in	 writing	 this	 thesis	 was	 to	 determine	 the	 frequency	 with	which	 patients	 invited	 for	 colonoscopy	 in	 the	 English	 NHS	 BCSP	 suffer	 from	colonoscopic	adverse	events.	This	thesis	has	reported	that	the	rate	of	perforation	at	0.06%	and	of	post	polypectomy	bleeding	(PPB)	at	0.44%	per	colonoscopy	and	0.23%	per	polypectomy	respectively	 is	 similar	 to	other	 reported	rates	of	 these	adverse	 events	 worldwide	 and	 reflects	 favourably	 on	 the	 safety	 of	 the	programme.	 Similarly,	 a	 BCSP	 only	 post	 colonoscopy	 colorectal	 cancer	 rate	 of	2.09%	 is	 lower	 than	 that	 reported	 from	 colorectal	 cancers	 presenting	symptomatically	in	England,	using	the	methodology	of	PCCRC	calculation	used	in	this	thesis,	and	again	reflects	a	reassuringly	low	compromise	of	patient	safety.		Despite	 the	 comparably	 good	 rates	 of	 adverse	 events	 found,	 it	 is	 important	 to	consider	the	impact	of	the	adverse	event	on	the	patient	involved.	Indeed	this	was	the	second	theme	I	 intended	to	examine	in	this	thesis.	In	the	perforation	study,	one	patient	died,	a	post	perforation	mortality	rate	of	0.87%.	A	death,	even	if	it	is	just	 one,	 from	 a	 screening	 investigation	 is	 disappointing	 for	 any	 screening	programme	 and	 this	 needs	 to	 be	 highlighted.	 It	 is	 also	 important	 to	 recognise	that	nearly	all	of	the	patients	who	had	a	perforation	were	admitted	to	hospital.	Over	 half	 of	 those	 admitted	 to	 hospital	 had	 surgery,	 over	 a	 quarter	 were	
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admitted	to	the	intensive	care	unit	and	over	a	quarter	left	hospital	with	a	stoma.	One	fifth	of	those	with	a	perforation	developed	a	complication	or	new	diagnosis	while	in	hospital.			The	 data	 from	 this	 study	 gives	 us	 a	 complete	 perspective	 on	 the	 impact	 a	perforation	 has	 on	 a	 patient	 and	 the	 extent	 to	 which	 patient	 safety	 may	 be	compromised	in	the	BCSP.	It	appears	that	the	poorer	sequelae	of	perforation	is	much	greater	than	that	of	PPB.	Despite	the	need	for	hospital	admission	and	even	surgery	 in	 one	 patient	 with	 PPB	 in	 my	 study,	 there	 were	 no	 deaths	 or	complications	associated	with	this	adverse	event.		Uniquely,	I	have	also	been	able	to	explore	the	impact	of	the	adverse	event,	in	the	form	 of	 a	 perforation,	 on	 the	 health	 care	 professional	 who	 performs	 the	colonoscopy.	 This	 thesis	 reports	 the	 substantial	 physical	 and	 psychological	impact	 on	 the	 professional	 and	 the	 effect	 on	 their	 personal	 and	 professional	lives.	 It	 highlights	 the	 importance	 of	 considering	 and	 supporting	 the	professional,	as	well	as	the	patient,	in	the	aftermath	of	an	adverse	event.		A	third	intention	of	this	thesis	was	to	identify	risk	factors	for	adverse	events	so	that	 the	 risk	of	 them	occurring	 in	 the	 future	 could	be	minimised.	The	 study	of	perforations	 in	 chapter	 4,	 although	 not	 specifically	 reporting	 risk	 factors	 for	 a	perforation,	 has	 nevertheless	 shown	 that	 diagnostic	 perforations	 are	significantly	associated	with	the	need	for	surgery	and	therefore	post	perforation	morbidity.	It	also	showed	that	perforations	in	the	sigmoid	colon	are	significantly	associated	with	 stoma	 formation.	The	one	death	 that	occurred	was	 following	a	
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diagnostic	perforation	in	the	sigmoid	colon.	This	work	shows,	therefore,	the	type	of	perforation	 that	 is	high-risk	 for	poorer	patient	outcomes.	From	chapter	5	of	this	 thesis	 we	 now	 have	 qualitative	 evidence	 to	 add	 to	 the	 quantitative	 data	reviewed	 in	 chapter	 2.5	 that	 the	 caecum	 is	 a	 high-risk	 colorectal	 location	 for	perforation.	 Chapter	 5	 has	 also	 shown	 that	 human	 factors	 such	 as	 fatigue	 and	expectation	 along	 with	 environmental	 factors	 such	 as	 time	 and	 equipment	problems	may	contribute	to	perforation.			A	 further	 intention	 of	 this	 thesis	 was	 to	 improve	 the	 assessment	 and	management	of	adverse	events	so	that	patients	have	the	best	possible	outcomes	when	 they	do	occur.	When	 considering	 the	 first	 of	 the	 adverse	 events	 studied,	perforation,	we	now	have	an	evidence	base	that	shows	which	patients	have	the	best	 outcomes.	 Those	 patients	 that	 did	 not	 have	 surgery	 and	 were	 managed	endoscopically	and/or	medically	avoided	both	intensive	care	admission	and	post	perforation	morbidity.	If	the	endoscopist	visualised	a	perforation,	the	application	of	endoclips	resulted	in	the	patient	not	having	surgery	in	the	majority	of	cases,	although	 the	 data	 didn’t	 reach	 statistical	 significance	 when	 this	 outcome	 was	measured.	 Where	 the	 visualised	 perforation	 was	 <	 5mm	 in	 size,	 this	 was	associated	with	 the	patient	not	having	 surgery,	 although,	 again	 the	 association	did	 not	 reach	 statistical	 significance.	 When	 considering	 the	 presence	 of	abdominal	 pain,	 those	 patients	 complaining	 of	 abdominal	 pain	 at	 presentation	were	significantly	more	likely	to	have	surgery.	Similarly,	when	measuring	initial	pulse	rate	and	respiratory	rate,	a	pulse	rate	greater	than	100	beats	per	minute	and	 a	 respiratory	 rate	 greater	 than	 20	 breaths	 per	 minute	 were	 both	significantly	 associated	with	 the	 patient	 having	 surgery.	 This	 suggests	 that	 the	
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absence	of	abdominal	pain,	a	normal	pulse	rate	of	60-100	beats	per	minute	and	a	respiratory	rate	of	less	than	or	equal	to	20	breaths	per	minute	may	be	indicators	for	 successful	 medical	 management,	 especially	 in	 the	 presence	 of	 a	 visualised	perforation	of	less	than	5mm	where	an	endoclip	had	been	applied.	This	work	has	also	 shown	 that	 the	 majority	 of	 perforations	 will	 present	 within	 the	 first	 48	hours	 post	 procedure.	 This	 has	 implications	 for	 our	 communication	 with	patients	in	the	aftermath	of	colonoscopy.	Likewise,	this	statement	also	applies	to	PPB;	the	majority	of	cases	of	PPB	also	presenting	within	48	hours.			The	 final	 intention	 of	 writing	 this	 thesis	 has	 been	 achieved	 by	 providing	 a	reference	point	that	all	colonoscopists	can	use	and	relate	to.	This	reference	point	involves	 not	 only	 how	 to	minimise	 their	 patients	 adverse	 event	 risk,	 improve	their	patients’	adverse	event	assessment	and	management	but	is	also	a	reference	as	to	how	they,	the	colonoscopist,	may	feel	in	the	aftermath	of	an	adverse	event.	The	 four	 stages	 of	 reaction	 of	 the	 colonoscopist	 described	 in	 chapter	 5,	 ‘The	
Realisation’,	 ‘Into	 the	 Mirror’,	 ‘Acceptance	 and	 Refocus’	 and	 ‘Reflection	 and	
Learning’	is	an	important	headline	of	this	work	that	I	hope	all	colonoscopists	will	find	useful	should	they	encounter	an	adverse	event	in	the	future		
8.2	Implications	of	findings	
	The	low	rates	of	the	adverse	events	that	I	have	studied	in	this	thesis	reassure	us	that	 colonoscopy	 is	 performed	 safely	 in	 the	 English	 National	 Health	 Service	Bowel	Cancer	Screening	Programme.	The	benefits	of	colorectal	cancer	screening	
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described	 in	 chapter	 2.3	 of	 this	 thesis,	 therefore	 continue	 to	 outweigh	 any	compromise	of	patient	safety	that	I	have	found	doing	this	work.			I	 hope	 that	 the	 findings	 of	 this	 thesis	 will	 influence	 future	 patient	 care	surrounding	 colonoscopy	 and	 colonoscopic	 adverse	 events.	 When	 considering	the	 implications	 of	 my	 findings	 we	 must	 first	 consider	 how	 the	 risk	 of	 the	adverse	 events	 I	 have	 studied	 can	be	minimised.	With	 regards	 to	 colonoscopic	perforation,	as	a	result	of	quantitative	data	added	to	by	qualitative	data	from	this	thesis,	 colonoscopist	 caution	when	 in	 the	 caecum	 and	 sigmoid	 colon	 is	 urged.	The	 qualitative	 evidence	 suggests	 that	 colonoscopists	 are	much	more	 cautious	when	 performing	 therapy	 in	 the	 caecum	 and	 one	 colonoscopist	 now	 routinely	applies	 endoclips	 to	 the	 polypectomy	 site	 following	 any	 endoscopic	 mucosal	resection	of	polyps	in	the	caecum.	Likewise	caution	is	urged	during	intubation	of	the	sigmoid	colon,	especially	 in	 the	presence	of	diverticular	disease	and	during	loop	 resolution,	 as	 these	 are	 likely	 to	 be	 the	 main	 causes	 of	 diagnostic	perforations	 in	 the	 sigmoid	 colon.	 Colonoscopists	 may	 wish	 to	 take	 these	recommendations	 on	 board	 in	 their	 future	 practice.	 The	 identification	 from	qualitative	 data	 of	 specific	 human	 and	 environmental	 factors	 associated	 with	perforation	 means	 that	 colonoscopists	 may	 wish	 to	 keep	 such	 associations	 in	mind	when	performing	colonoscopy.			The	 second	 main	 implication	 of	 this	 work	 relates	 to	 how	 to	 improve	 the	assessment	 and	management	 of	 adverse	 events	 so	 that	 patients	 have	 the	 best	possible	 outcome.	 As	 a	 result	 of	 this	 work	 the	 focus	 following	 a	 perforation	should	 be	 trying	 to	 ensure	 that	 patient	 is	 managed	 endoscopically	 and/or	
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medically	 and	 doesn’t	 have	 surgery.	 Of	 course,	 this	 may	 not	 be	 possible	depending	on	 the	 clinical	 situation	 that	 evolves	post	perforation.	However,	my	recommendation,	as	a	result	of	the	work	in	chapter	4,	 is	that	all	colonoscopists	should	 attempt	 to	 close	 a	 perforation	 with	 endoclips	 when	 the	 perforation	 is	visualised.	 Attempts	 should	 then	 be	made	 to	 treat	 the	 patient	with	 traditional	medical	management	of	intravenous	fluids,	antibiotics	and	bowel	rest,	especially	in	 the	context	of	 the	absence	of	abdominal	pain,	a	normal	pulse	rate	of	60-100	beats	per	minute	and	a	respiratory	rate	of	 less	than	20	breaths	per	minute.	My	qualitative	 data	 has,	 uniquely,	 showed	 that	 a	 large	 part	 of	 implicating	 such	management	plans	is	not	just	about	informing	clinicians	about	these	findings.	It	is	about	how	we	communicate	with	patients	and	each	other	in	the	aftermath	of	a	colonoscopy	 and	 from	 whom	 patients	 seek	 medical	 attention	 should	 they	develop	 symptoms	 following	 a	 colonoscopy.	 The	 qualitative	 data	 specifically	reported	how	two	medical	endoscopists	felt			
‘angry’,	‘disappointed’	(C4)	and	‘upset’	(C8)		at	not	being	involved	in	decisions	relating	to	patient’s	subsequent	care.	In	both	cases	the	patient	was	under	the	care	of	surgeons	and	not	them.	This	had	led	one	to	now	always	give	his	mobile	telephone	number	to	the	patient	following	a	high	risk	colonoscopy	and	polypectomy	procedure	asking	 them	to	call	him,	and	him	only,	 if	 there	was	a	problem	or	symptom	suggestive	of	perforation.	The	reason	being	 so	 the	 patient	 is	 assessed	 and	managed	 by	 the	 appropriate	 person	 and	doesn’t	needlessly	have	surgery	where	medical	management	only	may	have	been	more	appropriate.	This	provides	a	useful	guide	as	 to	how	communication	with	
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patients	 and	 their	 understanding	 of	who	 to	 seek	help	 from	may	 improve	 their	outcome.	While	it	may	be	inappropriate	to	expect	all	colonoscopists	to	offer	such	a	 service,	 indeed	 few	may	wish	 to	 do	 so,	 potentially	 at	 least	 the	 discussion	 of	such	 a	 patient’s	 case	 with	 an	 on	 call	 endoscopist	 or	 the	 colonoscopist	 who	performed	 the	 procedure	 may	 prevent	 unnecessary	 surgical	 intervention	 and	hence,	as	we	now	know	form	the	quantitative	data	in	this	thesis,	the	poorer	post	perforation	outcomes	that	are	associated	with	it.			Currently,	 all	patients	who	have	 colonoscopy	are	 contacted	by	 telephone	at	24	hours	 post	 procedure	 by	 Specialist	 Screening	 Practitioners	 (SSPs)	 who	 attend	each	procedure.	 From	 the	quantative	data	 reported	 in	 chapter	4	 and	6	we	 are	now	aware	 that	 that	 the	majority	of	perforations	and	post	polypectomy	bleeds	present	within	the	first	48	hours	post	procedure.	It	may	be	better,	therefore,	for	contact	 to	 be	made	with	 patients	 at	 48	 hours	 post	 procedure.	 For	 the	 reasons	described	earlier	 in	 this	chapter,	 the	 lines	of	communication	being	 through	the	SSP	 and	 therefore	 remaining	 within	 the	 BCSP	may	 result	 in	 the	 patient	 being	reviewed	by	the	appropriate	professional	and	their	outcome	improved.		A	third	implication	of	my	work	focuses	on	the	colonoscopists	themselves.	I	hope	this	 work	 will	 prepare	 those	 colonoscopists	 who	 have	 yet	 to	 experience	 a	perforation	for	how	they	may	feel.	This	work	also	aims	to	aid	the	passage	of	the	colonoscopist	 through	 the	 stages	 of	 physical	 and	 psychological	 response	reported	 in	 chapter	 5.	 All	 screening	 colonoscopists	 in	 the	 English	 NHS	 BCSP	should	 be	 assigned	 a	 mentor	 to	 oversee	 their	 colonoscopic	 performance	 and	provide	both	endoscopic	and	psychological	support	when	required.	 In	 the	 light	
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of	the	data	in	chapter	5,	the	role	that	the	mentor	may	have	in	the	aftermath	of	an	adverse	event	 takes	on	added	 importance.	 Indeed,	 I	would	recommend	 that	all	independent	 colonoscopists	 be	 assigned	 a	 mentor	 but	 particularly	 junior	colonoscopists	 and	 nurse	 colonoscopists.	 The	 support	 of	 colleagues	 whether	they	are	a	mentor	or	otherwise	 is	vital	 in	aiding	 the	colonoscopist	 through	 the	stages	of	 response.	Therefore,	 colleagues	or	 the	mentor	 should	be	prepared	 to	take	 over	 the	 endoscopy	 list	 where	 the	 adverse	 event	 occurs	 and	 even	 their	colleagues	subsequent	endoscopy	 lists.	They	should	also	offer	and	be	prepared	to	 discuss	 the	 case	 with	 the	 colonoscopist	 involved.	 It	 is	 hoped	 such	 actions	would	 help	 the	 colonoscopist	 through	 the	 stages	 of	 response	 to	 the	 adverse	event.		The	biggest	 impact	 I	am	hopeful	 that	 this	work	will	have,	however,	 is	 in	aiding	and	 developing	 a	 culture	 of	 openness	 surrounding	 adverse	 events	 among	 not	only	colonoscopists	but	also	other	health	care	professionals	more	generally.	This	culture	is	also	in	the	context	of	how	such	experiences	are	communicated	with	the	public.	The	qualitative	 study	 in	 chapter	5,	more	 than	any	other,	may	go	a	 long	way	 to	achieving	 this.	Over	 the	 last	9	years	of	working	as	a	 registered	medical	practitioner	 in	 the	National	Health	Service	 I	have	been	aware	of	a	hesitancy	of	health	care	professionals	to	discuss	mistakes,	complications	and	adverse	events	amongst	themselves.	Too	often,	openly	discussing	such	events	may	be	perceived	as	showing	a	sign	of	weakness	or	inadequacy	amongst	colleagues	both	junior	and	senior.	 Others	 may	 seize	 upon	 such	 events	 for	 the	 purposes	 of	 gossip	 or	mockery.	From	the	many	 local,	 regional,	national	and	 international	educational	events	I	have	attended,	I	can	rarely	remember	anyone	talking	about	an	adverse	
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event	 they	had	been	 involved	with	or	a	mistake	they	had	made,	 in	 the	way	the	colonoscopists	did	 in	 chapter	5	of	 this	 thesis,	 as	a	point	of	 learning.	 I	 also	 find	this	 point	 interesting	 when	 considering	 it	 in	 the	 context	 of	 endoscopy,	gastroenterology	and	surgery	as	 specialties	and	 the	professionals	who	work	 in	them.	One	of	the	nurse	endoscopists	interviewed	in	chapter	5	made	reference	to			
‘macho	stuff’	(C11)			among	colonoscopists	in	her	department.	I	suspect,	because	of	the	practical	and	visual	 nature	 of	 endoscopy,	 it	 is	 a	 competitive	 specialty	 with	 colonoscopists	eager	 to	 continually	 prove	 and	display	 their	 skill	 level	 to	 others.	Discussion	 of	adverse	 events	 is	 probably	difficult	 for	most	 professionals	 at	 the	best	 of	 times	but	may	be	more	so	amongst	colonoscopists	in	this	environment.	I	also	feel	this	leads	onto	another	important	point	about	communication.	My	feeling	is	the	same	nurse	endoscopist	who	said		
‘maybe	they	don’t	feel	comfortable	talking	about	emotions’	(C11)		is	probably	right.	I	would	agree	that	a	lot	of	professionals,	but	again	particularly	in	the	endoscopic	environment,	are	reluctant	to	talk	about	emotions	and	feelings	surrounding	 events	 at	work;	 it	 is,	 perhaps,	 something	we	 should	do	more	of.	 I	hope	these	are	points	that	I	can	bring	out	in	my	own	future	practice	and	I	now	feel	well	placed	to	encourage	others	to	do	so.	Furthermore,	I	feel	well	placed	to	support	others	 if	needs	be	 in	 this	context.	 It	 is	potentially	a	niche	area	 I	would	like	to	develop	in	my	future	career.	
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	There	 are	 also	 implications	 for	 how	 the	 experience	 of	 such	 events	 is	communicated	with	 the	 public,	 particularly	when	 they	 accept	 the	 invitation	 to	have	a	colonoscopy	as	part	of	the	BCSP.	Patients	and	their	relatives	will	always	want	to	be	in	the	hands	of	a	health	care	professional	who	is	‘good’	at	their	job;	a	professional	whom	they	can	trust	without	having	to	think	about	it154.	Clinical	and	ethical	 integrity,	 safety,	 up-to-date	 medical	 knowledge,	 diagnostic	 skill,	 sound	judgement	and	an	ability	to	form	a	good	relationship	are	all	characteristics	that	may	form	part	of	what	the	public	would	want	from	the	professional	looking	after	them155.	The	desire	for	these	characteristics	may	be	heightened	in	the	context	of	a	 screening	programme	 such	 as	 the	BCSP.	 From	 this,	 there	may	 come	a	desire	from	 the	public	 for	 such	professionals	 to	be	 explicit	 about	 adverse	 events	 that	have	occurred	in	their	career	so	they	can	make	an	informed	decision	about	who	performs	 their	 colonoscopy.	 Whether	 this	 would	 come	 in	 the	 form	 of	 a	conversation	during	the	consent	process	or	from	freely	available	data	to	look	at	online	 is	 open	 to	 debate,	 but	 patients	 may	 want	 to	 see	 this	 evidence	 for	themselves	and	expect	that	this	is	part	of	the	BCSP	service.		
8.3	Limitations	of	research	methods	
	The	 retrospective	 observational	 case	 series	 of	 colonoscopic	 perforations	 had	several	 limitations.	 Initially,	 this	 study	 was	 dependent	 on	 the	 details	 of	 the	perforations	 that	 had	 occurred	 in	 the	 BCSP	 being	 entered	 by	 Bowel	 Cancer	Screening	 Centres	 (BCSCs)	 into	 the	Bowel	 Cancer	 Screening	 System.	 The	BCSP	has	a	robust	system	for	capturing	the	details	of	any	adverse	event,	but	there	may	
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have	 been	 some	 perforations	 that	 were	 missed	 by	 BCSCs	 in	 which	 case	 they	would	have	been	missing	from	this	study.	Similarly,	I	did	not	receive	a	response	to	our	online	questionnaire	for	30	of	147	patients	in	this	study.	Reasons	for	this	included	no	response	to	emails,	notes	being	unavailable	to	be	reviewed	and	the	patient’s	admission	occurring	at	a	trust	outside	the	BCSC.	While	I	am	confident,	from	the	findings	reported	in	chapter	4.3.2.3,	that	the	limited	data	I	obtained	for	these	30	patients	from	the	BCSS	did	not	skew	the	findings	in	the	117	patients	in	whom	a	response	had	been	received,	it	is	possible	that	data	from	these	patients	could	have	added	further	weight	to	my	findings.	Collecting	data	retrospectively	from	 contemporaneous	 notes,	 as	 was	 done	 in	 this	 study,	 will	 always	 have	limitations	 in	terms	of	what	data	 is	available	and	how	it	has	been	documented.	While	 some	 of	 the	 data	 in	 this	 study	will	 have	 been	 collected	 from	 endoscopy	reports,	 which	 for	 the	 most	 part	 are	 entered	 in	 a	 standardised	 form	 into	endoscopy	reporting	systems,	most	of	it	will	have	come	from	medical	case	notes.	These	 notes	 are	 made	 in	 a	 free	 text	 format.	 The	 questionnaire	 attempted	 to	account	 for	 this,	 however,	 there	 are	 gaps	 in	 the	 data	 collected	 when	 it	 was	unclear	 from	 the	 notes	 if	 the	 specific	 question	 could	 be	 answered	 definitively	either	way.		Different	health	care	professionals	within	the	BCSP	completed	the	questionnaire.	Although	 the	 questionnaire	was	 designed	 to	 so	 as	 not	 to	 cause	 any	 ambiguity,	some	 of	 the	 questions	 may	 have	 been	 misinterpreted	 by	 those	 completing	 it.	Also,	when	reviewing	data	in	contemporaneous	medical	notes,	such	data	may	be	open	to	misinterpretation	by	those	reviewing	 it.	My	own	experience	of	reading	medical	 case	 notes	 tells	 me	 that	 notes	 are	 kept	 to	 varying	 standards	 and	
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occasionally	 vital	 information	 can	 be	 omitted	 or	 be	 incorrect.	 This,	 again,	may	have	influenced	the	quality	of	data	received	in	this	study.	Human	error	may	too	have	 limited	 the	 data	 received	 from	 the	 questionnaire	 if	 those	 completing	 it	transferred	it	from	case	notes	incorrectly.			There	 were	 also	 limitations	 in	 how	 data	 was	 collected	 for	 the	 retrospective	observational	case	series	of	PPB.	For	the	reasons	specified	above,	there	may	have	been	 cases	 of	 PPB	 that	were	 not	 initially	 reported	 to	 the	 BCSCs.	 Therefore	 no	‘adverse	 event	 alert	 to	 national	 office’	 would	 have	 been	 completed	 and	 they	would	have	been	 excluded	 from	both	bowel	 cancer	 screening	 records	 and	 this	study.	 The	 data	 for	 this	 study	 was	 taken	 from	 these	 forms,	 which	 had	implications	 for	 the	 study	 on	 several	 levels.	 The	 forms	 were	 not	 necessarily	completed	 to	 a	 uniform	 standard	 and	 key	 data	 may	 have	 been	 omitted.	 Also,	some	of	the	variables	for	which	data	would	have	aided	the	study	or	allowed	new	avenues	of	exploration	were	not	necessarily	asked	for	on	the	form	and	therefore	couldn’t	 be	 analysed.	 This	 meant	 that,	 unlike	 the	 questionnaire	 used	 in	 the	perforation	study,	I	could	not	ask	for	specific	data	relating	to	post	polypectomy	bleeds	 but	 had	 to	 use	what	 had	 already	 been	 entered	 onto	 the	 ‘adverse	 event	alert	to	national	office’	form.	The	other	main	limitation	of	this	study	was	that	it	was	a	 regional	 rather	 than	national	 study,	which	 resulted	 in	 fewer	numbers	of	patients	 being	 included	 in	 the	 study.	 The	 explanatory	 variables	 that	 were	explored	 as	 predictors	 of	 need	 for	 endoscopic	 therapy	 and	of	 the	more	 severe	PPB	 subgroups	 may	 therefore	 have	 lacked	 the	 statistical	 power	 required	 to	produce	any	significant	results.		
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The	one	obvious	 and	unfortunate	 constraint	 of	 the	 retrospective	observational	case	 control	 study	 of	 post	 colonoscopy	 colorectal	 cancer	 was	 the	 lack	 of	 data	from	interval	cancers.	The	data	used	in	this	study	related	to	those	PCCRCs	that	had	 been	 diagnosed	 within	 and	 not	 external	 to	 the	 BCSP.	 Therefore,	 those	cancers	that	had	presented	symptomatically	outside	the	BCSP	were	not	included	in	 this	 study.	 Because	 of	 delays	 in	 the	 linkage	 of	 two	 national	 databases,	 the	Bowel	Cancer	Screening	System	and	the	National	Cancer	Data	Repository,	which	was	 needed	 for	 this	 study,	 I	 could	 not	 access	 this	 data	 in	 the	 allotted	 time	 in	which	this	thesis	was	written.	The	actual	rates	of	PCCRC	are,	therefore,	likely	to	be	higher	than	those	reported	in	chapter	7,	however,	 it	 is	 impossible	to	predict	by	how	much	this	would	be.	I	also	had	no	data	specifically	relating	to	outcomes	following	 the	 diagnosis	 of	 a	 PCCRC.	 Being	 able	 to	 assess	 the	 rates	 of	 surgery,	morbidity	and	mortality	would	have	given	a	more	complete	picture	of	the	impact	of	PCCRC.		Despite	 the	data	produced	 from	 the	 interviews	 reported	 in	 chapter	5,	 perhaps	one	 limitation	 that	could	be	 labelled	at	 this	study	 is	 that	eleven	 interviews	 is	a	small	number	of	 interviews.	This	point	 is	more	pertinent	when	considering	the	difference	 in	 reaction	between	 the	 three	 specialties	 of	 colonoscopist	 that	were	interviewed;	 only	 one	 surgeon	 was	 interviewed.	 The	 eleven	 interviews	 is	 a	smaller	 study	 than	 others	 reviewed	 in	 chapter	 2.8.	 However,	 as	 with	 all	qualitative	 interview	 based	 studies,	 it	 is	 the	 point	 at	 which	 data	 saturation	 is	reached	when	recruitment	for	participants	ceases.	After	eleven	interviews	I	had	reached	a	point	of	data	saturation.	It	is	also	important	to	consider	the	context	of	the	 study	 and	 where	 it	 was	 performed.	 Invitations	 to	 take	 part	 were	 only	
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extended	 to	 those	 consultant	 gastroenterologists	 and	 bowel	 cancer	 screening	colonoscopists	within	Health	Education	North	East.	We	have	to	consider	that	not	all	of	these	colonoscopists	would	have	experienced	a	perforation	associated	with	a	colonoscopy	they	performed,	and	those	that	had	may	not	wish	to	discuss	such	an	emotive	experience	with	a	doctor	in	training	from	the	region	with	whom	they	may	have	worked	with	or	will	work	 in	 the	 future.	As	 this	study	recruited	 from	just	one	region	of	England,	the	experiences	and	abilities	of	those	colonoscopists	may	have	been	similar.	Recruiting	participants	nationally	or	internationally	may	have	 resulted	 in	 broader	 range	 of	 experience	 surrounding	 perforation	 though	this	has	to	considered	within	the	time,	travel	and	cost	constraints	this	study	was	performed	under.		
8.4	Reflections	
	I	 feel	 this	 work	 will	 be	 of	 benefit	 to	 all	 colonoscopists	 in	 not	 only	 their	professional	life	but	also	potentially	in	their	personal	life	should	they	encounter	an	adverse	event.	This	is	especially	the	case	for	those	colonoscopists	who	work	within	the	English	National	Health	Service	Bowel	Cancer	Screening	Programme	whose	work	the	quantitative	data	directly	relates	to.	I	also	hope	that,	in	time,	at	least	 one	adverse	 event	 can	be	 avoided	as	 a	 result	 of	 this	work.	 If	 the	 adverse	event	cannot	be	avoided	then	I	hope	that	the	patient	involved	will	have	a	better	outcome	than	would	have	otherwise	been	the	case.	The	work	in	this	thesis	will	then	have	been	worthwhile,	not	only	to	other	colonoscopists,	but	to	the	patients	themselves.			
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From	a	personal	point	of	view	I	feel	this	work	has	aided	my	knowledge,	skills	and	behaviour	 in	 several	 ways.	 	 Writing	 chapter	 2	 of	 this	 thesis	 allowed	 me	 to	develop	my	 ability	 to	 review	 and	 critically	 appraise	medical	 literature.	 I	 have	developed	 a	 much	 greater	 understanding	 of	 both	 quantitative	 and	 qualitative	health	research	methods	and	of	basic	statistics.		I	 now	 have	 a	 much	 greater	 knowledge	 and	 understanding	 of	 screening	programmes	for	colorectal	cancer,	colonoscopy	and	colonoscopic	adverse	events.	Furthermore,	 my	 knowledge	 and	 understanding	 of	 colonoscopic	 perforation,	post	 polypectomy	 bleeding	 and	 post	 colonoscopy	 colorectal	 cancer	 is	 now	 at	such	 a	 level	 that	 I	 feel	 well	 placed	 to	 not	 only	 reduce	 my	 own	 colonoscopic	adverse	event	risk	and	manage	such	patients	in	my	own	practice	but	also	advise	others	of	how	to	do	so.	Distinctively,	this	work	has	led	me	to	have	a	much	deeper	understanding	 of	 what	 a	 colonoscopist	 my	 experience	 following	 an	 adverse	event.	 I	 feel	 uniquely	 placed	 to	 be	 able	 to	 support	 colleagues	who	 experience	such	 events	 and,	 as	 reported	 in	 chapter	 8.2,	 would	 like	 to	 do	 so	 in	my	 future	career.		There	 is	 a	 further	 personal	 element	 to	 this	 work.	 I	 have	 yet	 to	 experience	 a	perforation,	post	polypectomy	bleed	or	post	colonoscopy	colorectal	cancer	in	my	own	colonoscopic	practice.	I	suspect	this	work	will	help	me	for	when,	inevitably,	this	 does	 occur;	 the	 degree	 to	which	 it	 helps	me	will	 be	 interesting	 to	 see	 for	those	around	me.	Coupled	with	this,	I	hope	writing	this	thesis	does	not	make	me	too	conservative	to	be	an	effective	colonoscopist.	I	have	already	felt	a	heightened	anxiety	 when,	 for	 example,	 performing	 polypectomy	 in	 the	 caecum	 or	 when	
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intubating	an	acutely	angled,	 fixed	sigmoid	colon	with	multiple	diverticulae.	As	we	 now	 know	 from	 the	 study	 in	 chapter	 5,	 part	 of	 being	 a	 successful	colonoscopist	 is	 accommodating	 to	 the	 fact	 that	 adverse	 events	 are	 inevitable.	Conversely,	 the	 examination	 of	 adverse	 events	 in	 this	 thesis	 could	 have	 the	opposite	 effect.	 I	 am	 now	 so	 aware	 the	 adverse	 events	 occur	 and	 what	 is	required	should	one	that	it	may,	psychologically	at	least,	seamlessly	become	part	of	my	future	practice.		
8.5	Conclusions	
	This	thesis	has	achieved	all	the	intentions	I	had	wanted	to	achieve	in	writing	it.	We	 can	 now	 be	 confident	 that	 colonoscopy	 is	 performed	 safely	 in	 the	 English	National	 Health	 Service	 Bowel	 Cancer	 Screening	 Programme	 and	 the	compromise	 of	 patient	 safety	 is	 minimal.	 The	 frequency	 with	 which	 adverse	events	 occur	 is	 low	 and	 in	 line	 with	 other	 data	 published	 globally	 when	colonoscopy	 is	 performed	on	 a	 similar	 scale.	Reassuringly,	 this	means	 that	 the	benefit	the	programme	confers	far	outweighs	the	potential	risks.		There	 is	 now	 a	more	 complete	 picture	 of	 the	 impact	 that	 adverse	 events	 have	both	 on	 the	 patients	 involved	 and	 the	 colonoscopists.	 Despite	 the	 low	 rates	 of	adverse	events	found,	we	should	be	mindful	of	the	potential	need	for	in	patient	hospital	 admission,	 surgery,	 morbidity	 and	 mortality	 all	 of	 which	 may	 be	associated	with	 colonoscopic	 adverse	events.	This	data	gives	both	us	 as	health	care	 professionals	 and	 patients	 a	 greater	 insight	 into	 the	 risks	 and	 benefits	 of	screening	for	colorectal	cancer.	It	allows	patients	to	make	a	much	more	informed	
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decision	when	they	are	invited	to	take	part	bowel	cancer	screening.	Likewise,	the	BCSP	can	now	be	much	more	mindful	of	the	effect	an	adverse	event	may	have	on	the	colonoscopist	involved,	what	they	may	require	and	what	should	be	offered	to	them	in	its	aftermath.		From	both	quantitative	and	qualitative	data,	this	work	has	identified	risk	factors	for	 adverse	 events	 and	 risk	 factors	 associated	with	poorer	outcomes	 following	adverse	events.	The	risk	of	these	adverse	events	both	occurring	and	the	poorer	outcomes	associated	with	them	may	therefore	be	minimised.	We	also	now	have	an	 evidence	 base	 for	 improving	 the	 assessment	 and	 management	 of	 these	adverse	events	so	 that	patients	have	the	best	possible	outcomes	 for	when	they	do	occur.			The	 final	 intention	 of	 writing	 this	 thesis	 has	 been	 achieved	 in	 providing	 a	reference	 point	 to	 all	 colonoscopists	 to	 use	 in	 their	 professional	 and	 personal	lives	should	they	encounter	an	adverse	event	in	the	future.		It	 is	 important	 to	 reinforce	 how	 to	 implement	 the	 findings	 of	 this	 work.	 The	mixed	methodology	used	in	this	thesis	has	showed	that	presenting	quantitative	data	will	only	achieve	so	much.	It	is	how	health	care	professionals	communicate	with	patients,	 each	other	and	 take	on	board	human	and	environmental	 factors	that	 will	 result	 in	 us	 minimising	 risk	 and	 improving	 the	 management	 of	colonoscopic	adverse	events.		
8.6	Recommendations	for	future	research	
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	Much	of	 the	 recent	 research	surrounding	colonoscopic	perforation	has	 focused	on	 either	 the	 endoscopic	 methods	 of	 closing	 perforations	 or	 on	 minimally	invasive	surgical	techniques	for	doing	so.	It	is	clear	from	this	thesis	that	avoiding	surgery	 results	 in	 better	 outcomes	 for	 patients.	 Therefore,	 the	 development	 of	techniques	to	close	perforations	without	the	patient	requiring	anything	outside	the	confines	of	 that	procedure	or	 that	endoscopy	room	is	paramount.	 I	suspect	further	studies	in	the	near	future	will	continue	to	develop	the	use	of	endoscopic	suturing	 devices	 and	 ‘over	 the	 scope	 clip’	 devices	 as	 the	 primary	 methods	 of	endoscopic	 repair.	The	prophylactic	use	of	endoscopic	clips	 following	high	risk	therapeutic	procedures,	 for	 example	EMR	of	polyps	>	2cm	 in	 the	 caecum,	may	also	 be	 an	 area	 that	 warrants	 further	 examination	 when	 comparing	 the	outcomes	 of	 similar	 procedures	 that	 don’t	 use	 endoclips	 prophylactically.	Prospective	 data	 relating	 to	 indicators	 for	 non	 surgical	 management	 of	perforations	would	 add	weight	 to	 the	 findings	 in	 this	 thesis,	 particularly	 with	regards	 to	 the	 presence	 of	 abdominal	 pain,	 the	 patient’s	 respiratory	 rate	 and	pulse	rate.		The	prophylactic	placement	of	endoclips	for	minimising	risk	of	Post	PPB	is	also	an	 area	 for	 future	 research,	 again	 this	would	 be	when	 comparing	 their	 use	 in	high	risk	therapeutic	procedures	against	procedures	where	no	endoclips	are	left	in	situ.	An	area	identified	for	further	research	from	the	study	in	chapter	7	is	how	to	 predict	 those	 patients	 with	 post	 polypectomy	 bleeding	 that	 will	 require	therapeutic	 intervention	 following	 representation	 with	 bleeding.	 The	 two	variables	that	were	explored	as	predictors	of	this	in	my	study	did	not	show	any	
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statistical	 association.	 A	 larger	 case	 series	 may	 help	 reach	 greater	 statistical	power,	 but	 data	 on	 other	 variables	 such	 as	 pulse	 and	 blood	 pressure	 at	presentation	or	 the	volume	of	blood	 that	was	 lost	per	 rectum	may	provide	 the	answer.		
	Post	 colonoscopy	 colorectal	 cancer	 is	 currently	 a	 topical	 area	 of	 colonoscopy	research	 as	 an	 indicator	 of	 colonoscopy	 quality	 assurance.	 I	 hope	 soon	 to	 add	data	from	interval	cancers	to	the	data	that	is	presented	in	chapter	7	so	as	to	give	a	 complete	 figure	 for	 PCCRC	 rates	 in	 the	 BCSP.	 While	 we	 are	 aware	 of	 five	mechanisms	 that	 contribute	 to	 PCCRC	 development,	 it	 is	 exploring	 the	differences	between	PCCRC	and	non-PCCRC	cancer	that	is	likely	to	be	the	major	force	 contributing	 to	 future	 research	 surrounding	 it.	 While	 risk	 factors	 for	missing	 cancers	 and	pre	malignant	 adenomas	 at	 initial	 colonoscopy	have	been	identified,	it	is	the	factors	such	as	the	biology	of	PCCRCs,	that	may	contribute	to	the	development	 of	 rapidly	 growing	or	de	novo	 colorectal	 cancers	 that	will	 be	the	focus	in	the	prevention	of	these	cancers	in	the	future.		
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Chapter	10	
Appendix		
	
Appendix	1	–	Questionnaire	for	study	of	perforations	
		1.	What	is	the	patient’s	unique	subject	identifier?	:	 		__	__	__	__	__	__	__	__		
	
Medication		2.	Was	the	patient	taking	an	anti	coagulant	or	anti	platelet	at	the	time	of	the	colonoscopy	that	resulted	in	the	perforation?		Yes	☐	No	☐	Unknown	☐ 
 3.	If	yes,	please	specify	the	name(s)	and	dose(s):______________________________________		4.	Was	the	patient	taking	steroids	at	the	time	of	the	colonoscopy	that	resulted	in	the	perforation?		Yes	☐	No	☐	Unknown	☐ 
 5.	If	yes,	please	specify	the	name(s)	and	dose(s):______________________________________		
Colonoscopy	Report		6.	Where	in	the	colon	was	the	perforation?	 	 	 	 		Caecum	☐	Ascending	Colon	☐	Splenic	flexure	☐	Transverse	Colon	☐	Hepatic	flexure	☐	Descending	Colon	☐	Sigmoid	Colon	☐	Rectum	☐ Unknown	☐			If	unknown,	proceed	to	question	16		7.	At	the	location	specified	in	question	6,	did	therapy	to	a	polyp	cause	the	perforation?			Yes	☐	
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No	☐	Unknown	☐		If	no	or	unknown,	proceed	to	question	12	8.	What	was	the	polyp	class?		Sessile	☐	Pedunculated	☐ Semi	Pedunculated	☐	Flat	☐	Flat	-	completely	flat	(IIb)	☐	Flat	–	slightly	elevated	(IIa)	☐	Flat	–	Laterally	Spreading	Type	Granualr	(LST-G)	☐	Other	(specify):	Unknown	☐		9.	What	was	the	estimated	endoscopic	size	of	the	polyp?		__	__	millimetres		10.	What	therapy	was	applied	to	the	polyp?		Biopsy	☐	Polypectomy	☐	Endoscopic	Mucosal	Resection	(EMR)	☐	Endoscopic	Submucosal	Dissection	(ESD)	☐	Submucosal	Lift	☐ Tattooing	☐	Tissue	Destruction	☐	Haemostatic	technique	☐	Other	(specify):	Unknown	☐		11.	What	was	the	polyp	therapy	device?		Cold	Biopsy	☐	Cold	Snare	☐	Hot	Biopsy	☐	Hot	Snare	☐	Injection	☐	Argon	Beam	☐	Laser	☐	Endoscopic	Knife	☐	Other	(specify):	Unknown	☐		12.	At	the	colorectal	location	specified	in	question	6,	was	there	any	pathology	other	than	polyps?		
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Yes	☐	No	☐ Unknown	☐		13.	If	yes,	please	specify	the	pathology:________________________________________________		14.	At	the	colorectal	location	specified	in	question	6,	did	any	therapy	take	place	other	than	that	to	polyps?		Yes	☐	No	☐	Unknown	☐		15.	If	yes,	please	specify	the	therapy:___________________________________________________		16.	Did	the	endoscopist	recognise	there	was	a	perforation	during	this	colonoscopy?		Yes	☐ No	☐	Unknown	☐		If	no	or	unknown,	proceed	to	question	22		17.	How	did	the	endoscopist	recognise	there	was	a	perforation	during	this	colonoscopy?		Visualisation	of	extra	intestinal	structure	☐	Visualisation	of	tear	in	serosa	☐	Unknown	☐	Other	(specify):___________________________________________________________________________		18.	Was	the	perforation	recognised	at	the	site	specified	in	question	6?		Yes	☐ No	☐		19.	What	was	the	size	of	the	perforation?		__	__	millimetres		Unknown	☐		20.	Was	an	attempt	to	close	the	perforation	with	an	endoclip	made	during	this	colonoscopy?			Yes	☐ No	☐		
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21.	How	many	endoclips	were	used?	 __	__	
	22.	Was	a	CT	scan	performed	immediately	following	the	completion	of	the	colonoscopy?	Yes	☐	No	☐	Unknown	☐		If	no	or	unknown,	proceed	to	question	26		23.	Why	was	the	CT	scan	requested?		Patient	had	abdominal	pain	☐	Patient	had	back	pain	☐	Patient	had	abdominal	distension	☐	Patient	had	abnormal	observations	☐	Endoscopist	visualised	extra	intestinal	structure	☐	Endoscopist	visualised	tear	in	the	serosa	☐	Endoscopist	clinically	suspected	a	perforation	☐	Staging	CT	scan	☐	Unknown	☐	Other	(specify):		24.	Did	the	CT	scan	show	evidence	of	a	perforation?		Yes	☐ No	☐	Unknown	☐ 
 25.	If	yes,	please	specify	the	result:_____________________________________________________	_____________________________________________________________________________________________	______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________		26.	Was	the	patient	discharged	or	admitted	to	hospital	following	completion	of	the	colonoscopy?		Discharged	☐		If	discharged,	please	proceed	to	question	27		Admitted	☐	
	If	admitted,	please	proceed	to	question	29	
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Presentation	following	readmission	to	hospital		 	 	 	 	27.	On	what	date	did	the	patient	present	with	symptoms	from	the	perforation?		Date	(dd/mm/yyyy):		__	__	/__	__	/__	__	__	__				28.	At	what	time	did	the	patient	present	with	symptoms	from	the	perforation?		Time	(hh:mm):		 __	__	:	__	__		
Presenting	symptoms	and	initial	observations		29.	What	was	the	presenting	symptom(s)?		Abdominal	Pain	☐	Back	Pain	☐ Abdominal	Distension	☐	 Unknown	☐	Other	(specify):		30.	What	was	the	patient’s	first	recorded	temperature	following	admission?		__	__°C		31.	What	was	the	patient’s	first	recorded	pulse	rate	following	admission?		 	__	__	__	beats	per	minute		32.	What	was	the	patient’s	first	recorded	blood	pressure		following	admission?		__	__	__	/__	__	__	mmHg	
	33.	What	was	the	patient’s	first	recorded	respiratory	rate	following	admission?	 	__	__	per	minute	
	
Initial	Management		 	 	 	 	 	 	 	34.	Was	the	patient	kept	Nil	By	Mouth?		Yes	☐  No	☐ 	Unknown	☐ 	If	no	or	unknown,	proceed	to	question	37		35.	On	what	date	was	the	Nil	By	Mouth	started?		Date	(dd/mm/yyyy):	 __	__	/__	__	/__	__	__	__		
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	36.	At	what	time	was	Nil	By	Mouth	started?		Time	(hh:mm):	 	 __	__	:	__	__	37.	Was	the	patient	given	intravenous	fluids?		Yes	☐       No	☐	Unknown	☐		If	no	or	unknown,	proceed	to	40		38.	On	what	date	were	intravenous	fluids	started?		Date	(dd/mm/yyyy):	 __	__	/__	__	/__	__	__	__			39.	At	what	time	were	intravenous	fluids	started?		Time	(hh:mm):	 	 __	__	:	__	__	 									40.	Was	the	patient	given	antibiotics?		Yes	☐    No	☐                  	Unknown	☐ 
 If	no	or	unknown,	proceed	to	question	43		41.	On	what	date	were	the	antibiotics	started?		Date	(dd/mm/yyyy):	 __	__	/__	__	/__	__	__	__			42.	At	what	time	were	the	antibiotics	started?		Time	(hh:mm):	 	 __	__	:	__	__																		
	
Initial	Investigations	
	 	 	 	 	 	 	 	43.	Did	the	patient	have	an	erect	chest	x-ray?		Yes	☐ No	☐	Unknown	☐		If	no	or	unknown,	proceed	to	question	48		44.	On	what	date	was	the	chest	x-ray	performed	?	(dd/mm/yyyy)																		__	__	/__	__	/__	__	__	__		
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	45.	What	was	the	Chest	X-Ray	result?		Normal	☐	Air	under	the	diaphragm	☐	Unknown	☐	Other	☐			If	other,	specify	the	result:		 ____________________________________________________________		46.	Was	any	clinical	action	taken	as	a	result	of	the	chest	x-ray?		Yes	☐	No	☐ Unknown	☐			If	no	or	unknown,	proceed	to	question	48		47.	What	was	the	clinical	action?		Specify	the	clinical	action:	______________________________________________________________	_____________________________________________________________________________________________		48.	Did	the	patient	have	an	abdominal	x-ray?		Yes	☐ No	☐	Unknown	☐		If	no	or	unknown,	proceed	to	53		49.	On	what	date	was	the	abdominal	x-ray	performed?	(dd/mm/yyyy)																	__	__	/__	__	/__	__	__	__				50.	What	was	the	abdominal	x-ray	result?		Normal	☐	Free	air	in	the	abdomen	☐	Unknown	☐	Other	☐			If	other,	specify	the	result:	______________________________________________________________		51.	Was	any	clinical	action	taken	as	a	result	of	the	abdominal	x-ray?		Yes	☐	No	☐ Unknown	☐		
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	If	no	or	unknown,	proceed	to	question	53		52.	What	was	the	clinical	action?		Specify	the	clinical	action:	______________________________________________________________	_____________________________________________________________________________________________		53.	Did	the	patient	have	a	CT	scan	following	admission	to	hospital	but	not	immediately	following	completion	of	the	colonoscopy?		Yes	☐ No	☐	Unknown	☐		If	no	or	unknown	proceed	to	question	58		54.	On	what	date	was	the	CT	scan	performed	?	(dd/mm/yyyy)		 		__	__	/__	__	/__	__	__	__			55.	What	was	the	CT	scan	result?		Specify	the	result:	________________________________________________________________________	___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________		56.	Was	any	clinical	action	taken	as	a	result	of	the	CT	scan?		Yes	☐	No	☐ Unknown	☐			If	no	or	unknown,	proceed	to	question	58		57.	What	was	the	clinical	action?		Specify	the	clinical	action:_______________________________________________________________	_____________________________________________________________________________________________	
	58.	Did	the	patient	have	surgery?		Yes	☐		
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If	yes,	proceed	to	question	59		No	☐ 	If	no,	proceed	to	question	69	
	
Surgery		59.	On	what	date	was	the	operation	performed?		Operation	date	(dd/mm/yyyy):		 __	__	/__	__	/__	__	__	__				60.	At	what	time	did	the	operation	start?		Operation	time	(hh:mm):	 	 __	__	:	__	__	 												61.	Was	the	operation	completed		in	normal	working	hours?	(Monday	–	Friday,	08:00–17:00)		Yes	☐	No	☐	Unknown	☐		62.	What	was	the	primary	surgeon	grade?			Consultant	Surgeon	☐	Surgical	Registrar	☐	Surgical	Staff	Grade	☐	Other	Surgical	trainee	☐ 	Unknown	☐		63.	What	was	the	primary	surgeon	specialty?	 		Colorectal	surgeon	☐	Non	colorectal	surgeon	☐	Unknown	☐    		64.	Was	the	operation	a	laparoscopy	or	an	open	laparotomy?	 	 		Laparoscopy		☐	 	Open	Laparotomy	☐	 	Laparoscopy	converted	to	open	laparotomy	☐ Unknown	☐ 	65.	What	operation	was	performed?	 	 		Simple	closure	of	perforation	☐	Colonic	resection	with	anastomosis	☐		
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66.	Did	the	operation	result	in	a	stoma?		Yes	☐	No	☐	Unknown	☐ 	67.		What	was	the	name	of	the	operation?		Specify	operation	name:_________________________________________________________________	Unknown	☐		68.	Were	there	any	postoperative	complications?		Yes	☐       No	☐	Unknown	☐		If	no	or	unknown,	proceed	to	question	70		69.	If	yes,	what	were	the	postoperative	complications	and	when	did	they	occur?		Complication	(1):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 	__	__	/__	__	/__	__	__	__			Complication	(2):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 __	__	/__	__	/__	__	__	__			Complication	(3):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 	__	__	/__	__	/__	__	__	__			Complication	(4):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 	__	__	/__	__	/__	__	__	__			Complication	(5):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 __	__	/__	__	/__	__	__	__			
Outcomes	
	70.	Was	the	patient	admitted	to	the	Intensive	Care	Unit/High	Dependency	Unit?			Yes	☐ No	☐		
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71.	If	yes	to	question	70,	how	many	nights	were	spent	on	HDU/ITU?	__	__	__	nights		72.	On	what	date	was	the	patient	admitted	to	a	general	ward?	(dd/mm/yyyy):		__	__	/__	__	/__	__	__	__			73.	Did	the	patient	develop	any	new	diagnoses	during	their	inpatient	stay?		Yes	☐       No	☐	Unknown	☐		If	no	or	unknown,	proceed	to	75		74.	If	yes,	what	were	the	new	diagnoses	and	when	did	they	occur?		New	diagnosis	(1):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 	__	__	/__	__	/__	__	__	__			New	diagnosis	(2):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 __	__	/__	__	/__	__	__	__			New	diagnosis	(3):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 	__	__	/__	__	/__	__	__	__			New	diagnosis	(4):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 	__	__	/__	__	/__	__	__	__			New	diagnosis	(5):	 	 ____________________________________________________________		Date	(dd/mm/yyyy):	 __	__	/__	__	/__	__	__	__			75.	Did	the	patient	die	during	this	in	patient	admission?		Yes	☐  No	☐	
      76.	If	yes	to	question	75,	on	what	date	was	the	death	confirmed?	(dd/mm/yyyy):	 	 	__	__	/__	__	/__	__	__	__		77.	If	yes	to	question	75,	what	was	the	cause	of	death	on	the	patient’s	death	certificate?		
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1a	____________________________________	1b	____________________________________	1c	____________________________________		11____________________________________		78.	If	no	to	question	75	,	on	what	date	was	the	patient	discharged	from	hospital?			(dd/mm/yyyy):				__	__	/__	__	/__	__	__	__			
Free	Text/Route	Cause	Analysis	
	79.	Please	enter	any	other	details	that	you	feel	may	be	relevant	to	this	case.					80.	If	a	Route	Cause	Analysis	took	place	for	this	case,	please	attach	an	anoymised	copy.	
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Appendix	2	–	Letter	sent	to	BCSP	screening	centres	for	study	of	
perforations	
			 	June	2014		
Colonic	perforations	in	the	BCSP	
	Dear	Bowel	Cancer	Screening	Centre	Director,		The	Bowel	Cancer	Screening	Evaluation	Group	is	reviewing	all	BCSP-related	colonic	perforations,	capturing	 details	 of	 the	 potential	 cause,	 presentation,	 management	 and	 outcome.	 This	 is	important	so	that	we	can	fully	understand	the	implications	and	outcomes	of	this	complication.			Where	possible,	we	have	captured	data	directly	 from	BCSS.	However,	additional	 information	 is	required	and	we	are	asking	each	centre	to	provide	this	on	a	pseudo-anonymised	online	form.	We	estimate	that	it	will	take	approximately	30	minutes	to	complete	the	form	for	each	perforation	–	this	will	require	patient	case	notes	and	clinical	experience	in	case	note	review	–	you	might	find	it	preferable	to	identify	a	specialist	registrar	to	do	this	in	conjunction	with	a	member	of	the	BCSP	team.		In	order	to	complete	the	form,	please	follow	the	steps	described	below:		1. We	 need	 to	 send	 you	 patient-identifiable	 information	 listing	 each	 perforation	 from	 your	centre.	We	can	only	do	this	 to	&	 from	an	nhs.net	email	address.	If	 you	have	not	 received	
this	email	 to	an	nhs.net	email	 address,	please	 reply	directly	 to	 this	email	within	 the	
next	2	weeks	with	an	nhs.net	email	address	that	we	can	use.			2. You	 will	 then	 receive	 an	 email	 to	 your	 nhs.net	 email	 account	 from	 the	 email	 address	edmundderbyshire@nhs.net	listing	the	NHS	number(s)	of	the	perforation	case(s)	from	your	centre.	Next	to	each	NHS	number	you	will	see	a	unique	‘subject	identifier’.	This	is	required	to	complete	the	form.		3. You	 will	 then	 receive	 an	 email	 to	 your	 nhs.net	 email	 account	 from	 the	 email	 address	edmundderbyshire@nhs.net	containing	a	link	to	the	online	form.	The	form	will	remain	open	for	4	weeks	after	you	receive	this	email.	Therefore,	we	recommend	requesting	the	case	notes	as	soon	as	you	receive	the	details.		We	 are	 particularly	 interested	 in	 those	 subjects	 with	 a	 sub	 clinical	 CT	 detected	 colonic	perforation.	 This	 relates	 to	 patients	 in	 whom	 incidental	 radiological	 evidence	 of	 a	 colonic	perforation	was	found.	Questions	22	-25	in	the	form	specifically	relate	to	these	patients.		We	do	appreciate	 that	 this	creates	additional	work	 for	your	 team.	Wherever	possible	 the	BCSP	Evaluation	Group	tries	to	avoid	this,	but	in	this	case	BCSS	doesn’t	capture	the	level	of	detail	that	we	require.		Many	thanks	in	anticipation.		Yours	Sincerely,				Professor	Matt	Rutter	BCSP	Evaluation	Group	Chair			 	 																																																																														 Professor	Julietta	Patnick	Director,	 NHS Cancer Screening	 Programme
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Appendix	3	–	Invitation	letter	for	‘Colonoscopists	narratives	of	a	
colonoscopy	associated	with	a	colorectal	perforation’			
	 			Dear	Northern	Deanery	Colleague,		
Re:	Colonoscopists	narratives	of	a	colonoscopy	associated	with	a	colorectal	
perforation		This	is	an	open	invitation	to	all	fully	accredited	colonoscopists	working	in	the	Northern	Deanery.		I	am	a	research	and	endoscopy	fellow	in	the	School	of	Medicine,	Pharmacy	&	Health,	Durham	University	and	at	North	Tees	&	Hartlepool	NHS	Foundation	Trust	being	supervised	by	Matt	Rutter	and	Pali	Hungin.		As	part	of	my	work	on	colonoscopic	adverse	events,	we	would	like	to	invite	you	to	take	part	in	a	brief	interview	study	surrounding	colonoscopic	perforaton.		The	study	aims	to	explore	how	colonoscopists	react	to	performing	a	colonoscopy	associated	with	a	colorectal	perforation	and	to	identify	human	&	environmental	factors	that	may	be	associated	with	colonoscopic	perforation.		If	you	have	performed	a	colonoscopy	that	resulted	in	a	colorectal	perforation	and	would	be	willing	to	discuss	your	experiences	around	the	case	during	a	brief,	anonymised,	voice	recorded,	face-to-face	interview	with	myself,	please	reply	directly	to	the	email	address	edmundderbyshire@nhs.net	so	that	I	can	provide	you	with	some	more	detailed	information	about	the	study.		The	study	has	had	full	ethical	approval	by	the	Durham	University	School	of	Medicine,	Pharmacy	&	Health	Ethics	Committee.		Please	pass	this	invitation	on	to	any	colleagues	you	feel	may	also	be	interested.		Many	Thanks,		Edmund	Derbyshire	Research	Postgraduate	in	the	School	of	Medicine,	Pharmacy	&	Health	Durham	University	Endoscopy	Fellow	North	Tees	&	Hartlepool	NHS	Foundation	Trust	
	 245	
Appendix	4	–	Interview	Guide	for	‘Colonoscopists	Narratives	of	a	
colonoscopy	associated	with	a	perforation’	
	
	
Participant	Demographics	
	1.	Age	2.	Sex	3.	Specialty	of	Endoscopist:		Gastroenterologist	Physician	(specialty	other	than	gastroenterology)	Surgeon	Nurse	Endoscopist	GP	Endoscopist		
Colonoscopy	Experience	 	4.	Years	of	experience	in	colonoscopy	5.	Approximate	number	of	colonoscopies	performed	to	date	6.	Approximate	number	of	colonoscopies	performed	before	perforation	7.	How	confident	were	you	were	to	perform	this	procedure/polypectomy?	8.	How	confident	were	you	in	your	training	to	perform	this	procedure/polypectomy?		
Event	Details	
	9.	When	was	the	perforation	case?	10.	Was	there	anything	unusual	about	the	day	of	the	case?		11.	Did	you	feel	different	to	normal	on	the	day	of	the	case?	12.	Were	there	any	unusual	circumstances	surrounding	the	case	on	that	day?		13.	Would	you	tell	me	about	the	case	that	resulted	in	the	perforation?	14.	What	specifically	caused	the	perforation?		
Immediate	Reaction		15.	How	did	you	feel	after	you	realised	there	was	a	perforation?	How	did	you	react	to	the	perforation?	16.	Did	your	feelings	change?	17.	What	happened	to	the	patient?	18.	How	did	you	feel	about	what	happened	to	the	patient?		
Professional	and	Personal	Reaction			18.	How	did	you	react	personally?	19.	Did	you	receive	personal	support?	20.	What	personal	support	would	you	recommend	for	others	in	this	situation?		21.	How	did	you	react	professionally?	22.	Did	you	receive	professional	support?	
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23.	What	professional	support	would	you	recommend	for	others	in	this	situation?	
	
Subsequent	Practice	
	24.	Has	the	perforation	case	changed	your	subsequent	practice?	25.	Has	your	endoscopic	technique	changed	as	a	result	of	this	perforation?	26.	Would	you	approach	the	same	clinical	scenario	differently	now?						 	
		
